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Summary
Epidemiological evidence suggests that individuals of blood
group B are more susceptible to infection by Neisseria gonorrhoeae
than individuals of other blood groups. This report tests the
hypothesis that this susceptibility might be due to a comparative
deficiency in 'natural' bactericidal antibodies reactive with the
gonococcus in individuals of blood group B. Titration of sera of
blood groups A and B for 'natural' bactericidal antibodies reactive
with a panel of gonococcal strains showed that differences in the
titres obtained depended on the gonococcal strain used in the tests
rather than the blood group of the serum. The hypothesis was found
to be true only with certain strains. Some strains were found to
be resistant to all the sera with which they were tested.
A correlation between serum-resistance and resistance to rod-type
(R-type) pyocins of Kageyama's class R1 is described. Strains of
N. gonorrhoeae were classified into two groups on the basis of pyocin
sensitivity; Group I strains were resistant to R1 pyocins and Group
II strains were sensitive to R1 pyocins. Both groups were sensitive
to pyocins of Kageyama's class R5. Group II strains were generally
found to be killed by normal human serum, whereas all Group I strains
were serum-resistant.
Since pyocins and 'natural' bactericidal antibodies react with
the lipopolysaccharide (LPS) molecule of the gonococcus, it was
proposed that physical, chemical and antigenic differences would exist
between the LPS molecules of Group I and Group II strains. Examin¬
ation of the LPS isolated from strain P280 (Group II) and its serum-
resistant, R1 pyocin-resistant, isogenic mutant, P280/J (Group I) ,
confirmed this proposal.
The hypothesis proposing that induction of phenotypic serum-
resistance in N. gonorrhoeae is associated with the loss of sensi¬
tivity to R1 pyocins was tested. When treated with the inducing
factor, N. gonorrhoeae strain BS4 (agar) lost sensitivity to class
R1 pyocins. This result was in agreement with the hypothesis.
Cross reactions between Group I and Group II strains were
demonstrated using bactericidal immune mouse sera. It was pro¬
posed that similar cross-reacting bactericidal antibodies reactive
with Group I gonococcal strains would be formed during human
infection. An examination of the sera of 22 patients with
gonorrhoea failed to support this proposal.
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Non-serogroupable strains of N. meningitidis have also been
shown to express the same pyocin sensitivity patterns as gonococcal
strains of Groups I and II. The hypothesis that a similar relation
between serum-sensitivity and pyocin-type exhibited by gonococci was
shown in non-serogroupable meningococci was examined. The experi¬
ments refuted this proposal.
In a short appendix to this report, a system to determine the
oxidative metabolism of glass-adherent mononuclear phagocytes
stimulated by N. gonorrhoeae is described. When stimulated by
N. gonorrhoeae, the responses of monocytes taken from four individuals,
one from each ABO blood group were heterogeneous. A tentative
speculation that the poor response observed with monocytes of blood
group B might be a factor associated with the observed increase in




Individuals of blood group B have been shown to be more
susceptible to infection by Neisseria gonorrhoeae than those of other
ABO blood groups. Isohaemagglutinins have been shown to opsonise and
kill bacteria possessing antigens with ABO blood group specificity.
The principal gonococcal antigen reactive with 'natural' bactericidal
antibodies, the lipopolysaccharide (LPS) molecule contains terminal
galactose residues. Galactose is the immunodominant sugar of B blood
group substance. This report examined the hypothesis that the
increased susceptibility of blood group B individuals was associated
with a lower bactericidal capacity of B serum against N. gonorrhoeae
due to the absence of anti-3 isohaemagglutinins which are present in
sera of blood groups A and 0. A comparison of the bactericidal
activity of 16 group A sera and 16 group B sera against 14 strains of
N. gonorrhoeae isolated from localised infection and 2 strains isolated
from disseminated infection was made. These strains were distributed
into two groups, Group I and Group II, on the basis of LPS type, as
determined by sensitivity to a panel of rod-type pyocins isolated from
strains of Pseudomonas aeruginosa. Group A sera gave higher titres
than Group B sera against 2/4 serum-sensitive strains (P< 0.005).
Absorption of isohaemagglutinins did not reduce the titra of bacteri¬
cidal antibody. It was removed, however, by absorption with other
Neisserias 3pecies. Serum sensitivity was related to pyocin type for
the strains isolated from localised infections: Group I strains were
serum-resistant; Group II strains were seruin-sensitive. The strains
isolated from disseminated infection were serum—resistant, irrespective
of pyocin type. The LPS of a serum-sensitive strain, P2B0 (Group II), and
an isogenic serum-resistant mutant, (Group I) were compared by
physical, chemical and biological criteria and were found to differ in
all three respects. Induction of N, gonorrhoeae strain BS4 (agar) to
phenotypic serum resistance by incubation with an ultrafiltrate from
guinea pig serum was found to be associated with changes in the pyocin
type which suggests that alterations occur within the structure of
LPS molecule during this treatment.
Cross-reactivity of N. gonorrhoeae strains of Group I and
Group II was determined in a bactericidal test using immune mouse
serum. It was proposed that bactericidal antibody reactive with Group *
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strains of gonococci would form during infection. An examination of
sera from 22 patients (mainly female) with gonorrhoea did not detect
bactericidal antibodies against Group I strains in 19/22 sera.
The susceptibility of strains of N. meningitidis to
bactericidal antibodies in serum from normal individuals and patients
with gonorrhoea was compared with that observed with strains of
N. gonorrhoeae. In contrast to the results obtained with N. gonorrhoeas,
pyocin type did not influence susceptibility of the non-serogroupable
strains to serum. No significant differences in titre was observed
between group A and group B sera. Whereas normal sera demonstrated
moderate titres of bactericidal antibody against a strain of serogroup
A (geometric mean titres - group A serum, 10.5; group B serum 24.7)
small or undetectable amounts of bactericidal antibody against strains
of serogroups A, B and C (geometric mean titres, 3.4; 2.6 and 4.0
respectively) were observed in 18 sera from patients with gonorrhoea.
The possibility that this absenca of bactericidal activity might
predispose patients with gonorrhoea to meningococcal disease is discussed.
A short appendix to this report is the development of a
system to determine the oxidative metabolic response of glass-adherent
human peripheral blood monocytes to stimulation with N. gonorrhoeae.
The test used nitroblue tetrazolium (NBT) reduction as qualitative and
semi-quantitative measure of superoxide generation by individual
monocytes. A comparison of the response of monocytes from donors of
blood groups A, B, AB and 0 to two strains of N. gonorrhoeae suggests
that there was variation in the degree of response which was dependent
on the presence of both reactive antibody and complement. The intensity
of response was less for monocytes of blood group 8 than for monocytes
of blood groups A, AB and 0.
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GENERAL INTRODUCTION
The major infectious diseases that once threatened mankind
have been controlled by preventive practices such as improvements
in sanitation, development of immunisation programmes and the usb
of antibiotic therapy and prophylaxis. There are still, however,
infectious diseases that continue to evade concerted efforts to
control them; two of these infections are meningococcal disease and
gonorrhoea.
Both of these infections are caused by members of the genus
Neisseria. In spite of the development of antibiotics and some
vaccines, disease due to Neisseria meningitidis is still a world¬
wide medical problem, particularly of the developing countries in
Africa and South America. Medical advances have also been slow to
halt the spread of gonorrhoea, a disease caused by Neisseria gon¬
orrhoeae.
Gonococcal conjunctivitis in the newborn (opthalmia neonatorum),
once a major cause of blindness, has been greatly reduced due to
the use of silver nitrate eye drops. (Rein, 1977). In contrast to
neonatal infections, gonorrhoea, especially in young adults, is one
of the most common notifiable infectious diseases in the United
Kingdom, and is a major burden on the financial resources of many
nations. In 1979 the cost of medical care for the
women in America who developed salpingitis as a consequence
of gonorrhoea was 1.25 billion dollars. (May, 1981).
Individuals are not equally susceptible to infectious diseases.
An examination of the mechanisms underlying the differential suscept¬
ibility within a population may lead to a fuller understanding of the
complex interactions between host and parasite. This information,
though not essential for the development of effective vaccines, is
a necessary basis for the scientific development of gonococcal
vaccines.
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This report examines the interaction between 'natural'
bactericidal antibodies, present in the serum of normal individuals,
and organisms of the pathogenic Neisseria species, N. gonorrhoeae
and N.meningitidis. In the subsequent introductory chapter I will
briefly outline the nature and occurrence of diseases due to these
micro organisms, and then discuss at greater length the role of their
surface components in the pathogenesis of the disease states that they
cause and the interaction of the immune systems of normal individuals
and patients with gonorrhoea with these organisms. The two species,
N. gonorrhoeae and N. meningitidis, are compared with regard to these
points, but throughout, the main emphasis is on the gonococcus.
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1.1 A Brief Description of the Diseases
Infections with Neisseria gonorrhoeae and Neisseria meningitidis
are limited to humans; there is no other natural host. When restricted
to the mucosa, the infection may be asymptomatic, or, as in the case
of gonorrhoea, result in distressing, but not life threatening,
symptoms. Bacteraemic spread from the submucosal tissues is
associated with much more serious conditions which can rapidly lead
to death of the host.
1.1.1 Gonorrhoea
Gonorrhoea results from infection with N^qonorrhoeae. This
disease is mainly transmitted by sexual intercourse and, consequently,
is principally an infection of the genito-urinary tract. Infections
of the oral and rectal mucosa are also frequently observed. Generally,
the organism is restricted to the mucosa at the site of infection,
but it may spread to adjacent tissues. In a small percentage of
cases bacteraemia results in disseminated gonococcal infection (DGI);
which may involve infection of the skin, joints and major organs of
the body.
1.1.2 Clinical features of uncomplicated gonococcal infection
1.1.2.1 Genital Infection
The majority of men (approx. 85%) with genital gonorrhoea
develop a purulent urethral discharge. This contrasts with infection
in females, where about 70% of infections are asymptomatic. Female
genito-urinary infection occurs predominantly in the cervical (85-90%)
and urethral (65-75%) mucosa (Robertson, McMillan and Young, 1980).
In both sexes the infection may spread from the mucosa of the
genito-urinary tract leading to abscess formation in the peri- and
para-urethral glands. Infection of the prostate, seminal vesicles
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and epididymis can occur as a local complication of infection in
the male. Similarly,infection in the female, especially when
untreated, can result in ascending spread of the infection to include
the uterus and fallopian tubes (salpingitis). This results in a
condition termed pelvic inflammatory disease (PID) and is found in
approximately 10 per cent of women with untreated gonococcal infection.
1.1.2.2 Oropharyngeal Infection
Infection of the pharynx results from oro-genital sex.
It is only associated with symptoms in about one fifth of cases.
ThB main clinical feature is a sore throat, perhaps with referred
pain in the ear (Robertson, McMillan and Young, 1980).
1.1.2.3 Ano-rsctal Infection
Ano-rsctal infection with N.gonorrhoeae is generally
asymptomatic. In symptomatic cases (about 30%) anal pruritus and a
purulent discharge are common features. Histological examination
shows epithelial degeneration and sub-Bpithelial infiltration with
granulocytes in only a small proportion (3/57) of cases (McMillan,
et al. 1983).
1.1.2.4 Gonococcal conjunctivitis
Gonococcal conjunctivitis is a purulent infection which,
if left untreated may result in the whole eye becoming infected.
This may lead to blindness. Although gonococcal conjunctivitis of
the newborn (opthalmia neonatorum) was once the largest single
cause of blindness, accounting for one third of all cases entaring
schools for the blind, no cases of blindness have occurred in the
United Kingdom due to this infection since 1955. (Robertson,
McMillan and Young, 1980).
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1.1 .3 Disseminated gonococcal infection (DGl)
Haematoganous spread of IM. gonorrhoeae from the primary
site of infection is a rare event. It is found in less than one per
cent of cases of gonococcal infection, and occurs most frequently
in ujomen and homosexual men in whom the primary infection was either
asymptomatic or untreated. Patients with DGI usually have the
following symptoms; fever, rash, and painful joints. In this form
of the disease the organism can usually be isolated from the blood,
but hot from the synovial fluid of affected joints. In another form,
which may be consecutive to the former one,the arthralgia is localised
to one joint. Examination of the synovial fluid shows a purulent
infiltrate of neutrophils. N.gonorrhoeae can be isolated from the
synovial fluid in this presentation.
Skin lesions may be associated with DGI. Two forms have
been described; haemorrhagic lesions and vesiculo-papular lesions.
Histological examination of these lesions has demonstrated infiltration
of granulocytes and mononuclear cells. Gonococcal antigens may be
detected using immunofluorescent techniques. (Robertson, McMillan
and Young, 1980) and circulating immune complexes have been detected
in a patient with gonococcal bacteraemia (Danielsson, Norberg and
Svanbom, 1975).




Infection of the oropharyngeal mucosa with N.meningitidis
usually results in an asymptomatic carrier state. Meningococcal
disease, which results from bacteraemic spread of the organisms from
the mucosa, is a rare event. A peak incidence of about 38 cases
per(00,000 individuals has been recorded during a severe epidemic
(Oe Voe, 1982). Herrick (1919) described three stages of invasion
by N.meningitidis :
1. A meningococcal bacteraemic phase resulting from
penetration of the oropharyngeal mucosa;
2. Involvement of the skin, eyes, joints, heart, adrenals
and meninges. 90% of cases are associated with
inflammation of the pia and arachnoid, and half of these
also have petechial and large purpura;
3. Eruption of skin lesions. Eruption of skin lesions is
one of the most consistent features of meningococcal
disease (Oe Voe, 1982).
The clinical response of the host to meningococcal
disease can vary from a benign meningitis to a fulminant meningococcaemia





Gonorrhoea has a world-wide distribution and is a major
health problem in many countries, flan is the only natural host for
Neisseria gonorrhoeas and Rein (1977) has attributed the success and
historical persistence of this pathogen to "the prodigious efforts
of humanity on its behalf".
During and after the Second World War the population of
the United Kingdom made considerable efforts on behalf of the
gonococcus, resulting in a peak incidence of 47,343 cases in 1946.
The incidence then dropped rapidly up to 1954, when only 17,536
cases were reported. (Venereal Diseases in England and Wales, 1959).
This drop may, in part, be attributable to the death of young people
during the war, since gonorrhoea is a disease of young adults.
Most cases occur among the 20-24 year olds. Women tend to get
gonorrhoea at an earlier age than men, and the second highest
incidence is in the 15-19 year olds, primarily due to the female
•contribution. (Rein, 1977; Robertson, McMillan and Young, 1980).
The 1960s saw a steady rise in incidence of gonorrhoea in
most countries in Western Europe that has continued up to recent
times. The United States and Sweden experienced a more explosive
increase in incidence of gonorrhoea, the peak incidence being about
400 cases per 100,000 inhabitants in both countries (Kellings and
Moberg, 1977). This rise in incidence is due to an increase in
promiscuity and a change in the pattern of contraceptive use. The
use of barrier methods of contraception, such as the condom, can
provide effective prophylaxis against genital gonorrhoea. Such
protection is absent for those using oral contraceptives or intra¬
uterine devices. (Rein, 1977).
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Thirty years ago epidemiological reports showed great
disparity between the sexes vis a vis the incidence of gonorrhoea.
In 1946 the ratio of mala infections to female infections was 3.5 s 1
and in 1954 it was 3.9 : 1. (Venereal Diseases in England and Wales,
1959). Nowadays this ratio is approaching unity. (Robertson, McMillan
and Young, 1980). This is probably due mainly to improved methods
of diagnosing gonorrhoea in the asymptomatic female, rather than any
radical change in patterns of sexual behaviour. (Rein, 1977).
1.3.2.1 Meningococcal Disease
Epidemic meningitis has been prevalent in many countries
for several centuries. In recent times an area with a high incidence
of meningococcal disease has been reported in equatorial Africa;
this is the meningitis belt. The reason for this geographical link with
disease due to N.meningitidis is not known, although the association
of perennial epidemics with the end of the season of dust storms
(the harmattan) and the beginning of the annual rainy season implicates
climatic and environmental factors.
There is no other endemic region comparable to the
meningitis belt. Epidemics occur less frequently in other parts of
the world. Prior to 1940, large epidemics occurred in all parts of
the world, with a local inter-epidemic period of about 10 years.
(Peltola, 1983) Exceptionally large epidemics were associated with
the Second World War. In spite of the successes in vaccine
development and the widespread availability and use of anti-microbial
drugs, meningococcal disease is "still with us". In the 1970's
epidemics of meningococcal disease were seen in at least thirty
countries. (Peltola, 1983).
1.3.2.2 Age-Distribution
During non-epidemic conditions cases of meningococcal
disease are seen most frequently in children less than five years old.
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In a study of meningococcal disease in the Netherlands during the
period 1971 to 1980, over half of the 202 cases were children in the
age group 0-4 years old and one fifth of the patients were in the
age range 10-19 years old. (Zanen, 1980). During epidemic conditions
a statistically significant shift in the age distribution towards
the older groups has been observed (Peltola, 1983). Peltola, Kataja
and Makela (1982) suggested that this shift in age distribution
might be predictive of an imminent epidemic.
1.3.2.3 Sex Distribution
Although meningococcal disease affects both sexes, a
higher incidence among males is generally reported. (Peltola, 1983).
This has been partly due to the large numbers of cases seen in male
institutions such as military camps and lodging houses for male
chronic alcoholics. With the information available it is difficult
to form any final conclusions on the influence of gender on
susceptibility to meningococcal disease.
1.3.2.4 Meningococcal Disease in Military Institutions
The incidence of meningococcal disease among military
recruits is ton times higher than in the general population (Peltola,
1983). The risk of disease is greatest during the first few weeks
of training, but not later. Bristow, van Peenen and Volk (1965)
described an epidemic within a Naval Training Centre in which 80/b
of cases were recruits who had been at the Centre for less than 5
weeks. Permanent military staff are not a special risk group.
1.3.2.5 Meningococcal Serooroup Distribution
At least eight serogroups of N.meningitidis have been
recognised (A,8,C,X,Y,Z,kJ135 and 29E (or Z')) on the basis of the
immunochemical characteristics of the capsular polysaccharide. (See
section 1.5.6.1) Groups, A,B and C account for over 90^ of all
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cases of meningococcal disease (Peltola, 1983). Recently there has
been an increase in the isolation of meningococci of serogroups X,Y,
Z, LJ135 and 29E (or Z')« Data from the Centre for Disease Control
in Atlanta, USA, shows that in 1978 infections due to serogroups C
and Y were approximately equal in number, wherease in 1971-2 group C
organisms accounted for 63$ of cases and group Y, 8.6$. (Counts and
Petersdorf, 1980). The reasons for such a change in frequency of
the serogroups causing disease are not completely defined. Since
meningococcal disease principally affects children, and the
resistance of older people is due in part to serum antibodies
reactive with the capsular antigens (Goldschneider, Gotschlich and
Artenstein, 1968; See section 1.8.4.1), these changes in prevalence
of 3erogroup are probably reflections of the state of anti-meningacoccal
herd immunity within a population.
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1.4 Some Host Factors Associated with susceptibility to
infection with Neisseria gonorrhoeae or Neisseria
meningitidis
All people are susceptible to infection by the pathogenic
Neisseria species, but some are more susceptible than others. The
differential susceptibility of individuals may arise from many factors.
Social conditions and behavioural patterns frequently determine the
risk of meeting an infected individual in circumstances which are
favourable to the successful transmission of the pathogen. This is
especially true of gonorrhoea, where the disease is almost exclusively
restricted to sexually active people. Other factors which may be
associated with increased susceptibility to infections with the
pathogenic Neisseria species include the genetic make-up of the
individual, HLA type; absence of 'natural antibodies', and the
presence of underlying pathologies.
1.4.1 Genetic Factors
Congenital absence of the terminal components of the
complement pathway predisposes to recurrent bacteraemias, especially
with N.gonorrhoeae and N.meningitidis (Lee et al. 1973; Lee et al;
1979; Nicholson and Lepow, 1979; See sections 1.7.2.3 and 1.7.3).
Certain haplotypes of the human major histocompatibility
gene complex have been associated with an increased susceptibility to
disease. For example, the haplotype B27 is found in a high proportion
of patients with ankylosing spondylitis. Little work has been done
in trying to find associations between human genotypes and susceptibility
to gonorrhoea. One report, however, shows that in the Chinese
population in Singapore, HLA-B12 is found more frequently {26%) in
prostitutes suffering from both gonorrhoea and syphilis than those
in the normal, uninfected population (7%). Furthermore, the HLA-
B17 haplotype was associated with a poor blastogenic response of
lymphocytes to gono coccal and treponemal antigens (Chan and Rajan,1982)
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1.4.1.1 ABO Blood Group
Epidemiological evidence has demonstrated the association
of several infectious diseases, including gonorrhoea, with ABO blood
group (Kinane et al; 1982; Foster and Labrum 1976; Kinane et al
1983 b). In a study of 565 patients attending a sexually transmitted
diseases clinic in Edinburgh, Kinane and colleagues (1983 b) found
the proportion of blood group B in all patients was 13.2%; similar to
the incidence of blood group B in that locality (10.7%). After
segregation of the patients on the basis of diagnosis, the incidence
of blood group B in those patients with gonorrhoea was 21.1%. This
is higher than the incidence in patients without gonorrhoea (12%)
but the difference is not statistically significant. It is, however,
a statistically significant increase in incidence of blood group B
compared with the control population.
Foster and Labrum (1976) proposed that the anti-B
isohaemagglutinin, which is absent in individuals of blood groups B
and AB might be a better opsonic antibody than the anti-A isohamag-
glutinin. This, they suggested, might provide an immunological basis
for the observed increased susceptibility of individuals of blood
group B. The data does not allow comment on the susceptibility of
people with the AB blood group, since their numbers were too small.
This project, in tandem with one conducted principally by
Or D F Kinane, sought to examine the biological effects of A and B
isohaemagglutinins on N,gonorrhoeae. The binding of gonococci to
human mononuclear phagocytes has been shown to be enhanced by
isohaemagglutinins. In addition, the degree of binding is greatest
for monocytes from blood group B individuals compared with cells
taken from individuals of the other ABO blood groups (Kinane et al,
1983 a). This evidence contradicts the proposal of Foster and Labrum
(1976), yet, when viewed in the light of a scheme for the pathogenesis
of gonorrhoea proposed by Novotny et al, (1977)it indicates a
mechanism by which the susceptibility of individuals of blood
group B may be increased. This is discussed in detail in Section
1.7.2.1.1 et seq.
A hypothesis relating the potential bactericidal activities
of anti - B isohaemagglutinins to increased host resistance to
gonorrhoea is stated in Section 1.10.1.
1.4.2 'Natural' antibodies
Susceptibility to meningococcal disease has been shown
to correlate with the absence of 'natural' antibodies which act
together with the complement system to kill N.meningitidis (Goldsch-
neider, Gotschlich and Artenstein, 1969; Goldschneider, GotschliGh
and Artenstein, 1969 b).
'Natural' antibodies reactive with the somatic antigens
of gram-negative bacteria, such as N»gonorrhoeae and N.meninqitidis
are principally of the IgM class (Michael and Rosen, 1963). Severe
IgM deficiency, which was thought to be familial, has been described
in patients dying from fulminating meningococcal septicaemia. (Hobbs,
Milner and Watt, 1967).
1.4.3 The influence of infection with N.gonorrhoeae on oropharyn¬
geal infection with N.meningitidis
The incidence of meningococcal colonisation of the
pharnyx has been shown to be higher in patients with gonorrhea than
in those without. Young,Harris and Robertson (1979) studied over
3000 patients with gonorrhoea and found that the meningococcus was
isolated 3.4 times more frequently from men and twice as frequently
from women with genital gonorrhoea than in those without. They
suggested that the preponderance of meningococcal isolates from
individuals with gonorrhoea may be more a reflection of behavioural
patterns than of any difference in host suscepitibility. Similar
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results wars obtained from a smaller sample by 0degaard and Gedde-
Dahl (1979).
Young and colleagues; (1983) have continued their studies
on this phenomenon; analysis of the serogroup of the meningococcal
strains isolated from the oropharynx of patients with gonorrhoea
revealed that women with gonorrhoea were more likely to be colonised
by serogroupable meningococci than were women without gonorrhoea.
There were no significant differences in the frequency of colonisation
with non-serogroupable meningococci between patients with gonorrhoea
and controls without gonorrhoea. Mo such differences were noted
for male patients.
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1.5 Anatomy and Physiology of the pathogenic Neisseria
species
1.5.1 Introduction
N. gonorrhoeae and N.meningitidis are, in common with
other members of the genus Neisseria, gram negative cocci. They
usually occur in pairs with the long axes parallel and opposing surfaces
showing slight concavity. All members of the genus can oxidise
dimethyl - or tetramethyl paraphenylene diamine (T[1P0), and this,
together with typical staining and microscopic morphology, form the
main distinguishing features used by medical microbiologists in their
identification of the Neisseria spp. Differentiation of the
Neisseria species is accomplished by sugar utilisation tests.
(Table I).
1.5.1.1 Colonial morphology
Uhen grown on solid medium both N.gonorrhoeae and
N.meningitidis exhibit a variety of colonial forms. Kellogg et al
(1963) described four colony types for N,gonorrhoeae; T1 to T4.
Colony types T1 and T2 predominate in fresh isolates, but
indiscriminate subculture results in a shift to the T3 and T4 colony
types. Each colony type can be maintained by daily selective
subculture, and the shift in colony type from T1/T2 to I3/T4 can be
reversed by isolation and selective subculture of revertants. After
prolonged selective subculture in vitro of the four colony types of
N.gonorrhoeae strain F62, Kellogg st al (1968) found that only
colony types T1 and T2 gave rise to infection after urethral
inoculation of human volunteers. Two additional gonococcal colony
types have been described; T5 (3ephcott and Reyn, 1971) and T1'
(Chan and Wiseman, 1975). Colony types T1, T2 and T1' are capable
of infecting embryonated hens eggs whereas types T3, T4 and T5 are
not (Chan and Wiseman, 1975). Electron microscopy has revealed that
pili are present in large numbers of organisms from colonies of
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TABLE I
Carbohydrate Utilisation of Neisseria species
glucose lactose maltose fructose sucrose
N.gonorrhoeae + - - - -
N.meningitidis + - + -
N.lactamica + + + - -
N.subflava
N.f lav/a




+ - + + +
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types T1 and 12, but sparse or absent in those of T3 and T4 (Oephcott,
Reyn and Birch-Anderson, 1971).
Penn, Veale and Smith (1977) developed a simple lighting
system which allows the colonies to be characterised by the number
of highlights observed. Organisms from double-highlight (DH)
colonies are similar to those in Kellogg's groups T1 and T2.
Organisms from single-highlight (SH) and no-highlight (NH) colonies
have fewer pili and are similar to those found in Kellogg's T3 and
T4 colonies (Kellogg et al, 1963).
N.meningitidis also exhibits variation in colonial
morphology and pilation. QeVoe and Gilchrist (1978) have described
six different colony types, (11 to (16. Host strains in their study
elaborated only an F11 colony type, that was similar in appearance
to T4 colonies of N.gonorrhoeae. Meningococci resemble gonococci
in possessing pili upon primary isolation and (usually) in subsequent
loss of pilus expression after subculture. However, there is no
correlation between pilation and colony morphology such as that
observed with gonococci. DeVoe and Gilchrist (1978) observed
several combinations of colonial morphology and pilation in their
meningococcal strains.
The question of a causal relationship between degree of
pilation and colonial morphology has been addressed by McGee et al
(1977). They found no consistent relationship and concluded that
unless the pili of N.gonorrhoeae are unique among Neisseria species
in their ability to influence colonial morphology, other factors,
in addition to pilation are responsible for the colonial morphology
of T1 and T2 gonococci.
The colouration and opacity of gonococcal colonies has also
been noted to vary. (Swanson, 1978a). Swanson found that these
optical properties of gonococcal colonies were independent of pilation
(Swanson, 1978a) and appeared to correlate with differences in cell
surface proteins that he termed ''colony opacity - associated proteins'
(Swanson, 1978b). Opaque colonies are predominant in isolates from
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male patients whereas transparent colonies are more typical of
female isolates,particularly if the woman is menstruating. This is
thought to be due to the susceptibility of the opaque colonial type
to proteolytic enzymes such as trypsin and, possibly, those
occurring in cervical mucus and menstrual blood. (Dames and Swanson,
1978).
1.5.2 The Cell Envelope
The cell envelope of the pathogenic Neisseria species
conforms to the general characteristics of gram-negative cells.
Electron-microscopic examination of thin sections of N.gonorrhoeae
reveals an undulating outer membrane, periplasmic space and pepti-
doglycan layer, with zones of adhesion between the outer membrane and
peptidoglycan occurring at frequent intervals. (Fitz-Dames et al.
1964). A similar picture is observed with meningococci (Swanscn and
Goldschneider, 1969). Both N.gonorrhoeae and N.meningitidis release
vesicles, or 'blebs', of outer membrane during rapid growth, (Stead
et al, 1975; DeUoe and Gilchrist, 1973). Pili are observed on both
species, but the evidence for possession of capsular material is
only clear-cut for certain strains of N.meningitidis.
The components of the cell envelope will be discussed with
regard to their role in host-parasite interactions.
1.5.3. Pili
Pili have been observed on both pathogenic and non¬
pathogenic Neisseria species. (Dephcott, Reyn and Birch-Anderson,
1971; McGee et al, 1977). ClcGee et al, (1977) described two types of
pilus: short pili (l75-210nm in length) found only on non-pathogenic
species, and longer pili (up to 4,300nm) found on both pathogenic and
non-pathogenic species. Pili are polymers of protein subunits.
Recent work has shown that a single strain of gonococcus, strain P9,
is capable of expressing one of four pilus subunit types :
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cX (Mr 19.5k), p (Mr 20.5k), V (Mr 21k) and ^ (Mr 18.5k) (Lambden
at al. 1981). Thesa pilus variants are antigenically distinct
(Uirji, Heckels and Watt, 1983) yet monoclonal antibody analysis has
shown a common epitope which has also been found on pili from fresh
meningococcal isolates. (Virji and Heckels, 1983). These workers
also found meningococcal pili that did not have this common epitope
and suggested that there may be greater antigenic diversity among
meningococcal pilu3 subunits. The complete amino acid sequence
analysis for a gonococcal pilus (Mr 17,497) from strain MS11 has
recently been elucidated (Schoolnik et al, 1984)
Bacterial pili have been demonstrated as adhesins in
other genera (Ottow, 1975) and studies on both the gonococcus and
the meningococcus have demonstrated that pili enhance the degree of
binding to cells of many types. Studies with the gonococcus show
enhanced binding to red blood cells (Punsalang and Sawyer, 1973;
Koransky, Scales and Kraus, 1975), human vaginal epithelium (Mardh
and Westrom, 1976),human fallopian tube (Watt and Ward, 1977) and
sperm cells (Dames-Holmquest et al, 1974). Care must be taken in
extrapolating these data to the invivo situation since the cell type
used in binding studies is not always that involved in pathogenesis.
Binding studies have shown pili to enhance attachment of
meningococci to nasopharyngeal and buccal cells (Stephens and
McGae, 1981). Two possible methods by which pili might facilitate
attachment have been postulated (Watt and Ward, 1977). The small
diameter of the pilus might allow it to penetrate tha repulsive
charge barrier between the surfaces of the bacterium and the epithelial
cells so as to facilitate binding by hydrophobic bonding. Alternatively
the pilus might act by binding to specific receptor(s) on the call
surface. They suggested that this recaptor might be a saccharide
moiety since this had been described for haemagglutinating pili of
other species (Ottow, 1975).
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Tha hypothesis that there is a saccharide pilus receptor
on the cell surface has gained impetus from the work of Buchanan
and colleagues (Buchanan, Pearce and Chen, 1978) who found that
binding of purified, radiolabelled gonococcal pili could be inhibited
from binding to a variety of human cell types by gangliosides (espec¬
ially GT2), heparin (a sulphated mucopolysaccharide) and pre-treatment
of the cell surface with glycosidases. This receptor is thought to
be an oligosaccharide since binding is unaffected by the constituent
simple sugars of the cell surface. However, small oligosaccharides
can disperse aggregated pili (Watt and Ward, 1980).
Gonococcal pili of the four variant types have been shown
to exhibit different binding characteristics (Heckels, 1982), but
with most cell types their effect is to enhance binding. However,
with PMN the gonococcal pilus appears to hinder cell-bacterium
interactions and prevent phagocytosis (Thongthai and Sawyer, 1973;
Ofek, Beachey and Bisno, 1974; Dilworth, Hendley and Mandell, 1975),
possibly by reducing membrane fluidity around the farming phagosome
(Densen and Flandell, 1978). Swanson (1977) suggested that the major
gonococcal determinant influencing binding to PNN is a gonococcal
surface protein which he has termed 'leukocyte association factor'
(LAF).
In addition to their role in promoting adhesion to cell
surfaces, gonococcal pili have been reported to enhance the microbe's
ability to acquire iron in vivo (Payne and Finkelstein, 1975). Iron
has been shown to increase the virulence of many pathogenic species
(Weinberg, 1978) including N.gonorrhoeae (Payne and Finkelstein,
1975). Pili also appear to increase the frequency of genetic
transformation of gonococci (Sparling, 1966), so increasing the chances
of acquiring new genes coding for such things as antibiotic resistance.
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D8spita the wealth of evidence suggesting that pili have
many roles to play in the infective process and enhancement of
virulence of pathogsnic Neisseria it is paradoxical to note that
gonococcal pili have been rarely observed in vivo (Watt and Ward 1977)
and so some caution is required when attempting to relate results
from in vitro experiments to the infective process in vivo.
1.5.4 Ma lor Outer Membrane Proteins
Analysis of the outsr membrane proteins of IM.gonorrhoeae
shows a relatively simple pattern. There are three major proteins
designated Proteins I, II and III (Swanson and Heckels, 1980).
Protein I, or the Major (Principal) outer membrane
protein M(P)0MP, as it was described in early reports, was first
recognised by Oohnston and Gotschlich (1974) as a protein of Mr 34.5k
that accounted for over 60 j of the outer membrane protein in strain
2686 (colony type 4). A later study by Oohnson, Holmes and Gotschlich
(1976) showed that there was considerable variation of Protein I
between strains. They described molecules with a Mr ranging from
32k to 39k.
Cross-linking experiments using strain 26B6 suggest that
Protein I exists as a trimer (Newhall, Sawyer and Haak, 1980) and
it is also closely associated with another membrane protein (Mr 28k).
They suggested that these protsin aggregates might act as water-
filled diffusion channels across the outer membrane, though they did
not refer to the evidence already presented by Heckels (1979) ,
demonstrating that Protein I was a transmembrane protein. This
hypothesis has now been confirmed (Heckels and Games, 1980; Douglas,
Lee and Nikaido, 1981).
In addition to Protein I, the opaque colonial forms of
gonococci contain a protein with Mr ranging from 24k to 30k. This
family of proteins is classed as Protein II. (Swanson 1978b). Their
apparent molecular weight on SDS-PAGE varies dependent on the temperature
of solublisation, the so-called heat-modifiability of Protein II
(Heckals, 1977).
Both Proteins I and II were radiolabelled when whole
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cells were exposed to an I - lactoperoxidase - system,
whereas Protein III was poorly labelled, suggesting that it is not
exposed at the cell surface. (Heckels, 1978) Protein III
(Mr 31-34k) appears to be closely associated with Protein I since
they are found in similar proportions in immunoprecipitation
experiments (Swanson, 1981) and antiserum produced against alectro-
phoretically purified Protein I immunoprecipitated both Proteins I
and III,yet reacted only with Protein I (McDade and Johnston, 1980).
N.meningitidis appears to possess a larger mosaic of
major outer membrane proteins than N.gonorrhoeae. Peptide mapping of
the major outer membrane proteins of Group B strains have demonstrated
five structural classes of proteins which correlate with the
"t* *}*
apparent molecular weights (46 - 1k, 41 - 1k, 38 - 1K, 33 - 1k and
28 - 1k). Tsai, Frasch and Mocca, 1981). Cell surface labelling
experiments suggest that proteins of classes 1, 2,4 and 5 are
exposed at the cell surface.
1.5.4.1 Role of outer membrane proteins in pathogenesis of
gonorrhoea
A number of studies have indicated that the protein II
molecules found in the opaque phenotype may be associated with
increased virulence of these strains of N.gonorrhoeae. Lambden et al
(1979) described opaque variants of a transparent parent strain, P9,
that showed increased adhesion to buccal epithelial cells and were
more resistant to killing by NHS than the parent strain . This
strain, however, has been reported to be relatively resistant to
killing by human serum (Stead et al 1975). They also confirmed the
reports of Swanson and colleagues (Swanson, 1977) that outer
membrane proteins in the molecular weight range 27-29k have a
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greater influence on the degree of interaction with PFIN than pili.
However, in the case of bacteria bearing Protein Ila* (Mr 28.5k) the
influence was to increase binding, whilst bacteria bearing Protein
lib (Mr 28.0k) exhibited decreased binding compared with the prototype
strain lacking Protein II. The ability of Protein II to enhance
binding to epithelial cells has been reported by other workers,
including Virji and Everson (1981), who used Chang conjunctival
cells. This is an improvement on the use of buccal cells and
erythrocytes, since N.gonorrhoeae does infect the eye.
Serological studies of intact gonococci have demonstrated
considerable antigenic diversity related to the Protein II species
present. (Diaz and Heckels, 1982). This paper also cites a
communication from P. Lambden suggesting that the antigenic variants
of Protein II had considerable structural homology. Since antibody
specific for protein II has been shown to inhibit binding on non-
pilate gonococci to Hela cells (Sugasawara et al, 1983), the ability
to alter antigenicity whilst maintaining structure and, presumably,
the functional capacity of this protein appears to be of advantage
to the microbe in evading the host immune response.
In contrast, the transparent phenotype of N.meningitidis
is most frequently associated with the disease state whilst opaque
colonies are most frequently isolated from the nasopharnyx of
asymptomatic carriers. The transparent colony phenotype, associated
with heat modifiable membrane proteins of Mr 25-32K, is more
resistant to NHS than the opaque phenotype. However, the increased
binding of opaque pilate meningococci to human buccal cells compared
with transparent variants is a point of similarity with the
gonococcus. (Stephens and McGea, 1983).
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1.5.5 Lipopolysaccharide (LPS)
Most of our information concarning the chemical nature
and biological effects of lipopolysaccharide (LPS) have come from
studies of LPSs produced by members of the Enterobacteriaceae. The
classical structure of an LPS molecule consists of three distinct
regions : a hydrophobic lipid called Lipid A; a core oligosaccharide
composed of a variety of sugars, but usually containing some heptose
molecules and 2-keto-3 deoxy-octulosonic acid (KDQ); a series of
repeating subunits, usually composed of a small number of sugar
molecules. It is these repeating subunits that confer serological
specificity to the LPS molecule. Spontaneous mutation leading to loss
or inhibition of an enzyme such as a transferase or synthetase
associated with the formation of these repeating subunits can result
in bacteria expressing an incomplete LPS molecule.
Since this imparts different surface characteristics to
colonies af the bacterium, this variation has been termed Smooth -
Rough variation, and the LPS molecules associated with each type are
called S-typs LPS and R-type LPS respectively. (Davis et al, 1980)
LPS is found at the microbial cell surface and a number of Neisseria
species have been shown to release LPS into culture medium. This
may be free LPS (Dohnson, Perry and McDonald, 1976) or LPS associated
with other outer membrane components - outer membrane complexes (De
Voe and Gilchrist 1973; Stead et al. 1975).
1.5.5.T Lipopolysaccharide - Chemical and Structural Analyses
Several groups have undertaken chemical analyses of
gonococcal LPS extracted from the cells by a procedure employing
phenol and water. An early analysis by paper chromatography of the
sugar components of gonococcal LPS isolated from strains grown in
liquid medium showed that it contained glucosamine, glucose, galactose,
a heptose and KDO linked to lipid in the following ratio 4:1:2:2:3.
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(Stead et al, 1975). They examined two strains in the T1 colonial
form (P9 and F62) and three strains in the TA form (G2, GA and G50)
and reported that there were no significant differences between LPSs
of 'virulent' and 'avirulent' gonococci, i.e. between strains of
T1 and TA colony types. It is curious that they did not examine
LPS isolated from colonial variants of the same strain. The absence
of deoxy-, dideoxy or N_- acetylated sugars, typical components of
the repeating subunits in LPS of the enterobacteria, led Stead and
colleagues to propose that gonococcal LPS occurs as the R-type.
Perry and colleagues (1975) analysed LPSs isolated from
strains grown on solid medium in both T1 and TA colony types. They
observed differences in LPS composition associated with the colony
type of four strains, (in 31, 188, G9, GC6). The LPS isolated from
TA colonies of these strains had lipid, aldoheptose and KDQ
concentrations consistent with those found in typical R-type LPS.
Sialic acid, deoxy-and dideoxy-glycoses were not observed. In
contrast, the LPS isolated from T1 colonies of the same strains
exhibited compositions comparible to those of S-type LPS preparations
from other gram-negative organisms. This work was later re-investig¬
ated and the opinion of Perry and colleagues in 1978 (Perry et al,
1978) was that the S-type LPS had not been satisfactorily determined
in N.gonorrhoeae . Wiseman and Caird (1977) undertook compositional
studies of LPSs extracted from 38 strains of N.gonorrhoea with
examples of colonial types T1 to T5. They grew the strains in liquid
medium, extracted LPS with phenol and water, and analysed the
carbohydrate fraction by gas-liquid chromatography of trimethyl silyl
derivatives of hydrolysed LPS. They identified the following sugars
in all colony types : glucose, galactose, mannose, N_-acetyl neuraminic
acid (sialic acid), 2-keto-3-deoxyoctulosonic acid (KDO), glucosamine
and galactosamine (probably in the _N-acetylated form) were also
invariably present. In contrast to the findings of Perry at al (1975)
they found rhamnose in the avirulent colony types (T3 to T5) and in
N,sicca and N.lactamica (colonial morphology not defined), but not in
T1 and T2 variants of the same strains. (Two exceptions being strains
3256 and KC, in which small amounts of rhamnose were observed in LPS
isolated from T2 colonies). Fucose was not found in the gonococcal
strains, but was present in N.sicca and N.lactamica.
Variants in colonial forms T1 and T2 generally contained
a greater total glycose concentration with higher ratios of mannose:
KQQ glucosei KDU and galactose: KDO, compared with T3 to T5 variants
of the same strain. This suggested to Wiseman and Caird that these
sugars might form part of a repeating unit typical of S-type LPS.
They concluded that the LPSs of virulent (T1) and avirulant (T4)
gonococci do not differ qualitatively (except, of course, for the
absence of rhamnose in the T1 colonial form), but they do differ in
the concentration of their respective constituents. Perry and
colleagues, in their later paper on analysis of gonoccal LPS, (Perry
et al, 1973), described LPSs which had the same mobility on SDS-PAGE
irrespective of the colony type from which they were isolated.
Carbohydrate analyses were typical of those expected for all R-type
LPS, viz. glucosamine, glucose, galactose, L-glycero-O-manno heptose
and 3-deoxy-Q-manno-octulosonic acid. Gel filtration of the oligos¬
accharide portions liberated from the LPS by mild acid hydrolysis
revealed two core oligosaccharide types in the same LPS preparation.
These were found to have the same structure, except one core type
(the faster moving fraction on gel filtration) had an additional
1-3 linked D-galactose unit. Both core oligosaccharide types had two
D-galactopyranose and one O-glucosamine units present as non-reducing
end groups (which tend to be immunodominant (Kabat 1968)). EnzymatiG
degradation with snail intestinal juices (rich in j3-D-galactosidase)
and further structural analysis suggested that one of the D-galactose
end residues is part of a 4-0 j3-0-galactopyranosyl-Q-glucose (lactosyl)
unit. The other terminal galactose, which was not removed by the
snail intestinal juice, was thought to be linked via an c* -linkage.
Investigations of a variety of Neisseria species have
demonstrated variation in LPS composition dependent on the growth
conditions. McDonald and Adams (1971) demonstrated the influence of
growth rate on the hexosamine concentration of LPS extracted from
N.sicca. When grown at a fast rate the galactosamine: glucosamine
and hexosamine : KDO ratios were higher than when the organisms
grew at a slower rate. In addition,greater quantities of LPS could be
isolated from cells which were growing at the faster rate. In these
experiments the growth rate was determined by the degree of aeration
of the culture. Morse et al (1983) used nutrient-limitation to alter
the growth rate of N.oonorrhaeae strain FA 171 and found a growth-
rate-dependent change in the auantity of LPS that could be
isolated from the cells. Cells growing at a high dilution rate
(0.56 h ) contained approximately eight times more extractable LPS
than those growing at a lower dilution rate (0.12 h ). The type of
LPS isolated differed in band pattern in SDS-PAGE,
and the cells growing at the higher dilution rate had less hydrophobic
surfaces, as determined by hexadecane binding, than those grown at
the lower dilution rate. Nutrients have also been observed to alter
the LPS of N.gonorrhoeae. Norrod et al (1983) observed changes in
LPS structure of strain F62 resulting from growth in medium containing
pyruvate and a high cysteine: cystine ratio. They were unable to
define a mechanism for this change.
The LPS of N.meningitidis has been studied extensively by
Jennings and colleagues (Jennings et al, 1973; Cannings et al, 1980;
Jennings, Johnson and Kenne, 1983) who have found LPS isolated from
strains of different capsular serogroups to be R-type LPS. Recent
electrophoretic studies are in agreement with this and show that they
have similar migration patterns to gonococcal LPS. (Tsai, Boykins
and Frasch; 1983; Mintz, Apicella and Morse, 1984). At least 11
immunotypes of meningococcal LPS have been found and, in general,
there is no correlation between LPS immunotype and capsular serogroups.
The exceptions are immunotypes 10 and 11, which have only been observed
in strains of serogroup A. (Zollinger and Mandrell, 1980). Different
immunotypes can be simultaneously observed in many strains, and
electrophoretic separation of LPS from strains of different imrauno-
types has shown that most contain two predominant components, (Tsai,
Boykins and Frash, 1983). The different mobilities of these compon¬
ents probably reflects compositional differences. The relative
quantities of each component have been found to alter in response to
changes in growth rate (controlled by the degree of aeration of the
culture). At fast growth rates the lower molecular weight species
increases in quantity, and the proportion of galactose in the LPS
decreases. This suggests that the lower molecular weight component
contains less galactose than the larger molecular species. (Tsai,
Boykins and Frasch, 1983). Irrespective of growth rate, qualitative
analysis of the core oligosaccharide from meningococcal LPS has
yielded glucose, galactose, glucosamine, heptose and KDQ. (Jennings
et al, 1973; Tsai, Boykins and Frasch, 1983; Jennings, Johnson and
Kenne, 1983).
Structural analysis of a core oligosaccharide bearing
determinants for the L3, L7 and L9 serotypes has yielded the structure
shown in Figure 1 (Jennings, Johnson and Kenne, 1983).
FIGURE 1
The structure of a core oligosaccharide from meningococcal LPS
(Jennings, Johnson and Kenna, 1983)










1.5.5.2 Lipopolysaccharide - Immunochemical Charactsrisation
Purified genecaccal LPS is a poor immunogen fer many
animals, including rabbits. However, it dnes provoke a substantial
immune r8spcnse in hens (Perry, Oiena and Ashton, 1977). Hen anti¬
serum to purified R-type LPS has been shown to agglutinate both T1
and T4 colonial forms of gonococcus, but not strains of meningococcus
(serograops A,8 and C), N.lactamica, or Pseudomonas aeruginosa. This
suggests a high degree of structural homology among gonococcal LPSs
from different strains. Cross-reactivity did occur with some
streptococcus strains, especially type A and G. (Wallace et al, 1978)
In gel and quantitative precipitation studies, lactose
and its structural analogue 3-Q_-j3-D-galactopyranosyl-D-arabinose
have been shown to inhibit precipitate formation by hen anti-LPS
sarum and gonococcal LPS (Perry, Diena and Ashton, 1977; Perry et al,
1978), suggesting an immunodominant rols for the lactosyl residue
on gonococcal LPS described by Perry et al (l978)(See Section 1.5.5.1).
In addition to common determinants, gonococcal LPS has
been shown to exhibit a high degree of antigenic heterogeneity -
presumably indicative of structural heterogeneity. Apicella and
Gagliardi (1979) describe how gonococcal LPS contains one of six
serogroup determinants (GC1 to GC6) and at least two sets of non-
serogroup determinants ; one which is common to all six serogroups,
and another found only on serogroups GC1, GC3 and GC4.
Structural analysis of a common determinant of gonococcal
LPS has been attempted by Apicella and colleagues (1981) using sugars
to inhibit binding of a monoclonal antibody reactive with this
determinant. They suggested that it reacted with the following
structure: D-galactosamine-0_-0-galactopyranosyl-(1-4)-0-glucopyranose.
The 1-4 linkage was suggested since glucose and galactose, alone or
in combination, failad to inhibit binding of the antibody whereas ck
and (3 lactose did.
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Meningococcal LPS also appears to be capable of binding
this monoclonal antibody, but to a lesser degree than gonococcal LPS.
Apicella and colleagues (1981) suggested that the meningococcal LPS
might only contain a portion of the putative binding site for this
monoclonal antibody. They proposed that the receptor in meningococcal
LPS for this antibody might be a galactopyranosyl (1-4) D-glucopyranose
moiety. This has been shown to be present from the structural
analysis dona by Jennings and coworkers. (Jennings, Johnson and
Kenne, 1983). (Figure 1).
1.5.5.3 Lipopolysaccharide - role as a receptor for Rod type
pyocins of Pseudomonas aeruginosa
Rod-type (R-type) pyocins are a class of bacteriocins
produced by Pseudomomas aeruginosa. The receptor site in Ps aeruginosa
for these bacteriocins has been shown to be the LPS (ikeda and Egami,
1969; Govan, 1974). Bacteriocins are usually only active against
species closely related to the producing species. R-type pyocins,
however, have been shown to inhibit growth of gonococci, (florse at al,
1976) meningococci (Blackwell and Law, 1981) and thermophilic
Campylobacters (Blackwell, Winstanley and Telfer Brunton, 1982). The
LPS molecule has been shown to be the gonococcal receptor for R-type
pyocins (Sadoff, Zollinger and Sidberry, 1978) and this molecule is
presumed to have a similar function in meningococci (Blackwell and
Law, 1981).
R-type pyocins have been classified in 5 groups R1 to R5
based on the location of their binding site on the LPS molecule of
Pseudomonas. (Kageyama, 1975) and a diagramatic representation of
the relationship between the LPS molecule and these binding sites




(Taken from Kageyama, 1975)
R2 R5




(Taken from Meadow and Uells, 1978)
Exposure of gonococci and meningococci (especially non-
serogroupable strains) to a panel of pyocins with representatives
from groups R1, R2, R3 and R5 has shown several pattarns of sensitivity
and this has been proposed as the basis for an epidemiological
typing scheme. (Sidberry and Sadoff, 1977; Blackball, Young and
Anderson, 1979; Blackwell and Law, 1981). Mutations from pyocin
sensitivity to resistance have been shown to correlate with compositional
changes in LPS. Sadoff, Zollinger and Sidberry (1978) described
pyocin-resistant mutants of gonococci which had higher glucose:
galactose ratios in the LPS (1.6) than the pyocin sensitive parent
strain (0.97). Connelly and Allen (1983) demonstrated loss of LPS
antigen reactivity associated with mutational loss of pyocin sensitivity.
These data suggest that non-reactivity with an R-type pyocin is due
to lack of a receptor determinant in the LPS.
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Reports concerning the stability of pyccin sensitivity
vary. Guyrnon, Esser and Shafer (1982) gave an approximate mutation
rata of strain FA19 to resistance to pyocins of Ps.aeruginosa strains
—6 ,
1 and 103 as 10 . Blackwell, Young and Anderson (1979), however,
describe strains maintaining their pyocin sensitivity spectrum over
more than 100 subcultures. There have been no reports of pyocin-
resistant gonococci developing pyocin-sensitivity, suggesting that the
mutation to resistance is a permanent step.
1.5.5.4 Lipopolysaccharide ; Reactivity with lectins
Lectins are proteins or glycoproteins that are able to
selectively bind to cell surfaces or to biopolymers via specific
oligosaccharide determinants. (Sharon ana Lis, 1972), many of
which have been structurally defined. By use of a panel of lectins
of defined binding specificity, it is possible to derive chemical
information about the occurrence of specific sugars, their location
and configuration in complex carbohydrates such as those found in
LPS molecules. Investigation of the lectin-binding of 54 strains of
M.gonorrhoeae by Allen, Conelly and Apicella (1980) suggested the
following structural features are common in gonococcal LPS :
1. multiple p-linked _N-acetyl-Q-glucosamine and [3-0-galactosyl
units.
2. <>. N.-acetyl-0-galactosamine and p-D-galactcse linked to N_-
acetyl galactosamine and/or _N-acetyl glucosamine.
Reference to the meningococcal core oligosaccharide structure
in Figure I shows a component like (1) above to be present.
1.5.5.5 Lipopolysaccharide : Toxic Properties
LPS forms the major part of endotoxin that is released
in large guantity from rapidly growing gonococci and meningococci
(Stead at al, 1975; De \loe and Gilchrist, 1973).
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Human fallopian tube mucosa is extensively damaged by
LPS released from growing gonococci (Welly, Gregg and McGee, 1981)
and by LPS extracted with phenol and water. (Gregg et al, 1981)
The haemorrhagic spots on the skin in meningococcal disease are thought
to be due to the potent LPS - containing endotoxin released from
N.meningitidis (Davis and Arnold, 1974)
The toxicity of gonococcal LPS for embryonated eggs is
abrogated by presence of anti-LPS antibodies (Oiena et al, 1978)
suggesting that immunity to the LPS might afford protection against
tissue damage.
1.5.6 Capsule
N.meningitidis can produce capsules with a great diversity
of compositions, many of which have been elucidated to the level of
their chemical structure (Table II). The evidence for capsule
production by M.gonorrhoeae is much more controversial. Few workers
have observed them. (Hendley et al, 1977; Richardson and Sadoff,
1977; Demarco de Hormaeche, Thornley and Glauert, 1978) Richardson
and Sadoff (1977) could only observe them on gonococci co-cultivated
with viridans streptococci.
N.meningitidis has been isolated from the genitourinary
tracts of males and females (Faur, Weisburd and Wilson, 1975, Blackwell
Young and Bain, 1978). It is curious to note that the capsulate
gonococci described by Demarco de Hormaeche and colleagues (1978)
retained the low, planoconvex T3/T4 colony type after growth for up
to 80 days in subcutaneous chambers implanted in guinea pigs, in
contrast to the T1/T2 colony type observed in other gonococcal strains
under similar conditions (Penn et al. 1976).
These T3/T4 colony forms are similar to the M1 colony type
elaborated by most strains of N.meningitidis (De Voe and Gilchrist,
1978). Welly et al (1979) believe that the observation of apparent
gonococcal capsules is due to peeling off of the lower membrane or
presence of the organism within an isolated phagocytic vacuole.
1.5.6.1 Capsule : Serotypes and Chemical Structures of Menin¬
gococcal Capsules
The serotypes and structures of meningococcal capsules
are given in Table II
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TABLE II
Capsular polysaccharides of ths meningococci






























6-D-Gal(l -2» 4)-NeuNAc(2 6)—
GIcNAc, phosphate DOGlcNAc(l-P -^*4)—










GalNAc, KDO, OAc D-GalNAc(l > 7)-KDO(2 —* 3)—
4,5
O-Ac
" The abbreviations used are: Gal, galactose; Glc, glucose; GIcNAc, :V-acety[glucosamine (2-acetamido-2-
deoxy-D-glucose); KDO, 3-deoxy-D-manno-octulosonic acid; ManNAc, iV-acetylmannosamine (2-acetamido-2-
deoxy-D-mannose); NeuNAc, jV-acetyl neuraminic acid (sialic acid); OAc, O-acetylated; NAc, N-acetylated;
phosphate, phosphodiester linkage.
b Group A is substituted with O-acetyl at C3 on ca. 70% of the ManNAc-P residues.
c Group C is substituted on C7 or C8 with 1 mol of O-acetyi per mol of sialic acid. One-quarter of the sialyl
residues are not acetylated. Some di-O-acetyiated (C7 and C8) may exist.
d The Y polysaccharide contains 1.3 moi of O-acetyl per NeuNAc residue. The most probable site for
acetylation is C3, C4, or C7 (26). 13C nuclear magnetic resonance studies have shown that the serogroup By
polysaccharide is identical to serogroup Y although Bo contains 1.8 moi of O-acetyl per mol of NeuNAc
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1.5.6.2 Capsule : The biological properties of meningococcal
capsules
Capsules have been shown to confer increased virulence
on bacteria compared with non-capsulate variant strains. In the case
of Streptococcus pneumoniae the increase in virulence is due to the
capsule hindering phagocytosis of the bacteria by leucocytes. This
hind8rence is not observed when anti-capsule antibodies are present.
(flims, 1982). Capsulate strains of meningococcus can be isolated
from patients and healthy carriers. However, an association between
capsulation and the virulence of meningococci is suggested by the
higher frequency of isolation of capsulate strains from patients
than from carriers (Poolman, Hopman and Zanen, 1580) and the high
frequency of isolation of non-serogroupable (many of which are non-
capsulate) strains from healthy carriers. (Oevine, Rhode and
Hagerman, 1972). This proposition has received some backing from
estimates of the lethal dose of capsulate strains of serogroup B
N.meningitidis compared with non-capsulate variants of the same
strains. Masson and colleagues (Masson, Holbein and Ashton, 1982)
4
found that the capsulate strains had a 10 fold lower LD50 compared
with the non-capsulate variants. The evidence for the role of
capsules in the natural human infection comes from the great success
in prevention of meningococcal disease achieved by use of capsular
polysaccharide vaccines. (Gotschlich et al, 1978).
It is interesting to note that capsules reduce the
enhacement of epithelial cell binding conferred by pili. (Stephens
and FlcGee, 1981), an effect presumably resulting from an increase in
repulsive forces due to an increase in bacterial negative charge
brought about by the capsule.
34.
1.5.7 PeptidoQlycan
Gonococcal peptidoglycan is a polymer of muramic acid,
glucosamine, alanine, glutamic acid and diaminopimelic acid in the
molar ratios 1:1:2:1:1. There appears to be no covalently linked
lipoprotein, such as that found in Escherichia colijWhich could
account for the loose association of peptidoglycan and outer membrane
seen in electron micrographs (Uolf-lilatz et al, 1975). However, the
outer membrane protein, Protein I, appears to be linked to the
peptidoglycan. (Heckels, 1979). The observation of a high degree
of Q-acetylation of peptidoglycan is gonococcal strains by Swim at
al, (1983) and others is of interest since this modification results
in increased resistance to the peptidoglycan-degrading enzyme
lysozyme. The indigestibility of this modified peptidoglycan is
thought to result in relatively large peptidoglycan oligomers
remaining after gonococci have been killed by serum components and/or
leukocytes. These complexes are more able to induce an inflammatory
response than monomeric peptidoglycan (Rosenthal quoted in Swim et al
1983).
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1.6 Microbial products associated with virulence
1.6.1 Iron-binding proteins (Siderophoros)
Availability of free iron has been shown to influence
the rate of growth and degree of virulence of many pathogenic
organisms (Payne and Finkelstein, 1978). The addition of free iron
enhances the growth and virulence for embryonated hen's eggs of both
gonococci and meningococci (Payne and Finkelstein, 1975). Since the
availability of free iron in body fluids is severely restricted by
specific iron binding proteins, such as transferrin and lactoferrin,
the mode of iron-acquisition by the pathogenic Neisseria spp has been
the subject of many investigations. Both gonococci and meningococci
have been shown to elaborate iron-binding proteins, called sider-
ophores; these appear to be related to virulence, since T1 (virulent)
gonococci produce larger quantities than T3 (avirulsnt) organisms.
(Yancey and Finkelstein, 1981).
In contrast to the commensal Neisseria species, meningoc¬
occi and gonococci have been shown to be capable of scavanging iron
from transferrin. (Mickalsen and Sparling, 1981) and lactoferrin
(Mickelsen, Blackman and Sparling, 1982) by a mechanism that appears
to require the interaction of transferrin with the bacterial celi
surface. However, the role of siderophores in this type of iron
acquisition is still to be elucidated.
1.6.2 Proteolytic enzymes that may contribute to pathogenesis
IgA is the predominant class of immunoglobin present in
the secretions bathing mucous membranes. Two sub-classss of IgA
occur, IgA1 and IgA2. Whereas in serum the ratio of IgA1 to IgA2
is 4:1, in ths mucous secretions, equal proportions of each subclass
are found. The role of this antibody is to protect mucous membranes
from colonisation by micro organisms via interference with the function
of molecules such as microbial adhesins.
The pathogenic Neisseria species have been shown to
elaborate a proteolytic enzyme that cleaves IgA. It is only active
against the IgA1 subclass. Possession of this IgA - protease is a
characteristic feature of the pathogenic Neisseria species, N.meningit¬
idis and N.gonorrhoeae, (Plaut et al. 1975) and, in the study of
Mulks and Plaut (1978) was not found in eight commensal species.
This enzyme could, presumably, reduce the efficiency of the protection
the mucosal surfaces derive from IgA1. The IgA protease cleaves a
prolyl-threonyl bond, present to the hinge region of IgA, but absent
together with 11 other amino acids, as a block deletion, in IgA2.
Proteases with other specificities have been observed in
culture supernates from both gonococci and meningococci (Chen and
Buchanan, 1980). The endopeptidase Gonocosin cleaves the alanyl-
alanine peptide bond, found frequently in elastin, and may contribute
to gonococcal invasiveness in opthalmic neonatorum. Chen and Buchanan
(1980) also described an asparaginase produced by the pathogenic
Neisseria spo. and suggested that its activity may interfere with the
immune response, since asparaginase has been shown to inhibit lymphocyte
blastogenesis (Ohno and Hersh, 1970). This inhibition is probably
due to asparagine starvation in the presence of the enzyme.
1.7 Pathogenesis of diseases due to Neisseria gonorrhoeae and
Neisseria meningitidis
A micro-organism must successfuly take many seguential
steps to cause disease. In the case of disease due to the pathogenic
Neisseria species the initial steps include attachment and colonisation
of the mucosal surfaces followed by penetration of the normally pro¬
tective mucosa into the sub-mucosal spaces. Here the organisms must
avoid or survive phagocytosis and resist the lethal effects of
antibody and complement. Having survived they cross from the blood
stream into other compartments such as the synovial cavities, in the
case of disseminated gonococcal infection, and the cerebrospinal
fluid, in the case of meningococcal meningitis.
This section will focus on the ultrastructural events
and possible molecular mechanisms of the steps leading to infection
by N.gonorrhoeae and N.meningitidis.
1.7.1 Attachment and transgression of the mucosal epithelium
After deposition onto a mucous membrane, bacteria must
adhere rapidly to the underlying cell surface if they are not going
to be washed away by mucus and, in the case of the urethra, the flow
of urine. It has been suggested that gonococci can adhere rapidly
and strongly to the urethral epithelium since micturition following
intercourse does not protect against infection. (Bernfield, 1972).
However, shearing forces, such as may occur at the urethral mucosal
surface during micturition, may enhance binding rather than reduce it.
(Brooks and Trust, 1983).
The bacterial surface components thought to first interact
with the cell surfaces, thereby mediating attachment, are the pili
(described in Section 1.5.3). Both gonococci and meningococci, when
first isolated from clinical specimens, are covered in large numbers
of pili, (Hephcott, Reyn and Birch-Andersen, 1971; Stephens and
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WcGee, 1981) and strains expressing piii have been shown to bind in
greater numbers to mucosal epithelial cells than those without
(Wlrdh and Westrom,- 1976; Stephens and McGee, 1981; Section 1.5.3)
Scanning electron micrographs of human fallopian tube organ cultures
infected with M.gonorrhoeae show the bacteria tethered to non-
ciliated mucosal microvillar surface by bundles of pili (Ward, Watt
and Robertson, 1974) (McGee, Johnson and Taylor-Robinson, 1981).
The importance of pili as gonococcal adhesins in vivo is still in
doubt dua to the curious infrequency with which pili are observed in
electron microscopy studies on fresh clinical material. (Ward
and Watt, 1972; Watt and Ward, 1977; Ovfiinnikov and Delektorskij,1971).
Other surface structures which may mediate bacterium-
mucosa adherence have been described. Protein II is actually a small
family of heat modifiable outer-membrane proteins. Gonococci that
have protein II tend to adhere to human cells with greater avidity
than gonococci lacking protein II (Lambden, et al, 1979; Section
1.5.4.1), but the association between meningococcal protein II and
adherence to host cells has not been investigated.
As an adjunct to the adhesion mediated by pili and/or
outer membrane proteins, reduction of the mucus flow by damage to
the epithelial cilia assists the colonisation process. Ciliarostasis
is mediated by lipopolysaccharide, which is liberated in copious
amounts by rapidly growing gonococci and meningococci (see Section
1.5.5), and monomeric peptidoglycan, which is released during
degradation of peptidoglycan by PMN lysosmal enzymes (Welly, McGee
and Rosenthal, 1984).
Subsequent to the attachment phase, gonococci and
meningococci migrate through to the sub-mucosal tissues. The elegant
experiments of WcGee and colleagues (1981) demonstrated the events
associated with gonococcal transgression of the human fallopian tube
mucosa in infected organ cultures. After attachment to the microvilli
of non-ciliated mucosa, gonococci entered the cells. Coincident with
the attachment and invasion of the nan-ciliated epithelium, there was
desquamation of ciliated cells. By 44 hours post-infection with T1
gonococci, ciliated cells accounted for less than 10>£ of the cells
in the epithelial cell surface. The internalised gonococci migrated
to the basal aspect of the non-ciliated cells through the cells. No
bacteria were seen in the inter-cellular spaces. About 40 hours after
infection gonococci began to be released into the sub-mucosal
tissues. This progressed so that by 60 hours post-infection and
thereafter, there was focal disruption of the epithelium and an
increasing number of gonococci in the sub-epithelial tissues. In these
experiments both T1 and T4 gonococci attached to, damaged and
traversed the fallopian tube mucosa, though the rate of infection and
invasion was much slower for the T4 organisms.
Similar studies using organ culture have been undertaken
by Stephens, Hoffman and ilcGee (1983) to examine the interaction of
N.meningitidis with human nasopharyngeal mucosa. The course of
events observed with this model closely resembled the events which
take place when gonococci infect fallopian tube mucosa in organ culture.
The meningococci appeared to adhere solely to the microvilli of non-
ciliated cells of the epithelium. The microvilli then appeared to
became restructured ana surrounded the micro organisms. Simultaneous
with this attachment phase (up to 12 hours post-infection) a rapid
decrease in ciliary activity together with sloughing off of ciliate
epithelial cells was observed. The meningococci attached to the
non-ciliate cells were engulfed within phagocytic vesicles. Despite
the apparent absence of endocytic vacuoles toward the basal aspects
of the cells, meningococci were seen in the subepithelial tissues
18-24 hours post-infection. No bacteria ware observed penetrating
the apical junctions and intercellular spaces.
In summary, both gonococci and meningococci appear to gain
access to the submucosal tissues by traversing through the epithelial
cells. This process involves endocytosis of the bacterium by the
epithelial cell. The exact mechanism for this is not fully understood,
though it is probably stimulated by a ligand-receptor interaction at
the epithelial cell surface. (Stephens, Hoffman and McGee, 1983).
The stimulating factor is probably not pili since T4 gonococci are
endocytosed at the same rate as T1 gonococci. (McGee, Johnson and
Taylor-Robinson, 1981).
1.7.2 Gonorrhoea
1.7.2.1 Symptomatic Localised Infection
Currant ideas concarning the pathogenesis of localised
gonococcal infection are, for th8 main part, derived from microscopic
examination of urethral pus. Such studies show clusters of gonococci
either free, or in association with epithelial or phagocytic cells
(Ov&.nnikov and Qelektoskij, 1977; Novotny and Short, 1977). The
gonococcal clusters on epithelial cells are located at the basal
aspect of the cells, and so are typical of those observed by McGee
Johnson and Taylor-Robinson (1981) in the fallopian-tube mucosal cells.
Moreover, these clusters of bacteria are regularly arranged and have
intact division planes, suggesting that they are healthy and viable.
Symptomatic localised gonococcal infection is characterised
by a purulent exudate containing many PMNs. These cells may be
attracted to the sits of gonococcal invasion by bacterial products
such as formyl-methicnyl peptides, but experiments by Idatt and Pledlen
(1978) using infected fallopian tube organ cultures suggested that
gonococci do not produce chemotactic substances. Their experiments
suggested that the predominant chemotactic component in gonococcal
infection is the complement fragment C5a which was produced by
activation of the alternative pathway. However, experiments by Games
and uJilliams (1978) and Rank and Holmes (1984) suggest that many,
but not all, clinical isolates of N.gonorrhoeae produce low molecular
weight substances which are chemotactic for PMIMs.
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Electron-microscopy has shown many gonococci within PF1N
phagocytic vacuoles.(Ovcinnikov and Delektorskij, 1971; Qviinnikov
and Delektorskij, 1977). In many phagosomes the bacteria appear to
be undergoing lysis. However, in some phagosomes the gonococci
appear healthy and intact. Novotny, Short and Walker, (1975) described
regular arrays of gonococci within membraneous packages covered with
granules which appeared to be the remnants of phagocytes. Later studies
showed this material to be reactive with anti-phagocyte serum.
(Novotny et al, 1977). The type of phagocyte could not be determined
using this serum, but examination of the granules and the occasional
nucleus which was seen in association with these membraneous packages
suggested that they were remnats of macrophages. These packages
have been termed 'infectious units' since gonococci multiply within
them, and appear to be protected from antibody and phagocytes.
According to Novotny et al, (1977) they are only derived fromnononuclear
phagocytes, not from PMN, nor epithelial cells. Novotny and
colleagues (1977) suggested that'infections units' were not formed
in P!*lN. PPIN can ingest large numbers of gonococci, even to self-
destructive levels; however, the appearance of gonococci released
from PNN is dissimilar to that of 'infectious units' due to the lack
of a dense granular coat. Novotny and colleagues (Novotny et al. 1977;
Novotny and Short, 1977) have outlined a scenario for the patho¬
genesis of gonorrhoeae which is summarised below : Figure 2
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1.7.2.1.1 Survival of N.gonorrhoeae within phagocytes
Evidence that gonococci can survive within human phagocytes
has corns from several workers. However, many reports are difficult
to interpret since there is uncertainty regarding the location of the
surviving bacteria, Were they really phagocytosed, or were they
just adherent to the phagocyte surface? By treating a mixture of
gonococci and phagocytes with an antibiotic such as peniciliin or
spectinomycin it is possible to kill the bacteria outside the
phagocyte, whilst not interfering with the fat8 of th8 intracellular
organisms. Subsequent lysis and viability counts will give information
on the survival of only those bacteria which have been phagocytosed.
These in vitro experiments have shown that gonococci can survive and
multiply within human PMN (klitt, Veale and Smith, 1976; Veale et al,
1979; Cas8y, Veale and Smith, 1979) and mononuclear phagocytes (Veale
et al, 1976) Using spectinomycin to kill non-adherent and surface-
associated gonococci Casey, Veals and Smith (1980) have examined the
theory of intracellular survival within urethral exudate cells
proposed by the electron-microscopy studies (QvcSinnikov and Delektorski j,
1971; Novotny, Short and Walker, 1975). Half the gonococci seen in
urethral exudates from acute cases of gonorrhoea are associated with
PNN (V8ale et al, 1979) and from th8 experiments of Casey, Veale and
Smith (1980) these organisms are within the phagocytes, viable and,
in some cases, growing. These experiments provide support for one of
the ideas proposed by Novotny and colleagues (1977), viz. that gonococci
can survive within phagocytes and so possibly avoid the immune response.
The nature of the gonococcal determinants conferring the
capacity for residence within phagocytes has been investigated by
Parsons and colleagues (Parsons et al, 1982). They associated three
non-pilus proteins, present in outsr membrane vesicles, with this
capacity.
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1.7.2.1.2 Opsonisation of N.gonorrhoeae by ABO isohaemaqqlutinins
ABO blood group has been shown to be a factor influencing
susceptibility to gonorrhoea (Foster and Labrum, 1976; Kinane et al,
1983b; Section 1.4.1.1). Studies comparing the relative degrees
with which mononuclear phagocytes of the four ABO blood groups
(A,B,A3 and 0) in the presence of autologous serum associate i.e.
bind and/or ingest, with [M.oonorrhoeae demonstrate that cells from
blood group B individuals bind more gonococci than cells of groups
A, AB and 0. (Kinane et al, 1983a). Furthermore, these experiments
showed that anti-A and anti-B isohaemagglutinings enhanced binding
of gonococci to monocytes since absorption of the isohaemagglutinins
reduced the opsonising capacity of the serum, reducing the degree of
bacterial binding to that observed in serum-free conditions.
Earlier experiments by Blackwell and colleagues (1983)
suggest that opsonisation by isohaemagglutinins is not involved in
the association of gonococci to PMN. When viewed in the light of the
schema proposed by Novotny and colleagues (1977), the increased
association of gonccocci with mononuclear phagocytes of blood group B
compared with those of other ABO blood groups could be a factor
increasing the susceptibility of group B individuals to gonorrhoea.
1.7.2.2 - Asymptomatic localised Infection
Asymptomatic localised gonococcal infection in women has
been recognised for a long time and recently the high incidence of
asymptomatic infections in males has been appreciated. Studies in
Denmark in 1975 showed that 57^b of infections of females were devoid
of symptoms, whilst the figure for infections of males was 15%.
(Nielsen, S^ndergaard and Ullman, 1975). These asymptomatic
individuals probably constitute a major reservoir of infection
since N.gonorrhoeae causing asymptomatic infection are virulent and
transmissible. (Brown et al, 1963)
The reasons for asymptomatic carriage are not clear;
however, gonococci isolated from these infections tend to have
auxotypes that are different from those isolated from symptomatic
localised infection, but similar to those strains isolated from
disseminated infections (Rein, 1977). Since strains causing
asymptomatic infection in one host cause symptomatic infections in
other hosts (Brown etal, 1963) the reasons for the lack of symptoms
are probably complex. The degree of bacterial invasion of the mucosa
and the propensity of the organism to activate complement are likely
to be factors influencing the development of symptoms. The similarity
of strains associated with asymptomatic infection to those isolated
from disseminated infections has been noted. These strains from
disseminated infections are slower to stimulate complement-mediated
neutrophil chemotaxis in vitro than strains isolated from localised
symptomatic infections (Densen, Mackeen and Clark, 1932).
1.7.2.3 Disseminated Gonococcal Infection (DGl)
Disseminated gonococcal infection (DGl) is a disease
complex resulting from haematogenous extension of the gonococcus from
the mucosa and submucosal tissues at the site of infection. DGl
is predominant in women. In an American study 80;H of DGIs were found
to occur in women, and this is thought to be associated with the
asymptomatic nature of gonorrhoea in most women (Al-Suleiman, Grimes
and Donas, 1993). The consequences of dissemination include migratory
polyarthralgias and tenosynovitis. There is either positive blood
culture, or positive synovial fluid culture. These appear to be
mutually exclusive. Skin lesions similar to those observed in
Schwartzman reactions are also observed (O'Brien, Goldenberg and
Rice, 1983).
Several factors have been proposed that are thought to
influence the dissemination of gonococci from the site of infection.
The increased susceptibility of women has already bean
mentioned. Among women with gonorrhoea, pregnancy or menses can
predispose to dissemination (Rein, 1977). Genetic absence of the
terminal components of the complement cascade, C6, C7 and/or C8,
increases the probability that dissemination will occur during
infection. (Petersen, Graham and Brooks, 1976; Lee et_al, 1978)
Common characteristics have been observed for strains associated with
DGI. These include; various auxotypes, predominantly Arg Hyx Ura ;
transparent colony phenotype (therefore absence of Protein II); a
particular coagglutination serogroup, WI, ; vary low MIC to penicillin
( < 0.03 ^ig/ml); resistance to the bactericidal activity of normal
human serum. (O'Brien, Goldenberg and Rice, 1983). Resistance to
Killing by human serum presumably assists dissemination through the
blood. In a study of 89 patients with DGI the gonococcus was
cultured from the blood in 19 cases. (Tronca et al, 1974). It is
also interesting to note that examination of the white blood cells in
the buffy coat from individuals for whom blood cultures were negative
demonstrated intracellular gonococci in four out cf eight cases.
(Tronca et al, 1974). These bacteria were identified by a fluorescent
antibody technique, so their viability was not assessed. However,
this observation provides in vivo evidence supporting the concept of
gonococcal spread and transmission whilst resident within phagocytes
proposed by Novotny and colleagues (1977).
1.7.3 Meningococcal disease
Meningococcal disease has a variety of clinical manifest¬
ations ranging from chronic meningococcaemia to fulminant meningococc-
aemia associated with coagulopathy. Although IM.meningitidis is
normally a harmless commensal bacterium it is one of the swiftest-
killing human pathogens. The natural habitat of the meningococcus
is the human oropharynx, where it lives in and around the mucous
membranes. Individuals harbouring meningococci are usually asymptomatic
and the frequency of carriage in the normal population ranges
from 5 to 30%, but during epidemics this can approach 1 QQ'/o. (De
\J oe, 1982).
The incidence of meningococcal disease is not simply
related to the carriage rate. The rarity of meningococcal disease
(up to 37.4 per 100,000) compared to the rate of carriage of
meningococci (up to 100,000 per 100,000) (De Voe, 1982) suggests
that host factors are very important in determining susceptibility
to meningococcaemia.
Immunity to meningococcal disease has been shown to
correlate with the presence of bactericidal antibodies in serum
reactive with the infecting strain (Goldschneider, Gotschlich and
Artenstein, 1969; Section 1.8.4.1). The importance of the lytic
components of the complement system, C6-C8, in preventing meningoc-
occaemia is highlighted by the susceptibility of individuals genetically
deficient in these components to repeated meningococcal bacteraemias
(Lee et al, 1978; Lee et al., 1979). Antibodies reactive with
meningococci are stimulated by carriage of meningococci (Rellsr,
McGregor and Beatty, 1973) and by other commensal organisms such as
enteric bacteria (Bobbins et al. , 1972). The bactericidal activity
of IgM and IgG can be blocked by IgA specific for the same antigens.
A high level of serum IgA reactive with meningococcal surface antigens
is thought to increase susceptibility to meningococcal disease by
allowing the development of a bacteraemic phase (Griffiss, 1977).
The colonisation and transgression of the mucosa has been
described in Section 1.7.1. If the organism enters the bloodstream
unchecked by bactericidal antibodies, one of the several facets of
meningococcal disease will develop. Concomitant with the bacteraemia,
the meningococcus is thought to metastasise to the skin, eyes, joints,
heart, adrsnal glands or meninges. 90% of all cases of meningococcal
disease have inflammation of the meninges, giving rise to meningitis,
and half of these cases will have dermal lesions (Qe Voe, 1982).
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The dermal lesions are part of a generalised Shwartzman
reaction. They result from vascular damage and intravascular coaggul-
ation. However, unlike experimentally induced ochwartzman reactions
in animals, histological examination early in the development of
these skin lesions does not show high concentrations of inflammatory
exudate cells. PMNs only infiltrate the area as the vascular
endothelium becomes damaged.
Death in fulminant meningococcaemic is due to acute
endotoxaemia and shock, Meningococci release copious amounts of
endotoxin during growth (De Uoe and Gilchrist, 1973) and it is
thought that meningococcal endotoxin may act directly on the central
nervous system to produce remote pathological effects (Oucker and
Simmons, 1368) such as haemorrhagic pulmonary oedema, visceral
congestion and adrenal haemorrhage. The consequences of this action
would be a rapid death.
Meningococcal meningitis is associated with a severe
inflammatory process. In this way it is distinct from the development
of skin lesions and similar to symptomatic localised gonorrhoea.
The brain becomes oedematous and there are small haemorrhages,
suggesting the action of endotoxin (De l/oe, 1982). As with gonorrhoea,
the meningococci are observed both inside and outside the neutrophils
in purulent cerebrospinal fluid. (De Uoe, 1982). The inflammation
of the meninges is thought to be due to meningococcal endotoxin.
The ability of meningococci to survive within human
phagocytes has yet to be fully examined. However, studies on the
interactions between the meningococcus and PMNs suggest that they are
killed (De lioe, 1980), degraded and then egested by a specific
exocytosis mechanism (De Uoe, 1976). This egestate has been found to
enhance the coagulopathic effect of meningococcal endotoxin in
rabbits (De Uoe and Gilka, 1976, The mechanism for this is not
certain, but DeUoe (1980) thinks that the sgestate stimulates release
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of PFlNs from the bone marrow which accumulate in the liver and the
lungs. There they compromise the main degraders of endotoxin, the
macrophages (Filkins, 1971), thereby seriously affecting the body's
capacity to cope with even small amounts of endotoxin. This endotoxin
could then stimulate thromboplastin production by leukocytes and
platelets, leading to intravascular coaggulation, the hallmark of
meningococcal diseasa (^sterud and Flaegstad, 1983; DeUoe, 1980)
1.7.4 Summary
The gonococcus and meningococcus cause radically different
disease states. They exhibit similarities in adherence and pene¬
tration of mucous membranes. Restriction to the mucous membranes
and sub-mucosal tissues appears to depend on effective serum
bactericidal activity for both organisms. The inability of phagocytic
cells to kill and degrade these bacteria is a significant factor
contributing to pathogenesis. The severity of systemic disease is
greater for meningococcal infection. This is, in part, due to the
pharmacological effects mediated by the profusely liberated endotoxin.
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1.8 NATURAL IMMUNITY
1.8.1 The protective role of 'natural' antibodies
Natural antibodias are immunoglobins which react with
antigens present on cells, such as pathogenic microbes and red blood
cells, with which the immune system has not been previously challenged.
They are cross-reacting antibodies. They develop in the classical
manner, as a response to antigenic stimulation. The stimulating
antigens are usually present in an innocuous form, such as in the
food we eat and in the micro organisms colonising the skin and gut,
rather than as components of virulent pathogenic bacteria. These
natural antibodies are identical to immune antibodias in their
biological activity and hence can be protective against pathogens
with which they fortuitously cross-react.
1.8.2 The role of natural antibodies in protection against
contain IgM, IgG and IgA antibodies which react with N.gonorrhoeae.
By a fluorescent antibody technique, Cohen (1967) found that IgG
and IgPl antibodies in NHS reacted with heat-labile (protein) and
heat-stable (carbohydrate) gonococcal antigens. IgA was found to
react only with the heat-stable antigens, and the titre was very low.
A study of the development of antigonococcal antibodies with similar
techniques found that the IgG antibodies are present in the newborn
at a similar concentration to that in maternal sera. This titre
was found to drop in titra for the first 3-4 months of life and then
return to adult levels. This pattern follows that observed for serum
IgG concentration during the first year of life and is due to the
ability of maternal IgG to cross the placenta. IgM and IgA do not
have this property. Antigonococcal Igfl was found in trace amounts in
Neisserial infection
1.8.2.1 Natural antibodies reactive with N.gonorrhoeae
Sera from normal children and adults have been shown to
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the newborn, but was found to increase in titre with increasing age.
Reactive IgA was not detectable in the first 4 months of life, and
the titres of older children never exceeded 1:2 (Cohen and Norrins,
1968).
1.8.3 The biological activities of natural antibodies
1.8.3.1 Bactericidal Effects
Normal human serum has been shown to kill N.gonorrhoeae
(Glynn and Ward, 1970) by means of an antibody-complement bactericidal
reaction. This is thought to be due to IgF! antibodies since treatment
of bactericidal serum with 2-mercapto—ethanol severely diminishes
this capacity. Further evidence obtained from the use of purified
immunoglobin fractions shows IgM to be bactericidal but IgG has
negligible activity (Schoolnik, Ochs and Buchanan, 1979).
The antigenic determinants) with which this natural
bactericidal antibody reacts has been shown to be predominantly in
the lipopolysaccharide molecule. (Glynn and Ward, 1970; Tramont,
Sadoff and Wilson, 1977) though in experiments with immune serum
raised in rabbits, outer membrane proteins can also be involved in
bactericidal reactions (Tramont, Sadoff and Artenstein, 1974).
Sera vary in their capacity to kill N.gonorrhoeae (Glynn
and Ward, 1970) but a greater source of variability appears to reside
in the bacterium itself. Ward, Watt and Glynn (1970) investigated
the serum sensitivity of gonococci in urethral pus. They found the
organisms to be resistant to the patient's serum and NHS; however,
after subculture most strains became sensitive to these same sera.
Other variations in susceptibility to NHS have been observed for strains
cultured in vitro. Not all strains isolated from localised infection
are serum-sensitive after subculture. Some maintain their resistance
(Glynn and Ward, 1970). However, in a study of the sensitivity to
NHS of 39 strains of gonococcus isolated from disseminated infection,
33 [91%) were resistant. (Schoolnik, Buchanan and Holmes, 1976). It
appears that strains associated with localised infection exhibit a
resistance to serum which is expressed in the environment of the
urethral pus but not in laboratory media, whereas strains associated
with disseminated infections exhibit a serum resistance which is
independent of the environment.
1.8.3.2 Inducible serum resistance
This variable serum resistance exhibited by strains
isolated from localised infections is also seen in strains adapted
to growth with subcutaneously implanted chambers in guinea pigs.
(Penn et al., 1976). Since this resistance was acquired and lost at
a faster rate than if it had occurred by mutation or selection, it
was thought to be phenotypic (Rittenberg et al, 1977). Analysis of
the factor(s) responsible for inducing this phenotypic serum resistance
in a laboratory strain BS4 (agar) indicate that a low molecular weight
( < 1200Q) fraction of guinea pig serum contains the inducing
principle. (Veale, Penn and Smith, 1981). In a study to determine
the influence this agent has on serum sensitivity of recant clinical
isolates, Martin et al (1983) described the induction of resistance
to a 1:4 concentration of serum in 13/20 isolates from males and 9/10
isolates from females. The eight isolates that did not exhibit
resistance to the 1:4 concentration of serum were found to be
significantly resistant to lower concentrations of serum compared to
the level of serum sensitivity before induction.
Human serum and genital secretions have been shown to
induce a similar phenotypic serum resistance. In a survey of the
capacity of 47 sera to induce serum resistance in strain 8S4 (agar),
only 13 positive sera were found (Martin et al, 1981). The nature
of the inducing agent appeared to be similar to that observed in
gjinea pig serum, but it was less potent. Human genital secretions
also induce strain BS4 (agar) to serum resistance. 5/11 samples of
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cervical secretions converted > 50% of approximately 10 gonococci
to serum resistance. A higher proportion of seminal plasmas, 9/10,
had the same effect (riartin et al. , 1982).
The clinical significance of the capacity of human serum
to induce phenotypic serum resistance in gonococci has been
investigated. (Martin et al. , 1982b). They suggest that this factor
does not affect susceptibility to the disease. Absence of the induc¬
ing factor was, paradoxically, associated with the development of
salpingitis and with females who had successive infections. However,
those sera from men with a previous history of infection and women with
their first infection were similar to control sera (Martin et al,
1982b; Martin et al., 1984).
1.8.3.3 Genetically determined serum resistance
The gonococcal determinants of constitutive serum
resistance are thought to be influenced by two genetic loci: sac-1,
and sac-3. (Shafer, Glymon and Sparling, 1982) sac-1 is closely
linked to a locus nmp-2 which influences Protein I. This led to a
misinterpretation of the role of protein I in determining serum
sensitivity. (Hildebrandt et al., 1978; Cannon et al, 1981).
Expression of these sac genes is thought to influence the gonococcal
surface so as to vary the degree of serum sensitivity.
Schneider et al. , (1982) have examined the potential role
of factors in both the serum and the gonococcus in an attempt to
define the immunological basis for serum resistance. They concluded
that neither intrinsic resistance of the gonococcal outer membrane to
the lytic action of complement, nor inaccessibility of the membrane to
C5b were involved in gonococcal serum resistance. It results from
absence of antigenic loci on the LPS molecule to which bactericidal
antibody binds. Consequently, the sac loci may influence the com¬
position and/or structure of the LPS, since serum-resistant strains
have LPS molecules which are immunologically distinct from serum
sensitive strains (Glynn and Ward, 1970).
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1.8.3.4 Disseminated Gonococcal Infection (DGl)
Strains isolated from disseminated gonococcal infactions
are constitutively resistant to the bactericidal effect of normal
human serum, though they can be killed by convalescent ssrum.
(Schoolnik, Buchanan and Holmes, 1976). Doiner st al (1983) suggest
that the lytic complex of complement is deposited on the surface of
DGI strains incubated in NHS to the same extent as that deposited on
serum-sensitive strains. However, the lytic complexes (C5b-9)are
aggregated on the membranes of the OGI strains and fail to penetrate
the membrane. The bactericidal antibody present in convalescent
serum is thought to allow insertion of the lytic complexes into the
membrane, resulting in cell death.
1.8.3.5 Does the complement mediated bactericidal activity of
Normal Human Serum confer protection against Gonococcal
Infection?
The bactericidal activity in normal human serum does
prevent dissemination of serum-sensitive gonococci from the mucous
membranes. The evidence for this comes from the predisposition of
individuals with deficiencies in the terminal components of the
complement system to gonococcaemia with serum-sensitive organisms.
Replacement of the complement components in vitro restores the
bactericidal capacity of the patient's serum for the infecting strain.
(Petersen, Graham and Brooks, 1976') Additional evidence is provided
by the serum-resistant nature of the great majority (97%) of strains
isolated from DGI in contrast to the smaller proportion (42',,o) that
are isolated from localised infections (Schoolnik, Buchanan and
Holmes, 1976). However, this also indicates that factors in addition
to serum-resistance may also influence dissemination. The role of
bactericidal immunity in protecting the mucosa is, however, more
uncertain than its role in preventing bacteraemia.
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1.8.3.6 Opsonic effects
igG antibodies present in normal human serum have been
shown to promote phagocytosis of gonococci by human neutrophils.
(Schiller, Friedman and Roberts, 1979). This opsonic effect is augmented
by the presence of complement, but complement alone was not opsonic.
The antigenic specificity for this natural opsonising antibody
resides in the Protein I molecule in the gonococcal outer membrane
(Sarafian, Tarn and Morse, 1983).Serum also enhances the degree of
binding of gonococci to human mononuclear phagocytes (Kinane et al.
1983a). This opsonic activity can be removed by absorption of the
isohaemagglutinins. Absorption of isohaemagglutinins by N.gonorrhoeae
has been previously reported. (Miler et al. , 1977).
1.8.4. Meningococcal Disease
1.8.4.1 Natural antibodies reactive with N.meninqitidis
Normal human serum has bactericidal (Matsunami and
Kolmer, 1918) and opsonising (Kolmer, Toyama and Matsunami, 1918)
activities against N.meningitidis. A study of the development of
bactericidal antibody (Goldschneider, Gotschlich and Artenstein,
1969) has shown an age-related pattern similar to that described for
anti-gonococcal antibody development (Cohen and Norrins, 1968;
Section 1.8.2.1). An inverse relationship exists between the develop¬
ment of bactericidal immunity and the risk of meningococcal disease.
(Goldschneider, Gotschlich and Artenstein, 1969). Neonates have a
low incidence of meningococcal disease; this is probably due to
anti-meningococcal IgG obtained from the mother by placental transfer.
Young children who have low levels of bactericidal antibody, are
at greatest risk from meningococcal disease. The development of
natural bactericidal antibodies reactive with serogroupable meningococci
confers the increased resistance observed to develop in later child¬
hood. , These antibodies are thought to develop as a consequence of
antigenic stimulation by commensal enteric bacteria (Robbins et al,
1972), and asymptomatic carriage of N.meninqitidis (especially non -
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sero-groupabl8 strains) and IM.lactamica in the nasopharynx. (Reller,
McGregor and Beatty, 1973; Gold et al. , 1978). Gold and colleagues
(1978) found that carriage and meningococci was low ( < ^1%) for the
first two years of life, but rose in later childhood and adolesence.
In contrast, carriage of N.lactamica was high in infants, reaching 2470
in 2 year old children but declined after the fourth year. They found
that 40/b of children who carried N.lactamica developed increased
titres of bactericidal antibody reactive with meningococci of serogroups
A,8 and C.
The role of antibody-complement mediated bactericidal
immunity in host defense against meningococcal disease is highlighted
by the frequency with which meningococcaemia is observed in individuals
deficient in the terminal components of the complement system. (Lee
et al. 1973; L88 et al., 1979). In a recent survey of 13 people who
suffered from recurrent meningococcaemia, 4 had genetic defects in the
complement system (Merino et al.. 1983). Investigations by Nicholson
and Lepow (1979) determined that neutrophil phagocytosis and intra¬
cellular killing of meningococci was unaffected by serum deficiency
of the complement component C8. The bactericidal function of the
serum was absent in the C8 deficient serum, but could be restored by
the addition of purified C8.
Natural resistance to meningococcal disease, therefore,
appears to be more dependent on bactericidal immunity than does natural
resistance to gonorrhoea.
In both diseases bactericidal immunity is a major defense
against haematogenous spread of the bacteria from the sites of mucosal
colonisation. However, gonococcal colonisation of mucous membranes is
generally mora pathogenic than carriage of N.meningitidis. The
relationship between localised gonococcal infection and serum bacter¬
icidal activity may be comparable with the relationship between
nasopharyngeal carriage of meningococi, and the bactericidal activity
of the serum. Serum bactericidal activity against the meningococus
does reduce the rate of nasopharyngeal carriage, but it does not prevent
nasopharyngeal infection. (Brooks and Ingwer,1978; Gotschlich,
Goldschneider and Artenstsin, 1969).
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In a study of the immune responsexiexperimental human
infection, Cohen, Kellogg and IMorins (1969) determined the levels
of serum igA, igG and igM reactive with heat-labile and heat-stable
gonococcal antigens over a 14Q day period by an immunofluorescence
technique. They observed an increase in jgG, I9A anc' 19^ activities
against the heat-labile (protein) antigens. The only immunoglobin
class to increase in titre against the heat-stable (lipop^lysaccharide)
antigens was jgA, However, IgG and IgM antibodies reactive with the
heat-stable antigens ware present in the sera.
In a similar investigation of natural gonococcal infection
McMillan et al♦, (1979) correlated the distribution of titres of
IgA, IgG and IgM antigonococcal antibodies with the duration of
infection. IgM and IgA antibody titres were found to be raised in the
early period of infection (up to 14 days) but then declined to the
levels observed in uninfected individuals. IgG antibodies were
retained at high titre for a longer period. Treatment of the infection
resulted in a rapid decline in IbvsIs of IgM and IgA, followed by a more
gentle drop in titre of IgG. This study, however, did not ascertain
the antigenic specificity of these antibodies.
An examination of the antigonococcal antibodies in urethral
exudates of 132 men with gonorrhoea demonstrated reactive antibodies in
129 cases. IgA and IgG were predominant, being observed in 129 {98%)
and 119 (90/g) cases, respecively. IgM was observed in only 64 (49^)
specimens. After treatment, the levels of IgA and IgM declined rapidly
whereas IgG levels dropped at a slower rate. This pattern was similar
to that observed with antigonococcal antibodies in serum. (McMillan,
MclMeillage and Young, 1979). These authors noted that three men in
their study ware asymptomatically infected with IM.gonorrhoeae yet they
elaborated a similar immune response as those men who showed symptoms of
infection.
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The functional aspects of IgG and IgA antigonococcal
antibodies in genital secretions have been examined by Tramont (1977).
He found that the secretions could inhibit gonococcal attachment to
epithelial cells, but the activity was relatively specific for the
antibody-inducing (i.e. infecting) strain. Bactericidal antibody has
been shown to increase in approximately one third of patients with
localised infection (Brooks and Ingwer, 1978) and patients with
disseminated infections. In particular, those with suppurative joint
infections tended to develop antibodies that killed the infecting strain
(Rice, McCormack and Kasper, 1980): Opsonisation of DG I strains has
been reported to occur only with sera bactericidal for the test strain
(Brooks, Israel and Petersen, 1976).
Patients with gonorrhoea have been shown to develop
elevated isohaemagglutinin titres (Milar ■ st al., 1977). Individuals
of blood group 0 developed raised titres against red cells of Groups
A, 3 and AB. Group A individuals only showed an increase in reactivity
with AB cslls. Group B individuals, however, showed significantly
lower titres against AB than control values. No simple relationship
between the agglutinin titres and the duration of infection was
observed. Other gram-negative organisms have been shown to induce
isohaemagglutinin formation (Springer, 1970). The isohaemagglutinins
induced by N.gonorrhoeae are IgM antibodies, and they can be present
in high titres ( 1:512). The absence of high titres of IgM reactive
with gonococci in the sera of patients with gonorrhoea is a paradox
(Cohen, Kellogg and Norins, 1969; McMillan et al.. 1979). An equally
curious observation is the failure to gonococcal immunisation to induce
o
high titres of is|haemagglutinins in rodents and primates (Milsr et al,
1977).
1.9.1.2 Meningococcal Infection
Meningococcal disease, if untreated, has a case fatality
rate in excess of 80%. Appropriate antibiotic therapy reduces this
figure to less than 10%. During meningococcal disease the antibody
response in adults and children over 2 years old is both rapid and
intense for the three major classes of immunoglobin (Zollinger,
Pennington and Artenstoin, 1974). Antibodies to membrane proteins,
lipopolysaccharide and the group-specific capsular polysaccharide are
formed (Artenstein et al., 1971). The group-specific polysaccharide and
lipopolysaccharide antigens of group B meningococci, however, are poor
stimulators of antibody (Zollinger, Pennington and Artenstein, 1974)
whilst the antibody response to the protein antigens is comparable to
that observed with other serogroups. Infants under 1 year old do not
respond to systemic disease in the same way as adults. They are
unable to elaborate a bactericidal antibody response (Baltimore and
Hammerschlag, 1977), yet they appear to be capable of developing
cross-reactive antibodies which are bactericidal for the meningococcus
as a result of carriage of N.lactamica (Gold et al. . 1978). The
observation by Griffiss (1975) that convalescent sera contain IgA
capable of blocking immune lysis probably accounts for the diminished
bactericidal activity in acute serum of patients with meningococcal
disease. Since bactericidal antibody is the main host defense against
systematic meningococcal disease, this observation provides a caveat
for the designers of meningococcal vaccines.
1.9.1.3 Immune response to meningococcal vaccines
Following the observation by Goldschneider, Gotschlich and
Artenstein (1969b) that the major antigen involved in the immune response
to serogroup C meningococci was the group-specific polysaccharide
capsule, vaccines containing groups A and C polysaccharides have been
developed and widely used. Group B polysaccharide does not appear to
stimulate an immune response in man and attempts are being made to
develop vaccines for group B meningococci with outer membrane proteins
associated with serogroup B (proteins 2 and 9) (Lepow and Gold, 1981).
Intracutaneous immunisation of a vaccine of group C poly¬
saccharide antigen results in increased levels of specific IgFl, IgG
and IgA. (Artenstein et al., 1970). This vaccination appears to
stimulate mucosal immunity since the carriage rate in the vaccinated
subjects is reduced in comparison to unvaccinated controls. (Gotschlich,
Goldschneider and Artenstein, 1969). The protective efficiency of this
type of vaccine is about 90% (Lepow and Gold, 1981).
These vaccines are also immunogenic for children, but the
antibody concentrations induced are only 50% that obtained in adults.
1.9.2 Cell-mediated Immune Response
Cell-mediated immunity is particularly important in host-
defense against intracellular pathogens and a close temporal relationship
has been demonstrated between development of delaysd-type hypersensit¬
ivity and acquired resistance to intracellular pathogens: Mycobacterium
tuberculosis, Brucella abortus and Listeria monocytogenes (Collins, 1971).
Sensitized lymphocytes respond to antigen by elaborating a variety of
factors, called lympr^<ines, one of the functions of which is to
increase the bactericidal capacity of phagocytes. (Morley, Hanson and
Rumjanek, 1984). In view of the intraphagocytic location of a large
proportion of bacteria in gonorrhoea and meningococcal disease,
lymphokine production nay have a major role in host-defense against
the pathogenic Neisseria species. In addition, K-lymphocytes (and
mononuclear phagocytes) can act in concert with specific antibody to
lyse cells. This is termed antibody-dependent cell-mediated cytotoxicity
(ADCC).
1.9.2.1 Gonococcal Infection
□elayed-hypersensitivity to gonococcal antigens has been
observed in patients with gonorrhoea. Corbus and Corbus (1941)
reiterated this observations, which had been the subject of forty-six
contributions since 1909. Lymphocytes isolated from patients with
gonorrhoea have been shown to elicit a blastogenic response when
stimulated with gonococcal antigens (Esquenazi and Streitfeld 1973).
Not all patients' lymphocytes respond to the same degree (Wyle,
Rowlett and Blumenthal, 1977). Some individuals were no more
sensitive to the stimulating antigen than uninfected controls. The
incidence of non-responders was much greater among male patients than
female patients.
Lymphocyte blastogenesis in cells taken from patients with
gonorrhoea can also be stimulated by antigens from N.meningitidis
(Wyle, Rowlett and Blumenthal, 1977), and, occasionally, from
N.catarrhalis (Esquenazi and Streitfeld, 1973). This gives further
support to observations of antigenic similarity among the Neisseria
species. (Apicella et al., 1981; Gold et al., 1978).
1.9.2.2 Neninqococcal Disease
Little effort has been made to investigate the cell-
mediated immune response to meningococcal disease because of the evidence
suggesting a dominant role for bactericidal antibody in host-defense
against N.meningitidis. Lymphocytes from patients with acute
meningococcal meningitis show a severely depressed response to
meningococcal antigens and the plant lectin stimulant of lymphocyte
blastogenesis, phytohaemagglutinin, (Greenwood, Cnduloju and Ade-
Serrano, 1979). Lymphocytes from vaccinees reacted in a similar
fashion to those obtained from control subjects. Sparkes (1983)
recently observed that meningococcal protein antigens in a CaCl^
extract were strongly mitogenic for murine B-lymphocytes, but markedly
impaired T-lymphocyte responses to mitogenic stimuli. This suppression
of T-lymphocyte responsiveness might account for the anergy observed
in acute meningococcal meningitis.
Antibody-dependent cell-mediated anti-meningococcal
activity by K-lymphocytes and mononuclear phagocytes has been reported.
(Lowell et al.. 1979). IgG and IgA antibodies specific for N,
meningitidis are equally effective in initiating this cell-mediated
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killing of meningococci. Convalescent igF) induced by Group C
meningococcal vaccine is ineffective. (Lousll et al., 1980). The
immune specificity of this cell-mediated antibacterial system has been
shown to depend on the antibodies to the group specific meningococcal
capsular polysaccharides. (Smith and Lowell, 1980).
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1.10 THE AIMS OF THIS STUDY
1.10.1 A comparison of sera of blood groups A and 3 in thsir
capacity to kill Neisseria gonorrhoea and Neisseria men¬
ingitidis
The epidemiological data reviewed in section 1.3 et seq
led to the investigation of the host-parasite interactions responsible
for the observation that individuals of blood group 8 appear to be more
susceptible to infection by N.gonorrhoeae than individuals of the
other ABO blood groups (Foster and Labrum, 1976; Pliler et al. , 1977;
Kinane et al., 1933). Gonococci have been found to absorb and
stimulate production of human ABC isohaemagglutinins (Miler et al■,
1977). Anti-3 isohaemagglutinins have also been shown to be capable
of opsonising and killing via an antibody-complement mediated
bactericidal reaction organisms, such as Escherichia coli 086, that
have galactose as the immunodominant sugar of the LPS (Muschel and
Osawa, 1959; Check et al., 1972). Terminal galactose residues are also
a feature of gonococcal LPS, and galactose-spscific antibodies cross-
react with purified gonococcal LPS (Bundle, 1979).
The suggestions of Foster and Labrum (1976) combined with
this information about the biological activities of anti-B isohaemagg¬
lutinins and the chemical nature of gonococcal LPS led to the
formulation of the following hypothesis :
Gononocci, by virtue of the terminal galactose residues
in the LPS molecule, react with human serum in a similar
fashion to E. coli 086, and so are a) opsonised and b)
killed much more effectively by anti-B antibodies than by
anti-A antibodies.
A comparison of normal sera from individuals of Groups A
and B should show a greater opsonising and bactericidal
activity against N.gonorrhoeae in group A sera (i.e. the
sera which contain anti-B antibodies).
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Studies by Blackwell et al (1983) have shown no differences
in the opsonising capacity of A and B sera.Serum did not increase the
degree of association between gonococci and neutrophils, Kinane et al
(1983a) found that autologous serum enhanced gonococcal association
with mononuclear phagocytes, especially to cells of blood group B.
Moreover, this opsonic activity was absent in AB serum (which has no
anti-A or anti-B antibodies) and in serum from which the ABO iso-
haemagglutinins had been removed (see section 1.7.2.1.2).
Consequently, the hypothesis proposing a greater opsonic
activity for N.gonorrhoeae in group A serum in comparison with group 8
serum has been disproved for neutrophils, but still requires further
invests/on with mononucler phagocytes.
This study tests the second part of the hypothesis: normal
serum from blood group A individuals has a greater antibody-complement
mediated bactericidal activity against IM.gonorrhoeae than serum from
individuals of blood group B.
Sinca IM.gonorrhoeae and N.meningitidis have similar outer
membrane structures, particularly the LPS molecule (with which
'natural' bactericidal antibodies react (see Section 1.5.5 et seq) )
comparisons will be made between the sensitivity of gonococcal and
meningococcal strains to normal sera from individuals of blood groups
A and B.
1.10.2 A comparison of the oxidative metabolic response of human
peripheral blood monocytes of blood groups A, B, AB and 0
in response to stimulation with Neisseria gonorrhoeae
The work of Kinane et al.. (1983a) demonstrated enhancement
binding of N.gonorrhoeae to human peripheral blood monocytes by
isohaemagglutinins. This enhanced binding was greatest for monocytes
of group 8 in autologous serum. (See Section 1.7.2.1.2). The
second part of this investigation comprises a short pilot study to
ascertain 1) whether there is any heterogeneity in response to
stimulation by IM.gonorrhoeae from monocytes of blood groups A,8,AB and
0 in the presence of autologous serum and 2) whether the response can
be diminished by absorbtion of the 'natural' antibodies reactive







2.1.1 Phosphate Buffered Saline (PBS)
2.1.2 Dulbecco's Phosphate Buffered Saline (DPBS)
2.1.3 Tris Buffer
2.2 Bacterial Strains 69
2.3 Bacterial Culture Media
2.3.1 Modified New York City (MNYC) Medium
2.3.2 Sodium Glutamate Broth (SGB)
2.3.3 Defined Medium





2.5.2 Induction and preparation of pyocins
2.5.3 Titration of pyocin activity - a plaque assay
2.5.4 Determination of the pyocin sensitivity spectrum of strains
of N.gonorrhoeae and N.meningitidis by a plaque assay
2.5.5 Isolation of a mutant strains of N.gonorrhoeae which was
resistant to Kageyama's class R1 pyocins
2.5.6 Modified pyocin-typing procedure
2.6 Bactericidal Tests 75
2.6.1 Introduction
2.6.2 Human Sera Page
2.6.3 Preparation of mouse immune serum against N.gonorrhoeae
2.6.3.1 Preparation of immunising antigens
2.6.3.2 Immunisation schedule
2.6.4 Complement
2.6.5 Assay of bactericidal actiuity in immune mouse serum
2.6.6 Titration of bactericidal actiuity in human serum
2.6.7 Inhibition of serum killing of N.gonorrhoeae by isolated
LPS2.7 Titration of Isohaemagglutinins SO
2.7.1 Absorbtion of isohaemagglutinins and other antibodies from
serum2.8 Lioopolysaccharide isolation and analysis 81
2.8.1 Lipopolysaccharide extraction
2.3.2 Analysis of the isolated LPS
2.8.2.1 Introduction
2.8.2.2 Hydrolysis of LPS and preparation of alditol acetates
2.8.2.3 Separation and identification of the alditol acetates by
gas chromatography
2.8.3 Extraction of outer membrane complexes
2.9 Sodium Dodecyl Sulohate - Polyacrylamide Gel Electrophoresis
(SOS-PAGE)
2.10 Silver Staining of Lipopolysaccharide 86
2.11 The Nitroblue Tetrazolium (NST) reduction test 87
Paae
2.11.1 Isolation of monocytes from human peripheral blood
2.11.2 Preparation of monocyte monolayers
2.11.3 Nitroblue Tetrazolium (NBT) reduction test
2.12 Statistical Methods 92
2. MATERIALS
All chemicals and biochemicals were obtained commercially
and were of a high technical grade or analytical grade of purity.
2.1 Buffers
2.1.1 Phosphate Buffered Saline (PBS)
50 rnM Phosphate buffer pH 7.2 containing 0.15 fl Sodium
Chloride.
2.1.2 Dulbecco's Phosphate Buffered Saline (DPB5)
Dulbecco's PBS (pH 7.3) was prepared from Dubecco's A
tablets (Oxoid Ltd., England) which give a solution containing NaCl
(5g/l) , KC1 (0.2 g/ 1 ), NagHPO (l.15g/l) and KH2?C 4 (0.2g/l),
0.2/c Phenol Red indicator was added to give a final concentration of
O.OOO273. Divalent cations were added by supplementing 100 ml DPBS
with 0.5 ml Dulbecco B (CaCl2 (20g/l), MgC^ (20g/l) (Q.PBS + 8).
2.1.3 Tris Buffer
This Tris buffer was used to store the partially purified




Recent clinical isolates of Neisseria gonorrhoeae were
obtained from Dr H. Young and colleagues, STD Diagnostic Laboratory,
University of Edinburgh. Strains mere also provided by Dr K. Shannon
and Prof. I Phillips, St Thomas's Hospital Medical School, London
and Dr Doan S. Knapp, Neisseria Reference Laboratory, United States
Public Health Service, Seattle, Washington. Strains of N.meningitidis
and N. lactamica were obtained from the culture collection of the
Infection and Immunity Laboratory, Bacteriology Department, University
of Edinburgh,as were the pyocin-producing strains of Pseudomonas
aeruginosa. The Kageyama classification (Kageyama, 1975) for the
pyocins produced by the strains of Ps.aeruginosa used in this study are
shoun in Table III.
in a humidified incubator in an atmosphere of air enriched with 10%
(U/U) CO?. The Pseudomonas strains were cultivated on nutrient agar
□




Kageyama classification of the pyocins
Kageyama
Classification
Pyocin producing strains of
Pseudomonas aeruginosa







R 5 ISA, ISC
R205, 9579Nongroupable
69.
2.3 Bacterial Culture Media
In addition to standard bacterial culture media, the following
were used *
2.3.1 Modified New York City (MNYC) Medium
This was prepared as outlined by Young, (1978). The medium
contained Difco GC Medium Base supplemented with 10% ('d/U) Group 0
human blood lysed by Saponin ( 0.5% U/v), 2.5% (ld/\/) yeast dialysate,
0.1% (Ui/U) glucose, lincomycin (ipg/ml), colistin (6 (jg/ml) amphotericin
B (l^jg/ml) and trimethoprim lactate (6.5 ^jg/ml).
2.3.2. Sodium Glutamate Broth (SGB)
This is a clear medium suitable for the production of
pyocins (Kageyama and Egami, 1962). It contains sodium glutamate, 20g,
glucose (20% (ld/V solution) 20 ml, Mg SO ^7H2Q 0.1g, NaH ^0^. 12H90
5.63g, KH^PO^ 0.25g, Ca(NC^ ) 210mg, yeast extract 1g; and distilled
water to 1 litre. The glucose solution was sterilised by filtration
and added to the autoclaved medium before use.
2.3.3 Defined Medium
This chemically defined liquid medium was used in the
cultivation of N.gonorrhoeae for part of the study which was conducted
in the Microbiology Department, University of Birmingham. It was
prepared according to the directions given by Veale, Penn and Smith
(1981).
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2.4 Enumeration of 8acteria
2.4.1 Total Counts
Bacteria ware counted microscopically in a Helber chamber.
At least 200 bacteria were counted in each estimation.
2.4.2 Viable Counts
Viable counts of bacteria were performed by plating out
tenfold dilutions of the bacterial suspension, either as six drops
of 50 jjl , as described by Miles, Misra and Irwin, (19JB) or by spreading
0.3ml of each dilution over a plate. After overnight incubation
the number of colonies was multiplied by the appropriate factor to give





Pyocins are bacteriocins producad by Ps.aeruajnosa that
bind to and kill bacterial strains bearing the appropriate receptor
molecules. Pyocin typing allows detection of bacteria possessing these
receptor molecules. The basic procedure involves mixing the pyocin
with the bacterial strain under test in conditions that allow pyocin-
binding and killing to take place, then determination of the residual
viable organisms. Bacteria expressing the pyocin receptor will be
killed, whereas those which do not will remain viable. By using a
range of pyocins which have different receptor molecules, a typing
schema can be developed based on the sensitivity spectrum of pyocin-
sensitive spectrum of pyocin-sensitive strains.
2.5.2 Induction and preparation
Pyocin-production and partial purification basically
followed a procedure outlined by Blackwell, Young and Anderson (1979).
An overnight nutrient-broth culture (2ml) of the pyocin-producing
strain of Ps.aeruginosa was added to 25 ml of sodium glutamate broth
(SGB). After 3 hours incubation at 30°C in an orbital incubator
(Gallenkamp) running at 100 r.p.m., Mitomycin C (1.3 jjg/ml) was added
and the cultures were incubated in the dark until the cells lysed. This
took approximately 3 hours. The lysate was centrifuged at 3000 xg
for 30 mins. to remove the cells and debris. The supernates were
shaken with chloroform (5/i V/V) to kill any remaining bacteria and
o
stored at 4 C overnight.
This crude pyocin lysate was ultracentrifuged (I00,000xg/
3 hours) and the supernatant, containing soluble pyocin activity and
Mitomycin C, was discarded. The pellet, containing the rod-type
(R-type) pyocins, was resuspended in Tris buffer.
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2.5.3 Titration of pyocin activity - a plaque assay
Pyocins were titrated according to the protocol described
by Blackwell, Winstanley and Telfer Brunton, (1982). Two fold
dilutions of pyocin suspension were made in DPBS t B 15 pi drops of
each dilution were placed on a dried nutrient agar plats. When the
drops had been absorbed the plate was flooded with a suspension of
7
Ps.aeruginosa strain ZD8/38 (10 cfu/ml), a strain which is susceptible
o
to all the pyocins used in the study, and incubated at 37 C for 12-18
hours. The pyocin titre was the highest dilution that produced a
clear area of inhibition of the bacterial lawn. The activity of aach
pyocin preparation was frequently checked against the indicator
strain Ps.aeruqinose ZD8/38. The pyocin preparations retained high
activity over a period of several months.
2.5.4 Determination of the pyocin sensitivity spectrum of
strains of N.gonorrhoeae and N.meningitidis by a plaque
assay
Discrete 10 pi drops of each pyocin preparation (standardised
to a titre of 54-128) were placed onto dried FINYC plates. After they
had been absorbed the plate was flooded with an 18 hours culture of
the bacteria suspended in DPBS + B (approx. 10 cfu/ml) and any excess
fluid was removed by gentle aspiration. After overnight growth the
results were recorded as + = inhibition, - = inhibition with some
overgrowth - = no inhibition.
2.5.5 Isolation of a mutant strain of N.gonorrhoeae which was
resistant to Kageyama's class R1 pyocins
Colonies growing within a zone of inhibition produced by
the R1 class pyocin, IS8, were subcultured and re-typed. One mutant
strain P280p, derived from a strain sensitive to pyocins of classes
R5 and R1 (P280) was sensitive to Class R5 pyocins only. This mutant
strain was used in this study.
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2.5.6 Modified pyocin-typinq procedure
A modification of the pyocin typing procedure was required
for part of this study uhich was conducted in the Microbiology depart¬
ment, University of Birmingham. The main modification involved the
removal of unreacted pyocin prior to determination of the numbers
of residual viable organisms. The procedure developed to meet these
needs was as follows : 15 pi of the pyocin suspension was added to
100 pi of the test organisms suspended in Defined Medium (DM) (10^ -
c
10° cfu/ml) in sterile plastic tubes (10 ml capacity). Control tubes
received DM (15 pi) but no pyocin. After 30 min, incubation at 37°£
0.5 ml DM was added to each tube. The gonococci were deposited by
centrifugation (1500 xg, 15 min) and the supernatant containing
unreacted pyocin was removed. The gonococci were resuspended in 0.3 ml
DM and plated onto 'chocolate' agar or MNYC medium. Results were
recorded as +, - and - when the viable counts were < 5/u, < 20/i





Complement activation by specific antibody can rasult in
killing and lysis of gram-negative bacteria. The aims of the
bactericidal tests are to determine the presence of serum bactericidal
antibodies reactive with test bacterial strains and to quantify these
antibodies by titration. As with the pyocin sensitivity tests (Section
2.5 et seq.), the principle of the test is to mix serum, or a dilution
of the serum, with a standard number of bacteria and a standard amount
of complement in an environment conducive to the activation of comple¬
ment by antigen-antibody complexes. After incubation at a standard
temperature over a fixed period of time the number of residual viable
organisms is determined. By comparison with a control experiment in
which the antibody is absent, an estimation of the degree of bacterial
killing can be made. The degree of killing which constitutes
significant bactericidal activity is an arbitrary decision. In these
experiments a significant bactericidal test results in a drop of at
least 30% in the number of viable bacteria over a 30 min period at
37° C.
The distinction between killing due to antibody -
dependent activation of the classical complement pathway and that due
to activation of the alternative pathway can be made by conducting
bactericidal tests in medium containing 10 mP|_ Pig - EGTA. This
specifically chelates the calcium ions which are essential for
activation of the classical complement pathway. Any bactericidal
activity observed in this system is due to activation of the alternative
complement pathway. The possibility that the alternative complement
pathway might be activated by the test organisms can be greatly
decreased by diluting the complement components by 1/16. This still
allow activation of the classical (antibody-mediated) complement
pathway (Schreiber et al, 1979).
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2.5.2 Human Sera
Normal human sera from individuals of blood groups A and
B were obtained in small quantities from women attending post-natal
clinics. They were kindly supplied by Drs P.L. Yap and S. Urbaniak,
Blood Transfusion Service, Royal Infirmary of Edinburgh. Sera from
patients with gonorrhoea were kindly provided from Or H Young and
colleagues, STD Diagnostic Laboratories, University of Edinburgh.
These sera were taken from the patents for syphilis serology, and I
used the small amounts remaining after the diagnostic work was completed.
o
All sera were heated to 56 C for 30 minutes to inactivate the
o
complement. They were stored at -20 C prior to use.
2.6.3 Preparation of mouse immune serum aqainst N.gonorrhoeae
2.6.3.1 Preparation of the immunising antigens
An eighteen hour growth of N.gonorrhoeae was harvested
from WNYC plates, suspended and washed twice in PBS, then rssuspended
in 10 ml PBS to which an equal volume of PBS containing 2.4T) formal-
o
dehyde was added. After overnight storage at 4 C the formaldehyde -
treated organisms were pelleted and resuspended in PBS, containing
Q.01/'o formaldehyde as a preservative, to the opacity of Brown's tube
No. 3 as judged by eye (Brown, 1919-1920). This is equivalent to
g
1.1 x 10 gonococci/ml (Cunningham and Timothy, 1924).
2.6.3.2 Immunisation schedule
Groups of 10 female CF1 mice, 5-6 weeks old, each with a
bactericidal titre of < 10 against the immunising gonococcal strain,
were immunised via the lateral tail veins with 0.25 ml of the
suspension of formaldehyde - treated bacteria. The mica were immunised
on days 0, 7 and 10. On day 14 a small quantity of blood was taken
from each mouse in the group via the retro-orbital plexus and pooled.
The separated serum was heat-inactivated (56°C/30 mins), distributed
into small tubes and stored at -20°C until required. The mice there¬
after received booster doses (0.25 ml) of gonococcal antigen at 14
day intervals and a small quantity of blood was taken from each mouse
five days after each booster dose. This was continued for ten weeks
with each group of mice.
2.6.4 Complement
Human AS serum from a donor with no history of gonococcal
infection was absorbed twice over a period of 24 hours at 4° C with a
'cocktail' suspension of the bacterial strains to be used in the
bactericidal test. This was done to remove any reactive antibodies.
The bacteria were removed from the serum by centrifugation (1500 xg/30
. a ~~
mins) at 4 C. The absorbed serum was then passed through a sterilising
membrane filter (pore diamdfeer = 0.22 jlm. X Care was taken to avoid
frothing since this might denature the complement proteins. This
absorbtion procedure did not affect the haemolytic titre of the
serum which remained at 32-64, but resulted in a serum which had no
bactericidal activity at a dilution of 1:4 against any of the strains
used in the absorbing 'cocktail'.
2.6.5 Assay of bactericidal activity in immune mouse serum
These tests were performed in round bottomed glass tubes
(15 x 75 mm). An eighteen hour culture of the gonococcal strain to be
tested was harvested from P1NYC medium and suspended in D.P8S + 3 to
6 ,
a concentration of approximately 10 /ml. 160 pi of this suspension was
added to 20 pi of a dilution of the heat-inactivated mouse serum and
20 pi of recently thawed complement serum which had been diluted 1 :2
with the buffer. Controls in which buffer replaced the mouse serum and/
or complement were included for each test. After thirty minutes
incubation at 37° C, 25 pi volumes of the test and control mixtures
were removed and viable counts performed as described in section 2.4.2.
A reduction in viable count of at least 80% compared with the complement
- free control was considered to indicate a significant level of
bactericidal antibody. The greatest dilution of immune mouse serum to
give a significant result was the titre of the serum.
2.6.6 Titration of Bactericidal Antibody in Human serum
Each of the 96 wells of an 8 x 12 microtitre plate (either
U - or U - well) was filled with 50 pi D.PBS + B and 50 pi of neat
serum or, in some tests, a dilution of the serum, was added to the
first well in each row. A series of six two-fold dilutions were then
made along each row. By starting a series of rows at column 7 it was
possible to titrate sixteen sera in the same plate. An 18 hour culture
of the heat bacteria was harvested from flNYC medium and suspended in
O.PBS + B to give approximately 10^ organisms/ml. To each well was
added 40 pi of the bacterial suspension and 10 pi of a 1:2 dilution of
the absorbed complement source. Serum and/or complement-free controls
were also included in the test. The plate was covered and incubated
at 37°C for 30 minutes. Two discrete drops of 20pl from each
well were plated onto dried P1NYC plates and incubated at 37° overnight.
Bactericidal activity of each serum against the bacterial strain under
test was considered significant if there was a reduction in viable
numbers of at least 80% that of the controls. Due to the small numbers
of bacteria in the inoculum, a reduction of ^ 80% in viable numbers
resulted in less than 40 colonies growing from each 20 pi drop. The
results of each experiment are expressed as the reciprocal titre of the
highest serum dilution to have significantly reduced the viable count.
In some experiments D.PBS + 3 was replaced by D.PBS + 10 mM
fig - EGTA . The addition of 1Qmf'1 fig—EOTA results in sequestration of
the calcium ions required for activation of the classical complement
pathway yet permits activation of the alternative complement pathway.
Tests conducted under these conditions will allow the detection of
bacterial killing due to the alternative complement pathway.
2.6.7 Inhibition of serum killino of M-gonorrhoeas by isolated LPS
The normal bactericidal test procedure (section 2.6.6)
was followed using serum at a final concentration of 1:10. Isolated
LPS was added to the test mixture to give a final concentration of
aither 20 pg/ml or 100 pg/ml. At times 0,10,20 and 30 minutes 20
aliquots wars removed from the reaction mixture and viable counts
performed as described in Section 2.4.2.
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2.7 Titration of Xsohaemaqqlutinins
50 pi of PBS was dispensed into each well of a U-well
microtitre plate and a series of two-fold dilutions of the heat-
inactivated test serum were made. A 0.5,3 (V/V) suspension of washed
red blood cells of the appropriate ABO blood group was prepared in the
same buffer and 50 pi volumes were added to each well. After mixing by
gentle agitation the plate was left at room temperature for two hours.
The titre of isohaemagglutinin was recorded as the reciprocal of the
highest serum dilution to give visible agglutination of the red blood
cells.
2.7.1 Absorbtion of Isohaemaqqlutinins or other antibodies from
serum
Isohaemagglutinins were removed from serum by absorbtion
with red blood calls of the appropriate ABC specificity and anti¬
bacterial antibodies were removed by absorbtion with a suspension of
bacteria. The method used was as follows : A heavy suspension of the
absorbant was mixed with heat inactivated serum and left at room temper¬
ature for one hour. The cells were deposited by centrifugation and
the serum supernate was absorbed a second time for an eighteen hour
o
period at 4 C. After removal of the cells by centrifugation, the
absorbed serum was passed through a sterilising membrane filter (pore
diameter 0.22 pm). uihen red blood cells were used as the absorbant,
this procedure reduced ischaemagglutinin titres to < 4.
2.8 Lipopolysaccharide isolation and Analysis
2.8.1 Llaopolvsaccharide extraction
The aqueous-phenol procedure of uJestphal and Luderitz (1954)
was used. Strains of N.gonorrhoeae were harvested from flNYC plates,
washed twice in PBS and pelleted. The bacteria in the pellet were
lysed by being suspended in distilled water to give approximately
10/a (U/V). After 1 hour incubation at 37° C with ribonuclease and
o
deoxyribonuclease, the mixture was heated to 65 C. An equal volume of
95% (W/V) phenol was added to the mixture and after 10 minutes stirring
the mixture was put on ice to allow separation of the aqueous and phenolic
phases. Centrifugation for 20 minutes at 2DCBxg assisted this phase
separation. The upper aqueous layer was removed and dialysed against
running tap water for 20 hours to remove the phenol. The volume was
reduced by rotary evaporation and the solution was clarified by
centrifugation (15,000 xg for 15 minutes). The LPS was concentrated by
ultracentrifugation (100,000 xcj_ for 3 hours). After being resuspended
in distilled water and washed by centrifugation at 100,000 xc[ for 3
hours, the resulting clear pellet was freeze dried in a small plastic
container.
2.8.2 Analysis of the isolated LPS
2.8.2.1 Introduction
Lipopolysaccharide, as the name indicates, is a molecule
with lipid and polysaccharide moieties. The lipid portion is inserted
into the membrane and the major antigenic determinant(s), the poly¬
saccharide portion, is expressed on the surface of the bacterial outer
membrane. Chemical differences between LPS molecules occur in the
polysaccharide portion.
The monosaccharide constituents of the LPS can bs liberated
by hydrolysis and subsequently separated and identified by chromatography.
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Gas-liquid chromatography can be used to separate and identify very
small quantities (0.1pg/pl) of sugars after they have been converted
to volatile alditol acetate derivatives. This procedure involves
reduction of aldose sugars to alditols and subsequent acylation.
2.8.2.2 Hydrolysis of LPS and preparation of alditol acetates
In this experimental procedure analytical grade reagents
and clean, acid-washed glassware were used throughout.
A small portion of LPS (approximately 2 mg) was dissolved
in 0.25 ml, 2f1 HC1, sealed in a glass ampule and heated at 100° C
for 3 hours to effect complete hydrolysis of the polysaccharide. The
hydrolysate was dried in vacuo in a dessicator containing anhydrous
Po05 and NaOH. The dried residue was washed with distilled water
(0.2 ml) and dried in the evacuated dessicator three times. This
removed any traces of HC1.
The residue was dissolved in 0.5 ml H2O and transferred to
a round-bottomed flask. The sugars were reduced by treating with
approximately 10 mg potassium borohydride for at least 1 hour at room
temperature. The excess borohydride was neutralised by addibion of
glacial acetic acid, sufficient to bring the pH down to pH5 (a few
drops was adequate). The borate was then removed by washing with
methanol (3ml). The methyl borate was removed by rotary evaporation
at 35°C. This washing procedure was repeated three times.
Acylation of the reduced sugars was carried out by addition
of a mixture of acetic anhydride and pyridine (1:1), and heating the
o
reaction mixture in a glass-stoppered vessel at 100 C for 1 hour.
The acetic anhydride and pyridine were removed by co-
distillation in the rotary-evaporator (35°C) with successive volumes
(5,7,9 and 10 ml) of toluene until the residue was dry. After one
more co-distillation with 10 ml toluene, the residue was dissolved in
2 ml chloroform, and washed three times with 3 ml distilled water. The
chloroform layer was then evaporated to dryness and the resulting
alditol acetates were dissolved in 0.25 ml chloroform and stored at
4° C in a tightly stoppered small glass vessel.
This procedure is that used by fir R Brown and Or I Pgxton,
Microbial Pathogenicity Research Laboratory, Bacteriology Department,
University of Edinburgh.
2.8.2.3 Separation and Identification of the Alditol Acetates by
Gas Chromatography
This work was undertaken on equipment in the Department of
Brewing and Biological Sciences. Heriot-hiatt University, Edinburgh
by kind permission of Mrs A Murray and Dr M Fleming.
The gas chromatography equipment consisted of a Packard
Model 428 gas chromatograph containing a 50 m x 0.25 mm 0V1 capillary
column through which the carrier gas nitrogen flowed at a rate of
1.5 ml/min. The split ratio was set at 30:1. The injector and
o o
detector temperatures were set at 230 C and 275 C respectively. The
detector was linked to a Carlo Erba MEGA series integrator which
plotted the peaks, gave retention times and peak areas. The synchron¬
isation of gas chromatograph and integrator was performed manually.
A 0.5 pi volume of the sample was injected into the
o
instrument and the following temperature programme was followed : 175 C
a , o
for 4 minutes followed by a rise of 4 C/min up to 250 C which was
maintained for 5 minutes before ending the run.
The alditol acetates of the LPS hydrolysates were chromat-
graphed, as were a series of alditol acetate derivatives of purs,
standard monosaccharides, identification of the components in the LPS
hydrolysate was made by comparing the retention times of the peaks with
those obtained using known monosaccharide derivatives.
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2.3.3 Extraction of outer membrane complexes
N.gonorrhoeae readily liberates outer membrane vesicles and
the method used to extract these outsr membrane complexes was simple.
An overnight culture of N.gonorrhoeae was harvested and suspended in
P35 + 10 mffi EDTA to approximately V/o U/V. The suspension was heated to
45° C for 30 minutes after which it was vortexed for 3 minutes with 3mm
glass beads. The supernate was decanted into a micro-centrifuge tube
and the bacteria were deposited by centrifugation (approx. 10,000 x£
for5"minutes) in a Beckman Microfuge. The clear supernate containing
o
the outer membrane complexes was separated and stored at -20 C until
required for study.
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2.9 Sodium Dodecyl Sulphate - Polvacrylami.de Gel Electrophoresis
(SDS - PAGE)
SDS-PAGE was conductad in slab gels (17 x 14 cm) using a
Raven electrophoresis tank (Raven, Haverhill, Sussex, England). The
gels were prepared using a stock solution of acrylaride - bisacrylamide
(30:0-.3) and a discontinuous buffer system containing 0.1% sodium
dodecyl sulphate (SDS) as described by Laemmli (1970). The final
concentrations of the buffers were as follows : stacking gel; 0.125
Tris-HCl, pH 5.3, Resolving gel 0.375 Tris-HCl, pH 8.8, Reservoir
buffer; 0.025 fl Tris, 0.1 92 PI glycine, pH 8.3. The final concentration
of the acrylamide in the stacking gel was 2.5%, and in the resolving
gel was 17.5%.
Samples were solublised in a buffer containing 2% SDS,
5% 2-mercaptoethanol, 10% glycerol and 0.002% bromophencl blue in
0.0625 PI Tris-HCl (pH 5.8) by heating to 100° C for 5 minutes. This
prolonged solublisation step was necessary to ensure disaggregation of
the micelles of lipopolysaccharide. (Oann, Reske and Oann, 1975).
After loading the samples onto the stacking gel, electrophoresis was
carried out at constant voltage until the dye front was about 2 cm from
the bottom of the gel.
On completion of electrophoresis the gel was carefully
removed from the cassette and fixed overnight in a solution of 40%
ethanol, 5% acetic acid in water prior to staining.
2.10 Silver Staining of Lipopolysaccharide
Lipopolysaccharide in polyacrylamide gels was stained using
a slight modification of the sensitive silver stain designed by Tsai
and Frasch(1982). As the authors remarked, it is essential that
distilled water and very clean staining baths are used to prevent
staining artefacts.
The staining procedure used was as follows : After overnight
fixation in 40/o ethanol - 5;i acetic acid the fixative is replaced
by 0.7; periodic acid in 40/a ethanol - 5;'o acstic acid to oxidise the
sugars in the LPS. After 45 minutes the oxidising solution was removed
and the gel washed for 90 minutes in three volumes (500 - 1000 ml) of
distilled water. The water was decanted and the gel immersed in
freshly prepared staining reagent which was prepared as follows :
2ml NH40H (s. q. 0.880) was mixed with 28 ml of 0.1_M NaOH. 5 ml of 201
(id/V) AgN03 was added dropwise to this solution while it was being
stirred. Later (115 ml) was then added to complete the staining
reagent. After a staining period of 10 minutes, the stain was decanted
and the gel was washed three times as described earlier. The waste
ammoniacal silver stain is potentially explosive and so was discarded
into a saturated solution of NaCl.
The stained and washed gel was developed with a formalde¬
hyde developer : 50mg citric acid and 0.5 ml of 37'! formaldehyde
solution in 1 litre of water. Development was stopped by washing in
water when the gel background showed slight signs of discolouration.
The gel was washed and stored in water.
This procedure stained LPS strongly, whilst proteins showed
much weak staining.
2.11 The Nitroblue Tetrazolium (NBT) Reduction Test
Professional phagocytes, both polymorphonuclear and
mononuclear, respond to various particulate and soluble stimuli by an
increase in oxidative metabolism. Phagocytosis of bacteria is associated
with this phenomenon. The increase in oxidative metabolism does not
provide the cell with extra energy; it is a means of producing various
reduced forms of oxygen; superoxide radicals, hydroxyl radicals and
hydrogen peroxide, which form one facet of the microbicidal machinery
of the phagocyte. Determination of the degree to which bacteria
stimulate the production of reactive oxygen species such as these is the
purpose of a series of tests, including the NBT reduction test.
N8T is a redox indicator. In the oxidised state it is
composed of yellow crystals which readily form aqueous solutions.
When reduced, it becomes a blue formazan which is insoluble in water.
NBT is reduced by professional phagocytes during phagocytosis. This
results in insoluble blue formazan deposits within the cells. Baehner,
Boxer and Davis (1976) suggested that NBT reduction by phagocytosing
neutrophils was due exclusively to activity of a superoxide radical-
generating oxidase.
These experiments on glass-adherent mononuclear phagocytes
use NBT reduction as an index of the stimulation of the oxidative
metabolism of individual cells by gonococci.
2.11.1 Isolation of monocytes from human peripheral blood
Human peripheral blood was obtained from healthy volunteers
by venepuncture and was quickly transferred to plastic vessels containing
heparin (10 Units per ml. of blood) as an anticoagulant. The mononuclear
cell fraction, containing phagocytes and lymphocytes, was obtained from
blood diluted 1:2 in DPBS + B by separation on Ficoll - Hypaque cushions
(9/o (W/V) Ficoll, 33.9/0 (W/V) Hypaque mixed in the ratio 2.4: 1 to give
a specific gravity of 1.078) containing 0.1/5 (d/V) Na2 EDTA, at 400 x£
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for 30 min. (Boyum, 1968). The interface cells (monocytes and
lymphocytes) were collected, washed twice in warmed D.PBS + B, and
resuspended in Hank's solution. (Oxoid Ltd., England). 100 pi of
the cell suspension was diluted 1:10 in white blood cell diluting fluid
(0.01/s gentian violet in "yf- acetic acid) and loaded into a haemocytometer.
On microscopic examination at x400 the monocytes^identified by their
morphology, were counted. The cell suspension was then adjusted to
6
give a monocyte concentration of 2 x 10 cells per ml.
2.11.2 Preparation of monocyte monolayers
Small monolayers (5mm diameter) of monocytes were prepared
on clean glass microscope slides using an apparatus borrowed from
Mr bJ Weill, Department of Bacteriology. This comprised a neoprene
block, in which there were 10 evenly distributed 5 mm holes, which was
opposed to the microscope slide and firmly held in place by sprung
steel clips.
100 pi aliquots of the cell suspension (containing monocytes
and lymphocytes) in Hank's solution containing 20/b autologous fresh
serum were distributed into the wells of two cleaned and sterilised
o
micro-well units. After 90 minutes incubation at 37 C in air enriched
with 5% Co2, each monolayer was gently washed several times with warmed
Hank's solution to remove any non-adherent cells (which are predomin¬
antly lymphocytes). Microscopic examination of each monolayer using an
inverted microscope showed the resultant monolayers to consist of well
separated monocytes with very few contaminating lymphocytes.
2.11.3 Witroblue Tetrazolium (NBT) reduction test)
An 18 hour culture of N.gonorrhoeae was harvested from MNYC
medium, suspended and washed once in Hank's solution, and adjusted to a
7
concentration of approximately 2x10 bacteria/ml. Another portion of
the bacterial suspension was centrifuged (3000x_g/l5 mins) and the pellet
was distributed into small volumes (about 100 pi) of fresh and heat-
inactivated (56 C/30 mins) serum autologous with the monocytes under
g
test, to give a final concentration of about 10 bacteria/ml. These
sera were kept in ice for 1 hour,after which the bacteria were quickly
pelleted by centrifugation in a Beckman Flicrofuge (approx. 10,000 xg)
for 1 minute. The supernatant sera were quickly removed and placed in
chilled vessels in an ice bath. This absorbtion procedure did not
reduce the activity of the complement in the fresh serum. In addition
to the fresh and absorbed sera, the following reagents were also used
in this test ; Nitroblue Tetrazolium (NBT); a sterile 1% solution
/ 0 \
of NBT in distilled water was stored frozen (-20 C) until required for
use. Opsonised Zymosan; zymosan, opsonised with fresh AB serum using
the method of Taffet and Russell (1981) and was standardised to 200 mg/
o
ml and storsd at - 20 C until required for use.
Pairs of monolayers were covered with the mixtures of

























































































After 50 minutes incubation at 37 C in the CO incubator,
the reaction mixtures were removed by gentle aspiration and the mono¬
layers were fixed by filling each well with saline containing 3.7;0
formaldehyde and leaving at room temperature for 30 minutes. When
the fixation procedure was completed the microscope slides were gently
removed from the neoprene block and the monolayers were stained with
1/u Neutral Red for 1 minute, washed and dried.
Microscopic examination was undertaken at a magnification
of x12Q0 using a water-immersion objective. Each monolayer was examined
by a series of S-shaped sweeps. 200 monocytes were counted and placed
into one of three categories based on the amount of reduced NET, a
blue formazan deposit, within the cell. These categories, -, + and
+++ are described as follows : -, monocytes in which there is no
blue formazan; + monocytes which have slight blueing, especially
around the periphery of the cell; +++ monocytes which have heavier
blue formazan deposits.
2.12 Statistical Methods
Comparisons between the titration data were made using the
Wann-Whitney U test. The results obtained from the NBT reduction
0<periments were compared by an analysis of variance. Comparison of
the means obtained from this analysis were compared by the protected
significant difference method described by Snedecor and Cochran (1980).
The difference between a specific pair of means is significant if it
exceeds the product of the standard error of the difference between
two means and the 5% value of _t for the appropriate number of degrees
of freedom. This test is 'protected' since it should only be applied
where the Variance Ratio (F) is significant.
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3.1 Hypothesis
This section tests the hypothesis stated earlier in
Section 1.10.1 that sera from individuals of blood group A have a
greater capacity to kill strains of N.gonorrhoeae in an antibody-
complement mediated bactericidal reaction than sera of blood group 3.
This is due to the ability of the anti-3 isohaemagglutinins, present




Sera from individuals of blood groups A and 3 were obtained
from women attending post-natal clinics. They were supplied by Dr. S.
Urbaniak and his colleagues in the Blood Transfusion Service laboratories,
Royal Infirmary of Edinburgh. This source of serum was chosen since
this population has a very low incidence of recent gonococcal
infection and, generally, high titras of isohaemagglutinins.
The target antigen for 'natural' bactericidal antibodies
against N.gonorrhoeae is the LPS (Glynn and Lard, 1970; Tramont,
Sadoff and Artenstein, 1974; Schneider et al, 19S2; Section 1.8.3.1).
Since differences in the pyocin type of gonococcal strains has been
correlated with differences in the LPS molecule (Sadoff, Zollinger and
Sidberry, 1973; Section 1.5.5.3), strains with different pyocin types
were used in this study.
These strains had well defined, stable pyocin sensitivities:
Group I strains were only sensitive to pyocins of Kageyama's class R5
and the unclassified pyocin 9579; Group II strains were sensitive to
the same pyocins as strains of Group I and, in addition, to pyocins of
Kageyama's class R1 and the unclassified pyocin, R2Q5 (Kageyama, 1975,
Section 1.5.5.3).
Since colony type has been shown not to influence the
susceptibility of l\l.gonorrhoeae to bactericidal antibody (Tramont,
Sadoff and Artenstein, 1974), non-pilate (T4) colony types were used
in these experiments. This reduced the possibility of the bacteria
clumping due to pili becoming entangled with each other, thereby
a,
decrq'sing the accuracy of the viable count estimations. (Kasper,
Rice and McCormack, 1977). One strain, P 280p, was a pyocin-resistant
mutant derived from the parent strain, P280, as described in section
2.5.5. The pyocin sensitivities of the strains used in this section
of the study are shown in Table \1.
TABLE V
Pyocin Types of Strains of N.gonorrhoeae
Pyocins with Kageyama group
R1
Gonococcal




























+ clear zone of inhibition.
+ zone of partial inhibition.
— no inhibition.
* ^-lactamase producing strains,
t strains from disseminated infection.
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The bactericidal test described in Section 2.6 et seq
was developed to allow optimal use of the small amounts (less than 1 ml)
of serum available. A standard complement level was used throughout
the tests. This was supplied by fresh human AB serum (which contains
neither anti-A nor anti-B isohaemagglutinins) from a donor with no
history of gonorrhoea. Before use the complement source was absorbed
with a 'cocktail' of the gonococcal strains under test using the method
described in Section 2.6.4 and was standardised in a haemolytic assay
to a minimum haemolytic titre of 1/32 - 1/64. The absorbed complement
source was added to the heat-inactivated A or B serum in the
bactericidal tests to give a final concentration of 1/30 - 1/60. This
concentration supplied sufficient complement to mediate antibody-
dependent bacteriolysis whilst minimising any bactericidal activity
due to activation of the alternative pathway. (Schreiber et al, 1979)
Additional assays were also carried out in the presence of 1Qmfl -ftg-EGTA
to determine if any bactericidal activity due to activation of the
alternative complement pathway occurred.
Small numbers of bacteria (approximately lO^/ml) were used
in this bactericidal test 1) to reduce the degree of bacterial clumping
and 2) to allow easy determination of the end-points of titrations.
Titre of bactericidal activity was arbitrarily assigned to the greatest
dilution of serum that gave at least 80/b decrease in viable count. All
titrations were conducted in duplicate and the titres obtained were
found to be comparable i.e. there was less than a fourfold difference
in titre. On those occasions where a two-fold difference in titre




The titres of bactericidal antibody in the sixteen group
A and sixteen group B sera against the sixteen strains of N.gonorrhoeae
are given in Table VI. The titres of isohaemagglutinin in some of
the sera are also shown. The alternative complement pathway was not
contributing to the bactericidal activity of the test system since all
reactions with the serum-sensitive strains were inhibited by the
presence of 1 Umf'l Mg-EGTA.
The geometric mean titres of the bactericidal antibody in
the Group A and Group B sera are shown for each of the serum-sensitive
strains in Table VII.
The distributions of the titres within sera of each blood
group were compared using a robust, non-parametric statistical test,
the Mann-Uhitney U test. The one-tailed test was used to test the
null hypothesis that the titres obtained with Group A sera were similar
to and not significantly greater than those obtained with Group B
sera. (Table VII). Some of the titres shown in Table VI have
undetermined values i.e. < 15 or > 480. In making the statistical
comparisons between the titres obtained with A and B sera the procedure
outlined by Lutz (1978) was adopted. This involves substituting
'likely' values of the true titre for values where the titre is an
undetermined value. I have considered a titre of < 15 to be equal to
a titre of 10 for the purposes of this analysis. Any significant
differences between the mean titres of the groups using this value
would be even more significant if the true titre was, in fact, lower.
In a similar manner, all titres of > 480 are taken to be equal to 480.
The titres of isohaemagglutinins (Table VI) tended to be
greater for individuals of blood group A, but did" not appear to
reflect the titres of bactericidal antibody. For example; whereas
the isohaemagglutinin titre of serum iii (Group 8) was high (128),
it had a low titre of bactericidal antibody. In contrast, serum _v
(Group B), which had a lower isohaemagglutinin titre (32), had high
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TABLE 'JI
Titres of bactericidal antibody in Group A and Group B sera against
strains of N.gonorrhoeae












Group II M8865 15 240 60 60 60 30 120 120 30 120 120 60 30 30 15 60
P2S0 > > > > > > 240 240 240 60 120 30 no no 30 no
E2590 < < 60 30 < 30 < < 30 30 no 60 60 60 15 60
P3290 15 15 30 30 30 30 15 60 120 120 15 15 15 60 30 120
•1560 < < . < < < < < < < < < < < < < <
Hactcnaoui Litre 01" aormai human senua from Group B iadividuaia
5«-a(,8]
Test strain of









M8865 15 30 30 30 > 15 120 • 30 15 15 < 30 < 15 30 15
P230 < 15 < 15 240 15 15 30 no 60 60 60 240 60 120 60
E2590 < < < 15 60 < < < 30 30 30 60 30 60 30 30
P3290 < < < 30 60 < 120 60 120 30 30 15 15 no 30 60
•1560 < < < < < < < < < < < ■c- - < -c < <
Group I
Group II
< aire ieu than 15.
> dire greater Than 430.
•strains cram disseminated ixu'ecdon.
[>8] isohaemaggluhinin litre (where determined)
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TABLE VII
Comparison of titres of bactericidal antibody against strains of
N.gonorrhoeae in sera of blood groups A and B.
Strain Geometric Clean Titre u1
Group A sera Group B sera
P28Q 185.06 42.12 40.5
C18865 55.02 26.15 59
E2590 27.60 21.67 106




U = the Mann-uJhitney U statistic
P = the probability (one-tailed) of the differences
between the groups having arisen by chance
NS = Not significant
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titres of bactericidal antibody.
A group A serum (j£}_ and a group B serum (vii) , each with
high titres of bactericidal antibody, were absorbed with the appropriate
red blood cells, using the method described in Section 2.7.1 to
remove the isohaemagglutinins. This treatment did not result in a
significant (i.e., greater than four-fold) reduction in the bactericidal
titre of the sera against strains P28Q, M8865 or E2590 (Table UIII).
A group A serum was absorbed with strains of N.gonorrhoeae
non-serogroupable N.meningitidis and N.lactamica. The bactericidal
activity against the gonococcal strain P280 was removed by absorbtion
with Group II strains of N.gonorrhoeae, but not by Group I strains.
One of the two strains of N.meningitidis which had a Group II pyocin
type (16797) also reduced the bactericidal titre of the serum, as did
one of the two N.lactamica strains (Table IX).
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TABLE VIII






Group A 1*18865 120 120
(k) E2590 30 30-60
120 120
Group B 15 < 15
(v/ii) E2590 15 15
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TABLE IX
Removal of bactericidal antibody by absorbtion with various Neisseria
species
Bactericidal Titre of serum against
N.gonorrhoeae strain P280
Unabsorbed serum 32
Serum absorbed with :
N.gonorrhoeae strain E757 (Group I) 16
It It [y,g131 It -jg
" " P280 (Group II) <4
" " 1*18865 " <4
IM.lactamica "a 16
" » b <4
N.meningitidis " 15373 (pyocin resistant) 32
" 16797 (Group II) 4
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3.4 Summary and discussion of the hypothesis
The comparison of the bactericidal activity of sera taken
from women of blood groups A and B can only be made for the serum-
sensitive strains of Group II. A cursory examination of the titration
data shows that sera from both groups A and group B individuals exhibited
bactericidal activity. Comparison of the geometric mean titrss (Table
VII) shows the greatest difference between A and B sera occurred in
tests against strain P280. This strain was very sensitive to both A
and B sera; group A sera gav8 a higher mean titre than group B sera.
This difference is described as highly significant by the Plann-Uhitney
U-test (P < 0.005). Although group A sera also gave higher titres than
group B sera against strain 1^8865, the difference is not so marked
as that observed with strain P280, but the significance of the difference
is still as great (P< 0.005). IMo significant differences between A
and B sera were found in th8 analysis of the titres against strains
E259Q and P3290.
Any difference between the titres of bactericidal antibody
in NHS of groups A and B appears to depend on the gonococcal strain
against which the sera ars titrated. In the two situations in which
significant differences were found, viz. titrations against strains
P2Q0 and 1^8865, sera from Group A individuals gave, on average, higher
titres than sera from Group B individuals.
Absorption of isohaemagglutinins from a group A and a group
S serum did not reduce the titre of bactericidal antibody when tested
against strains P280, T18865 and E2590. These data suggest that
isohaemagglutinins are not the antibodies in NHS which are bactericidal
for these strains of N.gonorrhoeae.
The absorbtion of the bactericidal antibodies by a strain of
N.lactamica and a non-serogroupable Group II strain of N.meningitidis
reiterates the observations of cross-reactive antigens between Neisseria
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species (Gold et al. , 1973; Apicella et al; 1981). The inability of
the Group I strains of M.gonorrhoeae to absorb the bactericidal antibody
reinforces the proposal by Schneider and colleagues (1982) suggesting
that gonococcal serum resistance was not due to the inability of the
complement lytic complex, C5b-9 to penetrate the outer membrane, but
was due to absence of the antigenic determinants that react with
natural bactericidal antibodies.
The most striking result of these experiments is the
relationship between pyocin sensitivity and serum sensitivity of the
strains of N.gonorrhoeae used in this study. LPS, the receptor for
'natural' bactericidal antibodies against M.gonorrhoeae (Glynn and
ward, 1970; section 1.8.3.1) is also the receptor for R-type pyocins
in both Ps.aeruginosa (Kageyama, 1975; Meadow and Wells, 1978) and
N.gonorrhoeae. (Sadoff, Zollinger and Sidberry, 1973; section 1.5.5.3).
Investigations into the LPS structure of Ps.aeruginosa have shown that
resistance to an R-type pyocin is due to absence of the appropriate
sequence of sugar residues that make up the receptor site on the
LPS molecule (Kageyama, 1975; Meadow and Wells, 1978). The molecular
basis fcr pyocin sensitivity of the gonococcus has not yet been
elucidated. However, it has been shown that pyocin resistant gonococci
isolated from a pyocin-sensitive parent strain have altered LPS
molecules compared with LPS isolated from the parents (Guymon, Esser
and s hafer, 1 982).
The pyocin-sensitivity patterns of the strains used in this
study suggest that Group II strains have additional LPS determinants,
absent (or cryptic) in strains of Group I, which are associated with
sensitivity to the pyocins of Kageyama's class R1. These determinants
might also be associated with the antigens to which 'natural' bactericidal
antibodies react. One possible source of antigenic stimulation for the
production of these antibodies may come from non-serogroupable strains
of. N.meningitidis with the Group II pyocin type which appear to cross-
react with gonococcal antigens involved in the bactericidal reaction.
All the Group II strains isolated from localised genital gonorrhoea
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ware sensitive to the majority of sera (both A and B) tested, whereas
none of the Group I strains were sensitive to any of the sera tested
in this system. Additional evidence for the involvement of the LPS
portion associated with the R1 pyocin binding site in gonococcal
sensitivity to NHS comes from the results obtained with the R1 pyocin-
resistant mutant, P2B0 p, which had been derived from a Group . II strain,
P280. Whereas the parent strain showed great sensitivity to the
majority of sera tested, the mutant strain, which had the same pyocin-
sensitivity pattern as the Group I strains (Table V), was resistant to
all the sera tested (Table VI).
Although all Group II strains from localised genital
infections were found to be generally serum sensitive, strain 1560, a
Group II strain isolated from a disseminated infection, was resistant
to all the sera tested. The availability of receptors for pyocins of
class R1 does not appear to imply serum-sensitivity in all cases.
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Analysis of the lipopolysaccharide
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4.1 Introduction
The results presented in Chapter 3 indicated a
correlation between pyocin type of N.gonorrhoeae and the sensitivity
of the gonococcal strains to bactericidal antibodies in normal serum.
These results suggested that structural differences may be found between
the LPS molecules of serum sensitive (Group II) strains and serum-
resistant (Group I) strains; serum-resistant strains lack LPS
determinants associated with the R1 pyocin binding site present in the
serum-sensitive strains. It was proposed that the LPS portion
associated with the R1 pyocin binding site was the antigen to which the
bactericidal antibody in normal human serum reacts.
106.
4.2 Hypothesis
This section examines the hypothesis that the LPS in a
Group I strain is chemically, physically and antigenically different
from the LPS in a Group II strain.
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4.3 Experimental Design
In order to minimise the differences between the Group I
and Group II strains under examination, a comparison was made between
the LPSs of strain P280 (Group II) and the R1-pyocin resistant,
serum-resistant strain, P280p, derived from strain P28Q as described
in section 2.5.5. Lipopolysaccharide was isolated from both strains
by the method of hJestphal and Luderitz (1954), described in Section
2.8 et seq. The isolated LPSs were fully hydroly.sed and the resulting
monosaccharides were derivatised to form alditol acetates.
The alditol acetates ware separated by gas chromatography
as described in Section 2.8.2.3. By comparing the retention times of
the derivatised components of the hydrolysate with alditol acetates of
pure monosaccharides (Kindly provided by Or I Poxton, Department
of Bacteriology) putative identification of some of the LPS sugars
was made.
Comparisons between LPSs were mads by comparing the ratios
of the main peaks of the chromatogram to a peak of substantial area
which was present in both LPS from P280 and P280jj. In addition to
the chemical studies on isolated LPS, the electrophoretic mobilities of
the LPSs present in outer membrane vesicles, isolated from the two
strains by the method described in Section 2.8.3, were compared.
After electrophoresis in polyacrylamide gel, by the protocol
described in Section 2.9, the LPS bands were visualised by means of a
silver-stain (Tsai and Frasch, 1982) described in Section 2.10.
The ability of the purified LPS from both strains P2S0 and
P280p to inhibit the killing of strain P280 by normal serum was
assessed. The bactericidal reaction (described in section 2.6.6)
was performed in the presence of either 20jjg/ml or 100(jg/ml LPS. The
number of residual viable organisms was assessed at 10,20 and 30 minutes
































Normalised Peak Areas for Chromatograms of Alditol Acetates from
LPSs of N.gonorrhoeae strains P280 and P280
P280
Ref. Peak = 18.95
Ref. Peak Area = 13308
Ref Peak = 19.02
Ref Peak Area = 11030
Peak rt Area/Ref. area Peak rt Area/Ref
A 7.91 2.92568 7.94 .71206
8 13.08 3.17583 13.13 3.40925
C 15.38 .20574 15.44 .16201
D 18.76 .34904 18.82 .31115
E 18.95 1.00000 19.02 1.00000
F 21.76 .45717 21.60 .18939
G 23.99 .66005 24.06 .62529
H 26.18 .65855 26.25 .51840
I 26.65 .27127 26.81 .24161
0 28.57 .48106 28.67 .39030
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TABLE XI
Retention times of alditol acetate derivatives of reference
sugars











4.4.1 Analysis by Gas Chromatography
The chromatograms obtained from the alditol acetates of
hydrolysed LPSs isolated from N.gonorrhoeae strains P280 and P28Q
are shown in Figures 3 and 4, respectively. The ratios of the areas
of the major peaks A-3 to the arbitrary reference peak, E, together
with their retention times is given in Table X. The retention times of
a few standard alditol acetates are given in Table XI.
Quantitative analysis of these chromatograms is not possible
since no internal standard was used. Comparison between the chromat¬
ograms can only be made on a qualitative basis and by examination of
the ratios of each component of the hydrolysate to an arbitrary refer¬
ence peak which is found in both samples. The overall pattern of the
chromatograms is the same. This suggests that the LPS from both
strains is composed of the same collection of sugars. By comparing the
ratios of the areas of each of the major peaks, A-3,with an arbitrary
reference peak which, in this case, is peak E, the relative quantities
of each sugar components can be determined for each LPS preparation.
These ratios are presented in Table X Peak A represents a low molecular
weight compound which is probably a breakdown product produced during
hydrolysis or the derivatisation of the sugars. Comparison of the
ratios of the peak areas to the area of peak E show great similarity
for all the major peaks, except peak F. In this case the ratio in
the P280 LPS is greater than twice that seen in the LPS from P280 fj;
0.46:1 compared with 0.19:1.
Comparison of the retention times of the peaks obtained
from the LPSs with those obtained with the standard sugars gives an
indication of the identities of the sugar in each peak. A temperature
programme was used in this analysis and retention times obtained from
two runs with the same sample varied slightly. Consequently, the true
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identity of each peak in the LPS analyses can only be made by co—
injection of a known standard sugar with the sample. The limited time
available to use the gas chromatography machine did not permit this to
be done. Nevertheless, comparison of the retention times of the
standard sugars with those of the peaks obtained with the LPSs suggests
the following sugars are present in the LPS isolated from both strains;
glucose, galactose and galactosamine (Table XII).
TABLE XII
Putative Identification of the chromatogram peaks
Peak Sugar









4.4.2 Analysis bv Polyacrylamide Gel Electrophoresis
After electrophoresis of the outer membrane vesicles
isolated from P230 and P28f!p, the LPS components were visualised by
silver staining. LPS from Escherichia coli and horse heart cytochrome
jo were included as molecular weight markers. (Figure 5). The two
gonococcal LPSs differed in their electrophoretic mobility and,
therefore, in molecular weight; the molecular weight of P230p LPS was
less than the P230 LPS. Llhen compared with the molecular weight
markers the molecular weight of P2S0 LPS was approximately that of the
114.
FIGURE 5
Electrophoresis of outer membrane vesicles isolated from N.gonorrhoeae




















































LPS !cor8' from E.coli. The LPS from P2SQ p was a slightly smaller
molecule (Figure 5).
4.4.3 Inhibition of serum killing of N.gonorrhoeae strain P2S0
by LPS isolated from strains P2S0 and P280 p
The results are shown in Figures 6 and 7 Isolated LPS
from both strains P280 and P280 p showed no inhibition of serum killing
at a concentration of 20 pg/rnl. 3oth LPSs were found to inhibit serum
killing of strain P280 at a concentration of 100 pg/ml, but the degree
of inhibition was greater with the LPS isolated from strain P280.
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4.5 Summary and Discussion of the Hypothesis
These results show that the LPS of strain P280jj has a lower
molecular weight, determined by SQS-PAGE, than the LPS of strain P2S0.
There does not appear to be any major difference in the qualitative
compositional analyses of the polysaccharide moiety of the two LPSs,
but there does appear to be a difference between the LPSs in the
proportions of each sugar component in the LPS. This difference is in
the sugar moiety responsible for peak F. In comparison with the other
sugar types in each LPS molecule, there is less of the Peak F sugar
in P280p LPS than in P2S0 LPS.
Unequivocal identification of the sugars was not possible
since there was insufficient time available on the gas chromatography
machine to allow co-injection runs to be made. Comparison of the
retention times of alditol acetates of known sugars with the retention
times of the peaks obtained with the LPS hydrolysates suggested the
identities shown in Table XII. Peak 8 has the same retention time as
both Ribose and Rhamnose. Ribose could be present if the ribonucleasa
with which the cell lysate was treated prior to extraction of the LPS
(Section 2.8.1) was inactive. Rhamnose, however, has been previously
identified in the LPS of some gonococcal strains (Wiseman and Caird,
1977; Section 1.5.5.1). Clarification of this point would require a
change of chromatographic conditions, or the use of mass spectroscopy
linked to the present system. The other sugars for which provisional
identification has been made, viz. glucose, galactose and galactosamine,
have been described in compositional analyses of gonococcal lipopoly-
saccharides by other workers. (Stead et al, 1975; Perry et al; 1975;
Wiseman and Caird, 1977; Section 1.5.5.1)
The ability of the LPS isolated from strain P280 to
inhibit the killing of strain P280 by serum was expected. The same
ability displayed by the LPS isolated from the serum-resistant strain
P280 u was surprising. However, the degree of inhibition was not as
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great as with P280 LPS. After 30 minutes incubation there were at
least 1 log-,0 fewer viable bacteria in the reaction mixture containing
the P230 p LPS (100 pg/ml) than in the mixture which contained the
same quantity of P280 LPS. When compared with the initial inoculum,
a significant degree of microbial killing ( ^ 80'/o drop is viable
numbers) was observed in the presence of P280 p LPS (100 pg/ml) but
not in the presence of P280 LPS (100 pg/ml).
These results support the hypothesis (section 4.2) that the
LPS of the serum sensitive gonococcal strain P2S0, is different in
both chemical, physical and immunological characteristics to the LPS
isolated from the serum-resistant variant, P280 p. The lower molecular
weight of P280 p LPS suggests that its resistance to normal human
serum and R1 class pyccins, compared with the parent strain, P280,
is due to loss rather than masking of sugar residues.
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5.1 Introduction
'Natural' bactericidal antibodies in human serum react
with LPS antigens of N.gonorrhoeae, (Glynn and Ward, 1570; Schneider
st al, 1932; see Section 1.8.3.1) thought to be associated with a
portion of the LPS molecule that serves as the receptor site (s) for
Kageyama's class R1 pyocins. (Chapters 3 and 4). One reason for
serum resistance among gonococcal strains is the absence of the LPS
antigen to which these bactericidal antibodies bind (Schneider et al;
1982; Chapters 3 and 4).
The mechanism for the inducible phenotypic serum resistance
in N.gonorrhoeae (Rittenberg et al., 1977; Veale, Penn and 5mith, 1981;
See Section 1.8.3.2) has not yet been elucidated. Development of
phenotypic serum resistance requires metabolic activity on the part
of the gonococcus (Veale, Penn and Smith, 1981) and is achieved by
+ 3
77)1 (SE - 27^) of a small inoculum (5 x 10 /ml) within 3 hours of
incubation with the inducting factor from human serum (Martin at al .1981).
In view of the excessive outer membrane production by the
pathogenic Neisseria species during growth (Del/oe and Gilchrist, 1973;
Steadet_al, 1975) and the lag phase and requirement of bacterial
metabolism observed in the induction of serum-resistance, inducible
phenotypic serum resistance may be due to rapid expression of an LPS
molecule lacking the determinants which react with the bactericidal
antibodies in normal human sera.
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5.2 Hypothesis
The hypothesis under examination in this Chapter is
that the induction of phenotypic serum resistance in N.gonorrhoeae
will be associated with a change in the LPS molecule resulting in
resistance to pyocins of Kageyama's class R1.
122.
5.3 Experimental Design
Pyocins were an ideal tool to probe the LPS structure of
the gonococci induced to serum resistance, since only small numbers
/ 4 5 x
(10 - 10 ) of resistant organisms can be produced by each induction
experiment. Other techniques lack the sensitivity required to analyse
such a small number of bacteria.
Since the induced organisms revert to the serum sensitive
state on culture in the absence of the inducer, it was necessary to
ensure that any unreacted pyocins were removed from the mixture of
pyocin and gonococcus prior to estimating the numbers of residual viable
bacteria. The chosen technique, described in Section 2.5.5, involved
mixing pyocin and gonococcus in liquid medium for a sufficient time
to allow the pyocins to bind to and kill sensitive organisms. The
bacteria were washed fres from pyocin by making a dilution of the
mixture, depositing the bacteria by centrifugation and decanting the
supernate containing unreacted pyocin. The bacteria were then
resuspended and the number of remaining viable organisms was estimated.
A comparison of the viable count with that obtained from a control
experiment, in which the aliquot of pyocin was replaced by an aliquot of
medium, allowed the degree of pyocin - sensitivity to be determined.
These experiments were conducted in the Department of
Microbiology, University of Birmingham. The induction of N.gonorrhoeae
strain BS4 (agar) to serum resistance by the method of Veale, Penn and
Smith (1981) was performed by P.V. Patel. This technique involves
incubation of the gonococcal strain with an ultrafiltrate from guinea
pig serum in a chemically defined medium containing 0.1 % (b/V) bovine
a
serum albumin for 3 hours at 37 C. Serum sensitivity of strain
BS4 (agar) prior to, and after induction of serum resistance was
performed by Or E L Tan. Concurrent examination of tho sensitivity of
strain BS 4 (agar) in the serum-sensitive and induced serum-resistant
states to a panel of pyocins was performed with assistance from Dr E L
































































































































































The results are summarised in Table XIII.During the 3 hour
incubation with the inducer - containing fraction of guinea pig serum
the serum susceptible form of strain B54 (agar) had developed reduced
sensitivity to the class R1 pyocin, 158, and resistance to the
unclassified pyocin, R205; also its full sensitivity to the class R5
pyocin, ISC;, was decreased.
As a corollary to the findings of this experiment, a pilot
study of the sequential changes in pyocin - sensitivity of gonococcal
isolates during repeated subculture after primary isolation showed
strains to generally follow this pattern : on primary isolation they
show resistance to pyocins of classes R5 and R1 and to serum in a
bactericidal test. In the course of daily subculture, strains become
sensitive to R5 pyocins and, usually, some or all of the panel of R1
pyocins. The degree of serum-resistance was also decreased in many
cases.
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5.5 Summary and Discussion of the Hypothesis
The changes in pyocin sensitivity associated with the
induction of serum resistance in N.gonorrhoeae strain BS4 (agar)
suggest that a change in LPS results from 3 hours incubation at 37° G
with a low molecular weight fraction ( < 5000 daltons) of guinea pig
serum. The mutant strain, P230 p, selected for resistance to R1
pyocins, retained sensitivity to R5 pyocins, indicating that the
receptor(s) for R5 pyocins is nearest the membrane, and the receptor(s)
for the R1 pyocins more distal (Chapters 3 and 4). This is similar to
the R5 and R1 pyocin receptor sites described for Ps.aeruginosa
(Kageyama, 1975; Meadow and dells, 1978). The loss of sensitivity to
the R1 pyocin, IS8 and the R5 pyocin, ISC, suggest that changes to the
polysaccharide moiety of the LPS may have taken place at sites both
proximal and distal to the lipid portion.
The results of this study are in general agreement with the
hypothesis that changes in expression of the polysaccharide portion of
the LPS would occur during induction to serum resistance. Whether
these changes in pyocin sensitivity are due directly to structural
changes in the LPS or to masking of the pyocin binding sites by other
components will require use of techniques of a more analytical nature.
The results obtained with the strains recently isolated
from patients with gonorrhoea are in keeping with the general theme
proposed by Ward, Watt and Glynn (1970) viz. that gonococci in urethral
exudates are serum-resistant on primary isolation and, after subculture
become sensitive. They also support the main result of this section,
namely that the factor inducing serum-resistance in gonococci effects
an alteration in gonococcal sensitivity to pyocins, presumably by
stimulating alterations in the LPS structure.
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CHAPTER 6
The immunoganicity of lipapolysacchari.de
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6.1 Hypothesis
Since sensitivity to class R5 pyocins is a feature common
to both Group I and Group II strains, similar structural features may
exist within the LPS molecules of both groups. If these common
portions are antigenic and capable of stimulating bactericidal antibodies
during infection, antibodies capable of killing Group I strains would be
expected to appear during gonococcal infection.
Bactericidal antibodies reactive with Group I strains were
not observed in a survey of 32 sera from normal individuals of blood
groups A and B (Chapter 3). If the hypothesis is substantiated, the
detection of these antibodies might form the basis for a serological
screening test for gonococcal infection.
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6.2 Experimental Desion
Antibodies raised in mice against N.oonorrhoeae strains
of Group I and Group II were used in an antibody-complement mediated
bactericidal reaction to determine the cross-reactivity of gonococcal
strains, both within and between the two groups. This tested the first
section of the hypothesis :
similar antigenic determinants, putatively associated with the R5 pyocin
binding site on the LPS, exist in strains of both groups.
Sera from patients with gonococcal infection were assayed
in the antibody and complement - mediated bactericidal test to
determine the activity against a strain of Group I and a strain of
Group II. The infecting strain wao also pyocin typed and used in the
assay against the patient's serum wherever possible. The second
section of the hypothesis was proved if bactericidal antibody against




Titration of Control and Absorbed murine sera raised against




Anti-(*19131 absorbed by (18865 64 <4
Anti—(*18865 256 1024
Anti-l*!8865 absorbed by (*19131 64 64
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6.3 Rasults
6.3.1 Cross reactivity of IM.gonorrhoeae of Grouos I and II
demonstrated bv murine antiserum
Antisera were raised in groups of mice against formalin-
treated suspensions of N.gonorrhoeae strains 1*19131 (Group I) and P!B665
(Group II) by the protocol described in Section 2.6.3 et seq
Bactericidal tests employing the method described in Section 2.6.5
were conducted on the homologous immunising strains and a titre of
1024 for each antiserum was demonstrated. 4fter cross-absorbing the
sera with the heterologous strain (Section 2.7.1) the absorbed and
control (unabsorbed) sera were titrated against the immunising strains.
The titres obtained are given in Table XIV.
Bactericidal tests with each antiserum, at a final
concentration of 1:100, were conducted on other gonococcal strains of
Groups I and II. The results were variable between experiments with
the same strain. The number of tests (out of four) giving at least
80% decrease in viable count in comparison with controls are given in
Table XV.
6.3.2 Screening sera from patients with gonorrhoea for bactericidal
antibody
Small quantities of heat-inactivated serum, taken for
syphilis serology from patients with gonorrhoea, were kindly provided
by Or H Young and his colleagues, 5TD Diagnostic Laboratory, Bacteriology
Department, University of Edinburgh. These sera were screened for
bactericidal activity against strains E757 (Group l) and P280 (Group II).
In many cases they were also tested for activity against the infecting
strain. This was undertaken before the third in vitro sub-culture of
the organism. Due to the small quantities of serum available, these
tests could only be performed once with each serum. To ensure that
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TABLE XV
Bactericidal action of immune mouse serum on strains of N.gonorrhoeae
(Number of tests out of 4 giving ^,80^ decrease in
Strain Antiserum
N9131 P18865















Titres of bactericidal antibody in sera from patients with
gonorrhoea against N.gonorrhoeae strains E757 (Gp I) and P280
(Gp II)
Pyocin Homologous
Patient No. Sex Group E757 P280 Strain
1 F NT < 4 > 128 16
2 F NT < 4 >128 >128
3 F NT <4 64-128 < 4
4 F NT 4 64 NT
5 F NT < 4 64 < 4
6 F NT <4 32-64 ■>1 CD
7 F NT <4 64-128 4-8
8 F NT <4 32-64 < 4
g PI NT <4 32-64 <■ 4
10 PI NT <4 64-128 <4
11 PI NT 4-8 64-128 >128
12 F NT < 4 32-64 4-8
13 F II <4 > 128 < 4
14 F II <4 >128 >128
15 F II <4 64-128 8-1
15 F I < 4 16 8
17 F II <4 64 < 4
18 F II <4 > 128 8
19 F II <4 128 64
20 F I <4 > 128 < 4
21 F II 4 > 128 <4
22 F I < 4 > 128 < 4
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the system was working, a positive control serum with known activity
against strain P280 was included in each set of experiments as a
control. The results of these titrations are given in Table XVI.
The majority (19/22) of the sera were obtained from
women; in addition to being the same gender as the sources of normal
human serum, women generally have a longer period of infection prior to
diagnosis and treatment than men. (Robertson, PIcFlillan Young, 1980).
This would give them potentially greatsr opportunity to produce an
immune response to gonococcal antigens.
Only three of the twenty-two sera tested demonstrated any
bactericidal antibody, at a titre of 4, reactive with the Group I
strain, E757. All the sera, however, showed activity at a titre of
16 against the Group II strain, P280. Reactions with the infecting
strain were variable. The pyocin type was only determined for ten of
the isolates; three were Group I strains and seven were Group II
strains. These tests with the patient's serum against the infecting
strain did not demonstrate the clear cut association between the
Group II pyocin type and serum sensitivity observed earlier with the
normal sera and laboratory strains. In some cases an infecting
strain of Group II was resistant to the patient's serum, e.g. E4092,
whereas the strain was typically serum-sensitive in other cases, e.g.
E4Q8Q. In one instance, E4095, the patient's serum was bactericidal,
at a titre of 8, for an infecting strain with the Group I pyocin type.
Similar results were obtained with a second set of 37 sera
from the 5TD Diagnostic Laboratory. The diagnosis for the patient
was not known at the time the sera were tested. They were screened
for bactericidal activity against strain P280 and another Group I
strain, 1*19131. It was later found that 12 sera were from patients
with gonorrhoea, and 25 sera from patients from whom no Neisseria
spp. were isolated. Although the titres against strain P280 were
similar to those in Table XVI, for both patients with and without
gonorrhoea, the titre against strain 1*19131 was < 4 for each serum.
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5.4 Summary and Discussion of the Hypothesis
Tha anti-gonococcal bactericidal antibodies in the murine
antisera raised against a strain of Group I (F19131) and a strain of
Group II (P280) demonstrated cross-reactions both within each pyocin-
defined group and between groups. This bactericidal antibody could be
removed from the serum by absorption with cross-reacting strains of
either group. (Table XIV). Inspection of Table XV shows that certain
tests e.g. anti-?19131 serum reacting with strain P280, gave a positive
result in only one out of the four occasions on which the test was
conducted. However, the majority of tests demonstrated bactericidal
activity on at least four occasions. The source of variability may be
the incorporation of human complement in a system with mouse antibodies.
This cross-species mixing of immunological reagents has shown
variability in other systems. (Zollinger and flandrell, 1983). The
incorporation of normal mouse serum as the complement source might
reduce the variability between tests. Another potential source of
interference in the consistency of the tests could arise from the use
of re-usable glass tubes as reaction vessels. The occasional tube may
have been inadequately rinsed after washing, and any residual detergent
would interfere with antigen-antibody interactions.
These experiments demonstrate the possession of shared
antigenic determinants among the strains tested that are capable of
stimulating bactericidal antibody in the mouse. The reactivity of the
test strains with the panel of pyocins showed that shared LPS
structures were associated with the R5 pyocin binding site(s). The
LPS associated with this region may be, or be closely associated with
the common antigen(s) suggested by these serological reactions.
The results obtained with human sera from patients with
gonorrhoea were radically different to those observed with the immune
mouse sera. During infection the human immune system does not appear to
produce bactericidal antibodies reactive with the gonococcal antigen(s)
associated with the Group I pyocin type. This contrasts with the
ability of the murine immune system to produce bactericidal antibodies
reactive with Group I strains whan immunised with either a Group I
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or a Group II strain. The antigen associated with the R5 pyocin binding
site appears to be available to an immune system, but the human
immune system either does not recognise it, or does not respond to the
antigen in the same manner as the immune system of the mouse.
Differences between the immune responsiveness of mice and
men have been observed for other antigens. Redhead (1984) described
a similar situation in the immune responsiveness of mica and men to
outer membrane proteins of 3ordetella pertussis. Although an antibody
response to the antigen was observed in mice, there was no similar
response observed in children exposed to the antigens.
This apparent lack of a bactericidal antibody response
might be due to unresponsiveness to certain antigens, such as has been
observed with CBA/N mice (0' Brien ,Scher and Metcalf, 1981). Alternatively,
bactericidal antibody reactive with the Group I LPS determinants might
be formed, but in conjunction with IgA specific for the same antigens.
If the IgA was produced in sufficient quantity, it would block the
bactericidal antibody and so result in an apparent lack of bactericidal
antibody in the tests. This has been shown to occur in bactericidal
tests against N.meningitidis using convalescent sera from patients
with meningococcal disease. (Griffiss, 1975). Raised titres of
antigonococcal antibodies have been observed in patients who have
been infected with N.gonorrhoeae for up to 14 days. After this time,
or after treatment, the titre of antigonococcal jgA was shown to
decline rapidly (McMillan et al., 1979). If blocking IgA antibodies
were present in the sera from patients with gonorrhoea, they are
probably only reactive with those determinants associated with the
LPS of Group I strains, since strain P280 and other Group I strains
were killed by these sera. Screening sera from patients with gonorrhoea
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7.1 Hypothesis
The results presented in Chapter 3 show that normal
human sera from individuals of blood groups A and 3 contain
bactericidal antibodies reactive with strains of N.gonorrhoeae which
are sensitive to R-type pyocins of Kageyama's class R1. These
antibodies could be absorbed by one meningococcal strain that was
sensitive to R1 pyocins (strain 15797) but not by a meningococcal
strain that was resistant to pyocins of classes R5 and R1.
Chapters 3 and 6 described the apparent absence of
bactericidal antibodies reactive with Group I gonococcal strains -
those reactive with class R5 pyocins only - in the sera of both
uninfected normal individuals and patients with gonorrhoea.
Meningococcal isolates with the Group I and Group II pyocin types have
been described (Blackwell and Law, 1981).
The hypothesis under examination in this chapter proposes
that meningococcal strains expressing the same pyocin sensitivities
as Group I and Group II gonococcal strains will show the same patterns
of sensitivity to the bactericidal antibodies in serum from normal




A panel of non-serogroupable meningococcal strains of the
same pyocin types as gonococcal strains of Group I and Group II,
together with two pyocin resistant and three serogroupable strains
the
were used as test organisms in the bactericidal test used in/previous
study (Chapter 3). The sera of blood groups A and 3 were obtained
from the same source as those used in Chapter 3, viz. women attending
the post-natal clinic, and the sera from patients with gonorrhoea
were obtained from the same source as those described in Chapter 6.
Non-serogroupable meningococci accounted for most of the strains used
in this study. They are more frequently observed to be pyocin


































































































The titres of bactericidal antibody found in a range of
normal women of blood groups A and B against tha panel of N.meningitidis
strains are given in a frequency table (Table XVIl). The geometric
mean titres for sera of each blood group against each strain are
compared in Table XVIII. The distributions of titres from sera of
blood groups A and B against each serum-sensitive strain were
compared by the Mann-Whitney U-tast. No significant differences were
observed in a one-tailed test at a probability level of 0.025.
Titres obtained using sera from patients with gonorrhoea
are given in Table XIX. In these experiments the small quantity of
serum allowed only one titration to be made against each test strain
by the individual patients' serum. Control positive sera were
included in each test to ensure that the experimental system was
functioning correctly.
The results show that normal sera contain bactericidal
antibodies which are reactive with both Group I and Group II strains of
non-serogroupable N.meningitidis. (Table XV/111) They also react with
the pyocin resistant strains, PA846 (also referred to as NG346) and
PA520 and strains of serogroups A and U135. None of the sera have
bactericidal antibody at a titre of ^.4 against a strain of serogroup
Y. There are no significant differences between titres obtained with
group A and group B sera against each strain.
Sera from patients with gonorrhoea have similar titres of
bactericidal antibody as those from normal individuals against two non-
serogroupable strains, PA 346 and 0.452 (Table XIX). They contrast with
the sera from normal individuals in having low titres or undetectable
amounts of bactericidal antibody against the strain of serogroup A.
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TABLE XVIII
Comparison of bactericidal litres obtained with sera of blood groups
A and B against strains of N.meningitidis.
Strain Geometric Mean Titres (Number of t!
sera
tested)
Group A sera Group 3 sera
Group I
PA 1190 30.7 (23) 43.5 13) 125.5 NS
NA 935113 18.2 (15) 15.2 16) 112 !!
42619-4 53.1 ( s) 34.5 3) 26 tf
PA 477 5.5 (17) 14.0 16) 114.5 ft
Group II
1419 57.9 (16) 29.0 16) 104 NS
PA 459 45.9 (13) 42.0 17) 108 tt
0452 137.3 (16) 136.0 9) 61.5 Tf
16795 13.5 (13) 14.1 12) 98.5 tf
Pvocin Resistant
PA U45 11.7 (16) 11.2 16) 123.5 NS
PA 520 71.2 (23) 63.1 8) 39 tt
Seroqroupable
Ref A 10.5 (15) 24.7 14) 70 NS
Ref Y 2.0 (16) 2.0 16) ft
Ref LJ135 3.7 ( 8) 4.3 a) 20.5 tt
U = value of U in Mann-Whitney U test




litres of bactericidal antibody against serogroupable and non-
serogroupable strains of N.meningitidis in sera from patients with
gonorrhoea
Seroaroupable
Patient No. Sex A B c 0452 PA(NG)846
1 F < 4 < 4 4-8 > 123 128
2 F 32-64 44 4 > 123 >/ 128
3 F < 4 4 4 4 4 >128 8-16
4 F £ 4 44 8-16 64-128 54-128
5 F 4 4 4-3 >123 32-64
6 F >128 4 4 4-8 >128 > 128
7 F 4-8 44 4-3 >123 >,128
a F < 4 3-16 4-8 32-64 15-32
9 n < 4 4 4 8-16 64-128 < 4
10 ri < 4 8-16 8-16 64-128 8-16
11 n < 4 < 4 < 4 16-32 < 4
12 F 8-16 8-16 17-32 64-128 32-64
13 F 4 4 4 4 4 4 >128 54-123
14 F 4 4 4 4 44 >128 4-3
15 F <4 4 4 4 4 64-128 16-32
16 F 4 4 4 4 44 16-32 < 4
17 F <• 4 < 4 < 4 64-128 4-8
13 F < 4 < 4 4-8 > 128 <4
Geometric flean titres * 3.4 2.6 ■4.0 74.7 16.0
* Determined using < 4 = 2 and ^128 = 123
141 .
Tests using strains of the other two common serogroups,
B and C, also show Iouj titres of bactericidal antibody in sera from
patients with gonorrhoea. The geometric mean titres obtained
against meningococcal strains of serogroups A, 3 and C using sera from
18 patients are 3.4, 2.6 and 4.0, respectively (Table XIX).
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7.4 Summary and Discussion of the Hypothesis
Normal sera reacted with N.meningitidis strains of the
pyocin types of both Groups I and II. In addition, pyocin resistant
and serogroupable strains were also susceptible to these sera. This
contrasts with the results obtained using sera from patients with
gonorrhoea. In these tests little or no bactericidal antibody was
found to react with strains of serogroups A, B and C.
The spectrum of pyocin groups of meningococcal strains
sensitive to the bactericidal antibodies of normal human sera is
broader than that observed with strains of N.gonorrhoeae. This does
not support the proposed hypothesis. Serum-sensitivity of the
meningococcal strains of Group I could be due either to possession of
other determinants reactive with normal serum or to subtle differences
in the LPS associated with the binding site for the class R5 pyocins
that allow reaction with the pyocins and also bactericidal antibodies.
The pyocin-resistant strains may, in fact, be capsulate. Possession
of a capsule may hinder the binding of pyocins to the LPS (Blackwell
and Law, 1981) and also provide other polysaccharide antigens as
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3.1 Introduction
This short series of experiments was a pilot study to
develop a methodology for examining the oxidative metabolism of glass-
adherent monolayers of human mononuclear phagocytes responding to
stimulation by strains of N.gonorrhoeae. In addition, it provided
an opportunity to determine whether the ABO blood group of the cells
was a potential source of variation in the response of these cells
to gonococci.
The need for a method of determining the burst of oxidative
metabolism of monocytes stimulated with gonococci arises from the
hypothesis of Novotny and colleagues (1977) that survival and
replication of gonococci within mononuclear phagocytes is central to
the pathogenesis of the disease. This hypothesis has received support
from other workers, (l/eale et al; 1976; section 1.7.2.1.1) who have
demonstrated the ability of gonococci to survive and grow within human
monocytes. In order to elucidate the mechanism by which gonococci
survive the bactericidal comnnunds produced by the phagocyte, estimation
of the production of bactericidal compounds is necessary. The
phagocyte's bactericidal armoory can be classified into two main groups
of compounds: those requiring oxygen for their formation - singlet
oxygen, hydroxyl radicals and hydrogen peroxide - and those that are
oxygen-independent - cationic proteins, lactofarrin and various
proteolytic and saccharolytic enzymes.
The precursor of the oxygen-dependent bactericidal species
is a one-electron reduction product of oxygen, the superoxide radical.
Qualitative and quantitative determination of this component, or its
dismutation product, hydrogen peroxide, forms the basis of tests to
determine the oxidative burst associated with phagocytosis.
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8.2 Experimental Design
Preliminary experiments employing ferricytochrome c_
reduction to quantify superoxide production were frustrated,
presumably by the very high cytochrome oxidase activity in the gonoc¬
occal outer membrane reviewed by Morse, Cacciapuoti and Lysko, (1979).
The determination of hydrogen peroxide was also subject to errors due
to the exceedingly high catalose activity found in strains of M.
gonorrhoeae (iMorrod and Morse, 1979). The experiments reported here
employed the redox indicator, nitroblue tetrazolium (NBT), to detect
superoxide. Its properties have been described in Section 2.11. In
the oxidised form it is soluble; when reduced it forms blue insoluble
crystals. The soluble oxidised form of iMBT incorporated into
monolayers of phagocytes from the medium forms blue crystals in cells
liberating superoxide. The proportion of stimulated (superoxide-
producing) cells can be estimated by microscopic examination of the
monolayers. Full experimental details are given in Section 2.11.1 et sag.
iM.gonorrhoeae strains A and B (Both recent isolates of
pyocin Group II with the double-highlight colonial morphology, a
phenotype that is associated'with gonococcal resistance to killing
by phagocytes. (Penn et al, 1976; see Section 1.5.1.1) were incubated
with monolayers of peripheral blood monocytes in the ratio of 10
bacteria per cell. Monocytes from one individual of each of the
four ABO blood groups were used. Due to the toxic nature of iMBT, it
was incorporated in the test medium to give a low final concentration
of 0.05)j. Tests were conducted in Hank's medium supplemented with 5%
autologous serum. In each experiment fresh and heat-inactivated serum
was used to detect the role of complement in the stimulation of
monocytes by gonococci.
In order to determine the role of 'natural' antibodies,
tests incorporating either fresh or heat-inactivated autologous serum,
o
which had been absorbed for one hour at A C with the stimulating
gonococcal strain,were also included. As a control procedure, opsonised
zymosan was used to stimulate monocytes in a medium containing 5)i FHS.
145.
After the experiment the monolayers were fixed with a
water-based fixative, formal saline, since the reduced NBT is soluble
in organic solvents. The cells were countsrstained with neutral red
(1 '/a) in order to give the greatest contrast with the blue formazan.
Preliminary experiments with May-Grunwald and Giemsa stains did not
allow any slight blueing of the cells to be detected.
200 monocytes were observed microscopically for each test
and cells were categorised —, + or +++, as described in Section 2.11







































































































































































































































































































































































































































The counts for each test are shown in Table XX. These
values were square-root transformed prior to analysis. This transform¬
ation stabilises the variance. This manipulation ensures that the
variance for data values such as counts that follow a Poisson distribution
are independent of the mean. (Snedecor and Cochran, 1980). The results
of duplicate experiments were pooled and subjected to an analysis of
variance (Anova) to determine if the blood group of the monocytes,
the serum treatment (heat-inactivation or absorption), or the
stimulating strain (A or 3) caused any significant heterogeneity in
the NBT reduction test. The results are summarised by two Anova tables
(Tables XXI and XXII).
The Anova table for the results obtained with the opsonised
zymosan (Table XXI) shows that significant heterogeneity exists between;
1) cells giving a + response and those giving a +++ response; and
2) cells incubated with zymosan and those incubated in the absence of
zymosan. No significant hetergeneity is observed between the responses
of monocytes of the four ABC blood groups. Zymosan stimulation resulted
in more cells reducing NBT than in monolayers without zymosan. Of
those cells that reduced NBT, more cells gave a +++ response than
gave a + response (Table XXII). The significant interactions were
due to effects from the primary sources of variation. (Factors A and B
in Table XXI).
A summary of the results obtained in the experiments with
N.gonorrhoeae strains A and 3 as stimulants are shown in Anova Table
2 (Table XXIIl). In these experiments no significant heterogeneity
due to the stimulating strain viz, strain A or strain 3 was observed.
The table of means for those factors that gave rise to significant
heterogeneity is given in Table XXIV. As in the experiments with the
control stimulus, opsonised zymosan, more cells gave a ■*•■*-+ response
than a +• response. The treatment of the serum was found to influence















































































































Table of fleans for Anova Table 1
Source of Variation Factors means
A (Degree of response) ( + 2.87
( + + + 5.46



















































































































































Tahlp nf Weans for Anova Table 2





C (serum treatment) FHS 3.828 1
FHS absorbed 3.058 0.1751
HIS 3.334
HIS absorbed 3.350
D (Blood Group) 0 3.664 1




































Weans are all means of square-root transformed counts
* SED = standard error of the differences between the means in each group
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stimulated in medium containing FHS compared with medium containing
absorbed FHS is the only significant difference of means in this
variate (p < 0.05). Cells stimulated in medium containing HIS or
absorbed HIS appear to give the same degree of response.
In contrast to the results obtained with the opsonised
zymosan, the ABO blood group of the monocytes was a significant source
of heterogeneity (Table XXIIl). Comparison of the mean numbers of NBT
reducing cells obtained for each blood group (Table XXIV) shows that
Group A cells gave significantly fewer positive cells than Group 0
(p <( 0.05) . No significant differences were noted between the
responses observed with Group B cells and those of the other blood groups.
An examination of the interaction between B, the degree of
response (+, +++) and C, the serum treatment, shows that the difference
between the mean number of NBT reducing cells giving a ++-r response
to those giving a + response is significantly higher (p < 0.05)
in these tests where a functional complement system is present i.e.
tests containing FHS or absorbed FHS, but not in those tests
containing heat-inactivated serum.
The interaction between the degree of response, B, and the
ABO blood group, 0 (Table XXIV) demonstrates that ABO blood group
influences the deqree of response to the gonococcal stimulants used in
these NBT tests. Whereas monocytes of blood groups A3, A and 0 give
significantly greater numbers of cells giving a +++ response than
a + response (p < 0.05), monocytes of group 3 do not.
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3.4 Summary and Discussion of the results
These are preliminary experiments. Firm conclusions cannot
be drawn from them. Nevertheless, they indicate potential areas for
further investigation and provide the experimental technique to answer
those questions. This NBT-reduction test provides a qualitative and
semi-quantitative method for examining the responses of glass-
adherent mononuclear phagocytes to standard stimulants, such as
opsonised zymosan, and bacteria, such as N.gonorrhoeae. Despite the
subjective and semi-quantitative aspects of this test, the results
obtained using the control stimulus, opsonised zymosan, displayed no
<5
significant hetergeneity between four sets of duplicate experiments.
The majority of NBT-reducing cells gave a strong, +++ , response to
both the control stimulus and the test bacterial strains.
Both strains of N.gonorrhoeae tested, strains A and B, were
pyocin Group II, double-highlight colonies. The monocyte responses to
both these strains were very similar. The treatment of the serum
(heat-inactivation or absorbtion) did not influence the numbers of
monocytes that reduced N3T, but did have an effect on the degree of
response ( + or +++). The presence of FHS in the medium resulted in a
larger proportion of cells giving a +++ response than in those exper¬
iments that used HIS. This suggests a role for the complement proteins
in stimulation of NBT reduction. Absorbtion of the serum was found to
reduce the number of positive, NBT-reducing monocytes only for the
experiments using FHS. (Table XXIV). No such reduction was seen between
the results obtained with HIS and absorbed HIS. This, together with
the results discussed above, suggests both reactive antibody and
complement are required for a +++ response to stimulation by these
strains of gonococcus.
Monocytes from the four individuals of blood groups AS,
A,0 and B gave a predominantly +++ response to the opsonised zymosan.
(Table XXII). A similar pattern of response was observed when the
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stimulant was N.gonorrhoeae for all tests except those using monocytes
of blood group 8. In these tests the ratio of cells ciuing a +++
response to those giving a + response was 1.114:1; this compares
with the ratios 2.331:1, 1.985:1 and 1.740:1 observed with monocytes
of blood groups 0, AB and A, respectively.
In summary, the NBT-test described in this section, is a
simple method to determine, in a semi-quantitative manner, the
oxidative burst of individual glass-adherent peripheral blood
monocytes stimulated by IM.gonorrhoeae and zymosan. The response of
these cells to f\l. gonorrhoeae is augmented by the presence of both
complement and reactive antibody. Monocytes isolated from four
individuals, each of a different ABO blood group, were stimulated
with opsonised zymosan and two strains of N.gonorrhoeae and the
responses were compared. Uhereas the monocytes from each donor reacted
to a similar degree in response to stimulation by opsonised zymosan,
the degree of response to N.gonorrhoeae was heterogeneous among the
four groups of monocytes; cells of blood group B gave a less intense
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9.1 Serum sensitivity among strains of N.gonorrhoeae and JM.
meningitidis
Healthy uninfected people have been shown to possess
bactericidal antibodies in their serum that react with certain strains
of w.gonorrhoeae and initiate a complement—mediated bactericidal
reaction. It was suggested in Chapter 3 that these antibodies were not
isohaernagglutinins, thereby refuting the hypothesis described in the
introductory Chapter (Section 1.10.1) : the increased susceptibility
of individuals of blood group 9 was due to their lack of anti-3
isohaemagglutinins, antibodies known to react with many species of
gram—negative bacteria, including the gonococcus.
Greater bactericidal activity among group A sera, which
possess these antibodies, was predicted,and removal of isohaemagglutinins
should have reduced the bactericidal activity of group A sera. The
results of these experiments in Chapter 3 support the former proposal
for two of the four serum-sensitive strains studied; P200 and M8865.
The latter proposal is, however, rejected.
If isohaemagglutinins are not a component of the 'natural'
bactericidal antibodies reactive with N.gonorrhoeae, which other classes
of 'natural' antibody might be involved in serum-killing of these
organisms.? Recent investigations by Lalezari and colleagues (Lalezari
et al, 1984; Lelezari and Jiang, 1984) have revealed that normal human
sera contain a wide range of sugar-specific antibodies. Since gonococcal
LPS is the 'target' antigen for bactericidal antibodies in normal
human sera, one or some of these sugar-specific antibodies could be
responsible for the 'natural' anti-gonococcal bactericidal antibody.
One possible contender, found in 100)1 of 350 sera examined by Lalezari
et al, (1984), is an antibody specific for melibiose. Plelibiose has
been shown to inhibit precipitation reactions between gonococcal LPS
and immune hen serum (Perry et al, 1978). These authors suggested that
a lactosyl unit might occupy a terminal position in the gonococcal
LPS (Section 1.5.5.1). Lalezari et al (1984) found lactose-specific
antibodies in 22.51) of 350 normal human sera. The reacting moiety of
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the lactose residue was associated with the 1-4 linkage between the
galactose and glucose residues (Lalezari and 3iang, 1984). This 1-4
linkage region between galactose and glucose is a structural feature
common to the six LPS sarogroups (GC1 to GC6) described by Apicella
and Gaqliardi (1970) (Apicalla et al. , 1981) . The possibility of these
antibodies cross-reacting with the galactosyl residue,which is
immunodominant in 8 blood group substance,may result in their formation
baing prevented in group 3 individuals. This may be one of the reasons
for the bactericidal antibody against strains P280 and 138365 being
observed at a higher titre in group A sera than in Group 3 sera (Table \JII).
The antigenic stimulus responsible for 'natural' bactericidal
antibodies reactive with N.gonorrhoeae is probably found in commensal
bacteria. The observation that these antibodies can be removed from
serum by absorbtion with a strain of l\l.lactamica and a Group II strain
of meningococcus (Table IX) gives support to this idea.
The lack of similarity between the serum-sensitivity
patterns observed for Group I and Group II strains of non-serogroupabla
meningococci (Chapter 7) is puzzling. Protein antigens might be acting
in bactericidal reactions mediated by 'natural' antibody (Frasch and
Gotschlich, 1974)^ thereby accounting for the serum-sensitivity of
Group I strains of non-serogroupable meningococci. Natural antibodies
to protein antigens of !\l. gonorrhoeae have been reported (Schiller,
Friedman and Roberts, 1973; Sarafian, Tarn and Horse, 1983),but opsonisation
is the principal biological activity of these antibodies. Another
possible explanation for the serum-sensitivity of Group I strains of
meningococci could be that capsular antigens of a hitherto unknown
serogroup may be reacting with bactericidal antibodies. If, however,
the observed serum-sensitivity of Group I strains of meningococci is
mediated via LPS antigens the possibility of differences in composition
and/or structure between gonococcal and meningococcal LPS molecules
must be considered.
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9.2 The relationship between pyocin type and serum sensitivity
in strains of N.gonorrhoeae
Gonococcal strains of pyocin Group I were uniformly
resistant to iMHS, whereas those of Group II were sensitive to the
majority of the 32 sera tested at a titre of j^15. (Chapter 3).
Examination of the LPS isolated from a Group II strain, P280, and a
pyocin-resistant variant, P280p that has the same pyocin type and serum-
resistance as Group I strains, suggests that the LPS of Group II strains
is a larger molecule than that found in Group I strains. This indicates
that the portion of LPS associated with the binding site for the class
R1 pyocins might be absent, rather than cryptic,in Group I strains.
This provides circumstantial evidence that the LPS locus that binds
bactericidal antibody is in the distal portion of the LPS and is
associated with the binding site for class R1 pyocins.
In contrast,Morse and Apicella (1982) and Guymon, Esser and
Shafer, (1982) observed that loss of pyocin—sensitivity in serum-
resistant gonococcal strains was coincident with a shift to serum
sensitivity. Only one of the pyocin classes used in these studies,
pyocin 1 (used by Guymon, Esser and Shafer, 1982) has been classified
by Kageyama. Pyocin 1 belongs to the R5 class of pyocins (Kageyama,
1975) that bind deep in the LPS molecule of Ps.aerupinosa (Kageyama,
1975; Section 1.5.5.3). If the gonococcal receptor for R5 pyocins has
a similar location, and this report suggests that it does bind closer to
the lipid moiety of the LPS than class R1 pyocins, then loss of its
receptor by mutation would result in a LPS molecule possessing very
little carbohydrate. These mutants may exhibit the high serum
sensitivity observed in deep rough LPS mutants of Salmonella spp.
(Taylor, 1983).
The serum-sensitive (Group II) strains in this study
presumably have more carbohydrate residues, or different linkages between
residues, in the LPS since they bind R1 pyocins. According to the
Pseudomonas model and this report, these bind at a site on the LPS
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distal to the binding site for class R5 pyocins. The Group I strains
might, therefore, be similar to the serum-resistant strain FA19 described
by Guymon, Esser and Shafer, (1982). Comparisons with the work of
Horse and Apicella is hindered by the fact that their pyocin 611-131 has
not been placed into one of Kageyama's classes (Kageyama, 1975).
The results of this report are supported by the findings
of Schneider and colleagues (1982) who proposed that the basis for
serum—resistance in strains of N.gonorrhoeae uas due to absence of an
LPS antigenic determinant rather than masking of an antigenic site.
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9.3 The prevalence of Group I and Group II strains of
N.gonorrhoeae in clinical isolates
The report by blackball, Young and Anderson (1979),
determined the pyocin type for a range of gonococcal isolates from
localised and disseminated infections. This was retrospectively
analysed for the prevalence of Group I and Group II strains of
N.gonorrhoeae. Strains that were sensitive to any of the R5 pyocins
were allocated to Group I, and strains that were sensitive to any R5
and any R1 pyocins were allocated to Group II. The hypothesis under
test was as follows : Strains isolated from DGI are all serum-resistant
whereas those from localised infections tend to be serum-sensitive
in vitro. Therefore, constitutively serum-resistant strains i.e.
those of Group I, should be predominant among those isolated from DGI
and serum-sensitive, Group II strains should form the majority in
strains isolated from localised infection.
The analysis supported the hypothesis, 95 (86.4)1) of 110
isolates from localised infections were of the Group II pyocin type,
compared with only 15 (13.6)=) of Group I. This contrasted with the
isolates from DG1 in which only 14 (58.4/) out of 24 isolates were of
Group II and a larger proportion 10/24 (41.5/), of Group I isolates
were found.
These results complement the observations of Schoolnik,
duchanan and Holmes, (1975) who found 97/ of strains isolated from
DG1 were serum-resistant, compared with 42/ of strains isolated from
localised infections. (See Section 1.8.3.5). The observation that a
Group II strain isolated from DGE, strain 1560, has a similar resistance
to serum as the Group I strains isolated from localised infection
suggest that at least two types of constitutive serum resistance may
occur. Lack of the LPS receptor for bactericidal antibody, such as
that observed with Group I strains and that described by Schneider et al
(1982) may present one form of serum-resistance. Another form of
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serum-resistance, which may have been responsible for the results
obtained with the Group II QGI isolate, strain 1560, may result from
the possession of a low molecular weight (P-lr 35K) protein I molecule
that has been associated with resistance to serum. (Dames et al, 1582)
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9.4 Inducible phenotypic serum-resistance in N.gonorrhoeae
- a possible mechanism.
This report demonstrated that changes in pyocin -
sensitivity are associated with the development of phenotypic serum
resistance (Chapter 5). These changes suggest loss or masking of
pyocin receptor sites, and are consistent with the ideas expressed in
Chapters 3 and 4: loss of the LPS portion associated with the binding
site for class R1 pyocins results in a shift from serum-sensitivity to
resistance.
N.gonorrhoeae is capable of expressing two distinct LPS
molecules simultaneously (Guymon at al, 1980; Rappuoli, 1981).
Rappuoli (1981) reported that gonococcal strain R-10 simultaneously
contained two antigenically distinct R-type lipopolysaccharides, only
one of which contained the lactosyl determinant which Perry et al (1978)
described as being an immunologically dominant feature. Both LPS
types were shown to have similar compositions and molecular weights.
The differences in antigenicity might be attributable to differences
in the linkage between the constituent sugars of the LPS. Antigenically
distinct gonococcal LPS with very similar molecular weights have also
been described by Schneider at al. (1978).
If the LPS species containing the lactosyl moiety reacted
with natural bactericidal antibodies and class R1 pyocins and the other
LPS species, in which the lactosyl unit was absent, was resistant to
these antibodies and pyocins, then a reduction in expression of the
lactose-containing LPS would be associated with an increase in
resistance to serum and R1 pyocins. Since the structure of the poly¬
saccharide portion of LPS is dependent on the specificities of the
glycosyl transferases, and the availability of the subunit sugars is
dependent on membrane transport proteins and epimerases, interference
with any one of these proteins could halt LPS synthesis. However, in
the proposed mechanism for the development of phenotyp'ic serum
resistance, only one LPS species is proposed to be affected. Since
the two LPS species described by Rappuoli (1981) had similar chemical
compositions interference with a specific glycosyl transferase is the
most likely event to result in inhibition of the production of one LPS
species whilst permitting synthesis of the other. This interference
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might be due to direct steric inhibition of a transferase, or to
repression of the genes coding for the transferase by the serum-
resistance inducing factor.
Another possible mechanism of inducing phenotypic serum
resistance could involve the liberation of enzymes capable of
degrading the polysaccharide moiety of the LPS molecule, thereby
destroying the antigenic and pyocin-reactive properties of the molecule.
Such enzymes have been observed in the supernates of sonic extracts of
N■gonorrhoeae and N.meningitidis (Apicella, Sreen and Gagliardi, 1978).
Chemical analysis of culture supernatants before and after treatment
with the inducer uould test this hypothesis.
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9.5 The absence of functional bactericidal antibody reactive
with N.meningitidis strains of serogroups A,8, and C in
the sera of patients with gonorrhoea
Sera from patients with gonorrhoea were screened for
bactericidal antibody against meningococcal strains of serogroups A,8
and C and two non-serogroupable strains, 0452 and PA(NG) 846. Normal
titres against the non-serogroupable strains were found; the geometric
mean titres were 74.7 and 16.0 for strains 0452 and PA(lMG) 846,
respectively. Antibodies reactive with the serogroupable strains were
not detected in the majority of sera tested. The geometric mean titres
against the strains of serogroups A,8 and C were 3.4, 2.6 and 4.0,
respectively. (Chapter 7). This lack of antibody against the
serogroupable strains contrasts with the results obtained with serum
from healthy people. (Chapter 7). Individuals of blood group 3 had a
geometric mean titre of 24.7 against the serogroup A strain, and indiv¬
iduals of blood group A had a geometric mean titre of 10.5. Craven and
colleagues (1982) report even higher titres against strains of
serogroups A,8 and C in the sera of seven normal individuals.
The absence of detectable bactericidal antibody against
serogroupable meningococci but not against the non—serogroupable strains
in the patients' sera could be due to lack of antibodies or to the
presence of IgA blocking antibodies. The patients with gonorrhoea
may never have had high titres of bactericidal antibody against thu
serogroupable meningococcal strains in this study. However, they were
shown to have bactericidal antibody reactive with the non-serogroupable
strains at titres similar to those observed in healthy uninfected
people.
Anti-meningococcal antibodies may be absorbed by cross-
reacting gonoccal antigens during infection. Antigenic similarities
between gonococcal and meningococcal LPSs have been reported
(Apicella at al; 1981; Section 1.5.5.2) and Neisseria species are
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known to release free LPS and outer membrane vesicles during growth
(De Voe and Gilchrist, 1973; Johnson, Perry and McDonald, 1975).
These may act as absorbants of antibody, possibly leading to the
observed reduction (transient?) in antibodies bactericidal for the
serogroupable strains tested. A similar phenomenon occurs during
pneumococcal infection (Oownie, 1937).
Another explanation for these observations comes from the
work of Griffiss (1975 and 1983) which shows that IgA specific for the
same antigenic determinants as bactericidal jgfl and IgG can block the
binding, and, therefore, killing of meningococci by these antibodies.
Moreover, Griffiss (1975) demonstrated the presence of these TgA
blocking antibodies in the serum of patients convalescing after an
episode of meningococcal disease. Infection with N.gonorrhoeae
may result in the stimulation of IgA antibodies that cross-react with
meningococcal antigens and block the binding of bactericidal antibodies
to INI.meningitidis, I gA antibodies reactive with serogroupable
meningococcal strains have been described both in patients with
gonorrhoea and in healthy controls, but no major differences between the
two groups were observed (McMillan et al, 1979).
If the bactericidal activity was due to natural antibodies
of the IgM class, as in the case of N.gonorrhoeae (Schoolnik, Ochs and
Buchanan, 1979), then low titres of IgA blocking antibodies in patients'
sera would produce a prozone (Griffiss, 1983). This was not observed
in our experiments.
The role of bactericidal antibodies in preventing
dissemination of N.meningitidis from the mucosa of the upper respiratory
tract has been discussed in section 1.7.3. Absence of bactericidal
activity against IM.meningitidis, whether due to absence of bactericidal
antibody, as seen in young children (Section 1.8.4) or due to the
presence of IgA blacking antibodies inhibiting the action of the serum
bactericidal antibodies, predisposes the human host to meningococcal
disease. (Griffiss, 1983; Kahty et al, 1981),
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Is there any link between infection with N.gonorrhoeae
and susceptibility to meningococcal disease? An examination of some
epidemiological data provides circumstantial evidence to suggest that
there may be. Analysis of the age-distribution of patients with
meningococcal disease shows the greatest morbidity to in the first four
years of life. These children have not yet developed bactericidal
antibodies against meningococci (Goldschneider, Gotschlich and
Artenstein, 1969b). The group in which the next highest incidence
occurs is the 15-19 year olds (Peltola, Kataja and flake la, 1982; Section
1.3.2.3), an age range corresponding to the onset of sexual activity
and in which there is a high incidence of gonorrhoea (Kallings and
Ploberg, 1977; Section 1.3.1)
Outbreaks of meningococcal disease in military institutes
occur predominantly among recruits, 80'/o of infections developing within
5-6 weeks of their entry (Bristow, van Peenen and Uolk, 1965; Varela
and Gilmore, 1971). The majority of patients with meningococcal disease
in one well documented outbreak in a military establishment fell into
the age range of 18-24 years (Koppes, Ellenbogen and Gebhart, 1977) which
is identical to that in which most military cases of gonorrhoea are to
be found. (Uhite and Blount, 1957).
The incidence of meningococcal colonisation of the pharynx
is higher in patients with genital gonorrhoea than in people without
the disease. (Young, Harris and Robertson, 1979; jZfdegaard and Gedde-
Oahl, 1979; Section 1.4.3). Analysis of the serogroup of the meningoc¬
occal strains isolated from the oropharynx of patients with gonorrhoea
has revealed that women with gonorrhoea had a higher rate of colonisation
with serogroupable meningococci than women without gonorrhoea. In
contrast, no difference in carriage rate was observed among women for
non-serogroupable meningococci. No differences in carriage of
meningococci were observed between men with and without gonorrhoea.
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The carriage rate of serogroupable meningococci has been
shown to be reduced by the presence of serum bactericidal antibodies
(Gotschlich, Goldschneider and Artenstein, 1969). It is tempting
to speculate that the absence of bactericidal antibody reactive with
serogroupable strains of meningococci among the sera from patients
(Predominantly women) with gonorrhoea surveyed in this report
(Chapter 7) may be one of the factors responsible for the increased
carriage of l\l,meningitidis among women with genital gonorrhoea.
Similar titres of bactericidal activity against non-serogroupable strains
of N.meningitidis were present in sera from women with gonorrhoea and
from healthy women.
These observations provide circumstantial evidence to
support the suggestion that recent gonococcal infection may be one of
the many factors contributing to susceptibility to meningococcal
disease and could partially account for the higher incidence of this
disease among young adults.
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9.6 The oxidative metabolic response of human monocytes of
blood groups A,3, AS and 0 to stimulation by strains of
N.gonorrhoeae
This report describes a simple method for determining,
in a qualitative and semi-quantitative manner, superoxide production of
individual glass-adherent mononuclear phagocytes by reduction of the
redox indicator, nitroblue tetrazolium (NBT). A standard stimulus,
opsonised zymosan, gave similar responses in duplicate experiments
using monocytes from four donors, one of each of the four ABO blood
groups. This uniformity of response, as determined by analysis of
variance (Tables XXI and XXII), provides a reference point to which
other stimuli can be compared.
This was only a pilot experiment, designed to develop
the technique and discover sources of hetergeneity in the oxidative
metabolic responses of monocytes from donors of the four ABO blood
groups to stimulation by strains of N.gonorrhoea♦ In view of the
increased susceptibility of individuals of blood group B to gonorrhoea
(Section 1.4.1.1) and the evidence suggesting that intracellular
survival of gonococci within phagocytes is an important aspect of the
pathogenesis of gonorrhoea (Section 1.7.2.1), the observation, in these
experiments, that the monocytes from the blood group 3 donor produce
superoxide less intensely than the monocytes from the dcnors of blood
groups A,A3 and 0 ( Chapter 3 ) requires further investigation.
If, after examining the monocytes from a larger sample of people, this
observation was confirmed as a general phenomenon of monocytes from
blood group B donors, it could be one of the factors causing the
increased susceptibility of individuals of blood group 3 to gonorrhoea.
Blackwell et al (1984) conducted IMBT reduction experiments
stimulating monocytes in suspension with gonococci and other Neisseria
species. Experiments conducted in the absence of serum gave more
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formazan - containing monocytes than experiments in which serum was
incorporated into the medium. These results were interpreted as
indicating an inhibitory role for serum. This could, however, be a
misinterpretation. Since the experiments were conducted on monocytes
in suspension, a population that would contain potentially glass-adherent
cells, the presence of serum may have assisted many of the cells,
to the reaction vessel and, therefore, not be present in the aliquot
that was removed from the reaction mixture for mounting and
microscopic examination.
reactive antibody and complement from the serum added to the reaction
mixture resulted in a decrease in the number of superoxide - producing
monocytes. (Tables XXIII and XXIV; Section 8.3 ), These differing
responses might be due to mononuclen/phagocytes being a heterogeneous
population of cells with a variety of functions and surface components.
(Dougherty and FlcSride, 1934). Examination of the distribution of
Fc and complement receptors between the two populations, viz. glass-
adherent monocytes and monocytes in suspension, might indicate the
reason for these differences.
especially those stimulated the bacteria, to adhere
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10.1 Lipopolysaccharide typa and serum-sensitivity of the
pathogenic Nessieria species
Grouping by sensitivity to R-type pyocins has provided a
simple and rapid means of discriminating between strains of the
pathogenic Neisseria species on the basis of putative differences in the
LPS molecule. In the case of the gonococcus, these differences have
been associated with differences in the interaction of strains with
the humoral and phagocytic components of the human immune system. The
information provided by pyocin-sansitivity is primitive. Deeper
understanding of the interactions between the LPS of Group I and Group
II gonococcal strains with 'natural' bactericidal antibodies and the
differences between serum-sensitivity of Group I strains of N.gonorrhoeae
and Group I strains of non-serogroupable meningococci will depend on
structural analysis. ■ of these molecules. LPS analyses are also an
important step in determining the effects of the component of guinea pig
and human blood that induces N.Gonorrhoeae strains BS4 (agar) to serum-
resistance .
At oresent, only small numbers of bacteria can be used in
the induction experiments because of the small quantities of inducer
available. If the inducer is actively taken up by the bacteria,
isolation of the membrane receptor could provide a means for purifying
and concentrating the inducer by affinity - chromatography.
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10.2 Does gonorrhoea predispose to meningococcal disease?
This report shows that patients with gonorrhoea have lower
titres of 'natural' bactericidal antibody against meningococci of
serogroups A, 3 and C than normal healthy people. This may increase
the susceptibility of patients with gonorrhoea to meningococcal disease.
Anecdotal and circumstantial evidence suggests that gonorrhoea may be
one of the factors that predispose the host to meningococcal disease.
Validation of this hypothesis would require clinical observations to
determine whether young adults with meningococcal disease had a recent
history of gonorrhoea.
The possibility that gonococcal infection stimulates IgA
blocking antibodies could be investigated by screening patients' sera
for IgA antibodies reactive with capsule and LPS antigens.
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10.3 The oxidative burst in rnsnocytes stimulated by N. gonorrhoeae
The continuation of the preliminary experiments described
in this report would involve an examination of the reactivities of
monocytes taken from a larger number of donors of the four ABO blood
groups. If the subdued response of blood group 9 monocytes to this
stimulus was found to be a general phenomenon, two questions arise :
1) since complement was found to increase the intensity of superoxide
production, do the stimulating strains of N.gonorrhoeae activate
complement equally efficiently in sera of the four ABO blood groups?
and 2) do monocytes from donors of blood group B have as many antibody
and complement receptors per cell as monocytes of blood groups A, AB
and 0?.
Phagocyte responses to external stimuli, opsonised
bacteria, complement fragments etc., are triggered via a system that
uses calcium as a secondary messenger (Romeo, 1982). The development
of fluorescent indicators of cytosolic calcium, such as Quin-2, allow
the ionic fluxes of cells, such as monocytes, to be monitored during
stimulation. (Tsien, Pozzan and Rink, 1984). These techniques would
allow the stimulation of monocytes by M.gonorrhoeae to be assessed
at the level of an event that occurs after membrane stimulation but
prior to and concurrent with the activation of the membrane oxidases
responsible for the production of superoxide.
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BLOOD GROUPS AND SUSCEPTIBILITY TO GONOCOCCAL
INFECTION.
II. THE RELATIONSHIP OF LIPOPOLYSACCHARIDE TYPE TO
GONOCOCCAL SENSITIVITY TO THE BACTERICIDAL
ACTIVITY OF NORMAL HUMAN SERUM
F. P. Winstanley, C. C. Blackwell, D. M. Weir and D. F. Kinane
Department ofBacteriology, Vniversity ofEdinburgh Medical School, Teviot Place, Edinburgh EH8 9AG, UK
(Received 2 August 1982)
SUMMARY This study examines the bactericidal activity of normal human sera from individuals of
blood groups A and B for gonococcal strains with simple and complex lipopolysaccharides (defined by
pyocin-sensitivity) isolated from localised and disseminated infection. The bactericidal activity did not
depend on A or B isohaemagglutinins. Resistance to normal human serum exhibited by strains from
localised infections appeared to be due to lack of part of the lipopolysaccharide antigen, whereas
resistance of strains from disseminated infection appeared to depend on a separate mechanism yet to be
defined.
Introduction
Individuals of blood group B are especially susceptible
to genito-urinary infections with Escherichia coli (1, 2)
and Neisseria gonorrhoeae (3, 4, 5). There is evidence that
the anti-B isohaemagglutinin found in individuals of
blood groups A and O may play a role in host-protection
against infection by gram-negative bacteria (6).
In this study we investigated the sensitivity of a number
of strains of N. gonorrhoeae with different lipopolysac¬
charide (LPS) to "normal human serum" (NHS) from
individuals of blood groups A and B to determine
whether anti-B isohaemagglutinin is involved in a non¬
specific host defence mechanism against gonorrhoea.
Previous work from this laboratory has indicated that
attachment of gonococcal strains to polymorphonuclear
leukocytes (PMN) varies according to differences in the
structure of the LPS (7) as detected by differences in
sensitivity to partially purified R-type pyocins of Pseudo-
monas aeruginosa (8). Since LPS is one of the major anti¬
gens involved in bactericidal killing (9,10), strains of both
of the pyocin-defined groups (7) were tested to determine
whether differences in LPS structure could be correlated
with differences in sensitivity to the bactericidal effects of
NHS and conventional immune sera prepared in mice.
Correspondence: Dr. D. M. Weir, Department of Bacteriology




Ten gonococcal strains from localised infections were supplied by the
Department of Genito-urinary Medicine, Royal Infirmary of Edinburgh
(R.I.E.). Three /Mactamase-producing strains were kindly supplied by
Dr. K. Shannon and Professor I. Phillips, St. Thomas's Hospital
Medical School, London, and two strains from disseminated infections
were obtained from Dr. Joan S. Knapp, Neisseria Reference
Laboratory, United States Public Health Service, Seattle, Washington.
All strains, together with the grouping based on pyocin sensitivity (7)
are listed in Table 1. They all conformed to the morphological and
biochemical characteristics of N. gonorrhoeae and were of colony type 4
(11).
Culture
Strains were cultured on Modified New York City (MNYC) medium
(12) at 37°C in a humidified incubator with 10% C02 in air.
Isolation ofPyocin-resistant Mutant
Colonies growing within a zone of inhibition produced by pyocin IS8
were isolated and re-typed. One mutant strain (P280p), sensitive to
Kageyama group R5 pyocins only, was used in the study.
Preparation of Immunising Antigens
An 18-hr growth of gonococci was harvested from MNYC plates
with sterile cotton swabs and suspended in 0 01M phosphate-buffered
saline (PBS) pH7-2. An equal volume of PBS containing 2-4%
formaldehyde was added to the suspension which was stored overnight
at 4°C. The formaldehyde-treated organisms were centrifuged at 900 x
g for 1 hr and resuspended in PBS containing 0-01 % formaldehyde to
the opacity of Brown's Tube No. 3 as judged by eye (13). This is equi¬
valent to 1-1 x 109 gonococci/ml (14).
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Table 1 Pyocin type of gonococcal strains
Pyocins with Kageyama group
Gonococcal























+ clear zone of inhibition.
± zone of partial inhibition.
— no inhibition.
* ^-lactamase producing strains,
t strains from disseminated infection.
Immunisation Schedule
Female CF1 mice, 5-6 weeks old, caged in groups of 10, were given
0-25 ml of the standard suspension of formaldehyde-treated gonococci
(gonococcal antigen) intravenously, via the lateral tail veins. The mice
were immunised at day 0 and again on days 7 and 10. On day 14 a small
quantity of blood was taken from the retro-orbital plexus of each mouse
of the group and pooled; the serum obtained was inactivated by heating
to 56°C for 30 min and then distributed into small tubes and stored at
— 20°C until required. The mice thereafter received booster doses
(0*25 ml) of the gonococcal antigen at 14-day intervals and blood was
obtained 5 days after each immunisation.
Complement
Human AB serum from a donor with no history of gonococcal
infection was adsorbed for 24 hr at 4°C with a live suspension of the
gonococci used in the study, distributed in 200 pi aliquots and stored at
— 70°C before use. The minimum haemolytic titre of the serum was
32-64.
Normal Human Sera from Individuals ofBlood Groups A and B
Kindly supplied by Drs. S. Urbaniak and P. L. Yap of the Blood
Transfusion Service, R.I.E.
Screening Testfor Bactericidal Activity ofNormal Human Serum
An 18-hr culture of gonococci was suspended in Dulbecco's Phos¬
phate Buffered Saline supplemented with Mg + + and Ca++ ions
(0-5mM and 0-9 mM respectively) (DPBS + B) to give approximately
104 cfu/ml.
A series of two-fold dilutions, from 15 to 480, were made in a micro-
titre plate for each serum to be screened to give a final volume of 50 pi
per dilution, 40 pi of gonococcal suspension and 10 pi of a two-fold
dilution of the complement source were added to each well and incu¬
bated at 37°C for 30 min. Two drops of 20 pi from each well were plated
onto MNYC medium and incubated for 24 hr. The highest serum
dilution to give a reduction in viable count of ^ 80% was considered to
be the bactericidal titre of the serum.
Bactericidal Assay with Immune Mouse Serum
These were performed in round-bottomed glass tubes (15 mm x
75 mm). An 18-hr culture of gonococci was suspended in D.PBS + B to
give approximately 106 cfu/ml. The assay mixture contained 160 pi of
bacterial suspension, 20 pi of a two-fold dilution of heat-inactivated
mouse serum and 20 pi of freshly thawed AB serum as the complement
source. Controls lacking serum and/or complement were included for
each experiment. After static incubation at 37°C for 30 min in a humidi¬
fied atmosphere with 10% C02 in air, 25 pi volumes were removed
from each tube and viable counts were performed (15). A reduction in
viable count of 80% or greater when compared with controls was
considered to be significant.
Results
The gonococcal strains were all typed by pyocin sensi¬
tivity and classified into two broad groups: Group I
strains were sensitive to Kageyama group R5 pyocine;
Group II strains were sensitive to Kageyama groups R5
and R1 pyocins (table 1).
The AB serum used as the exogenous complement
source for the bactericidal reactions was found to have
slight microbicidal activity against strains of Group II.
This activity was removed by absorption at 4°C with the
sensitive strains and the procedure had no effect on the
complement titres. Absorbed AB serum was used in all
the bactericidal tests.
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Table 2 Bactericidal titre of normal human serum from Group A individuals
Sera
Test strain of








M8865 15 240 60 60 60 30 120 120 30 120 120 60 30 30 15 60
P280 > > > > > > 240 240 240 60 120 30 120 120 30 120
E2590 < < 60 30 < 30 < < 30 30 120 60 60 60 15 60
P3290 15 15 30 30 30 30 15 60 120 120 15 15 15 60 30 120
*1560 < < < < < < < < < < < < < < < <
Group I
Group II
< less than 15.
> greater than 480.
* strains from disseminated infection.
Normal human sera from individuals of blood groups
A and B were found to be bactericidal to gonococcal
strains of Group II to a titre of >15, but no activity
towards Group I strains from localised infections or a
disseminated infection could be demonstrated at the
lowest serum dilution of 15. The titre of bactericidal anti¬
body against strains of Group II was slightly greater in
individuals of blood group A (tables 2 and 3). No bacteri¬
cidal activity could be demonstrated towards strain 1560
(Group II) from a disseminated infection (tables 2
and 3).
This bactericidal activity of NHS towards strains of
Group II is inhibited by 10 mM Mg-EGTA which
sequesters Ca + + ions necessary for the classical pathway
of complement activation.
There was no discrimination between strains ofGroup
I and Group II by the microbicidal mechanism in
immune mouse serum. Serum raised against a strain from
Group I (M9131) killed other strains in Group I and also
strains in Group II. This same lack of discrimination was
shown by antiserum raised against a strain from Group II
(M8865) (table 4). Similar experiments with two
gonococcal strains from disseminated infections (1560
and 7425) showed no detectable microbicidal activity.
One serum from each of the blood groups A and B was
absorbed twice for 24 hr at 4°C with a heavy suspension
of erythrocytes expressing A or B antigens to remove the
iso-haemagglutinins. This absorption did not remove any
bactericidal activity from the sera. Absorption with a
heat-killed suspension of P. aeruginosa strain ZD8
slightly reduced the bactericidal activity of the sera (table
5).
Table 3 Bactericidal titre of normal human serum from Group B individuals
Sera
Test strain of








M8865 15 30 30 30 > 15 120 30 15 15 < 30 < 15 30 15
P280 < 15 < 15 240 15 15 30 120 60 60 60 240 60 120 60
E2590 < < < 15 60 < < < 30 30 30 60 30 60 30 30
P3290 < < < 30 60 < 120 60 120 30 30 15 15 120 30 60
*1560 < < < < < < < < < < < < < < < <
< titre less than 15.
> titre greater than 480.
* strains from disseminated infection.
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Table 4 Microbicidal action of immune mouse serum. Number of tests
out of 4 giving ^ 80% kill
Table 6 Relative positions of pyocin receptor sites on Iipopolysaccha-
ride (LPS) of Pseudomonas aeruginosa
Antiserum
Gonococcal
strains M913I (group I) M8865 (group II)












Our findings suggest that the increased susceptibility of
individuals of blood group B to infection by N.
gonorrhoeae is not related to differences in susceptibility
of the organism to isohaemagglutinins. Although N.
gonorrhoeae isolates have been shown to absorb anti-A
and anti-B isohaemagglutinins (4) the bactericidal acti¬
vity of normal human serum (NHS) could not be re¬
moved by absorbtion with red blood cells expressing A
and B antigens.
Variations in the susceptibility of gonococci to the
bactericidal effects ofNHS have been reported (9,16, 17).
Although the LPS has been found to be the target antigen
for "natural" antibody (16, 18), the particular com¬
ponents involved in the reaction had not been identified.
Classification of gonococcal isolates by the sensitivity
pattern to partially-purified R-type pyocins of P. aeru¬
ginosa has provided a method for detecting differences in
LPS antigens. Clinical isolates of Group I which appear
to have a simpler LPS structure are resistant to NHS
while those with more complex LPS (Group II) are sensi¬
tive. The importance of LPS components in determining
the reaction with NHS is illustrated by the change from
sensitivity to resistance found in the mutant P280p
(Group I) derived from a NHS-sensitive clinical isolate,
P280 (Group II). Alterations in the LPS associated with
R3* R4* R2* Rl* R5*
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* Arranged in order of the receptor sites on the lipopolysaccharide
(LPS) fraction of P. aeruginosa suggested by Kageyama 11975).
The receptor for R5 is nearest to, and that for R3 furthest from the
cytoplasm.
this mutation was shown by gel-electrophoresis and gas-
liquid chromatography (unpublished data). These
findings are similar to those of Morse and Apicella (19)
for their gonococcal LPS mutant selected for resistance
to pyocin 611-131.
A schematic representation of the relative positions of
pyocin receptors on the LPS of P. aeruginosa proposed
by (20) is shown for our range of pyocins and those used
by Sidberry and Sadoff (21) in Table 6. The "natural"
antibody of NHS appears to be directed against either:
(1) the LPS structure(s) that form the receptor site(s) for
pyocins of Kageyama's group Rl; or (2) to one or more
structures distal, but linked, to the receptor site for the Rl
pyocins. Evidence for this second proposal comes from
the work of Sadoff and co-workers (22). Gonococcal iso¬
lates were typed with pyocins from their collection and
they found that the growth of serum-sensitive strains was
inhibited by pyocins D, H and I. These three pyocins
belong to Kageyama groups R2, R4 and R3 respectively
which attach to LPS receptors distal to those for Rl
(table 6). In contrast, our pyocins of these three groups
Table 5 Titres of bactericidal antibody before and after absorption
N. gonorrhoeae Before Absorbed with Absorbed with
strain absorbtion erythrocytes P. aeruginosa
P280 120 120 60
Group A serum M8865 120 120 60
(K) E2590 30 30-60 15
P280 120 120 15
Group B serum M8865 15 < 15
. (v»V E2590 15 15 <
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had no activity against any of the gonococcal isolates
tested (8).
The putative "natural" antibody responsible for the
microbicidal activity of NHS differs in specificity com¬
pared with conventional immune sera raised in mice.
While the "natural" antibody recognises determinants
present only on organisms expressing the more complex
LPS, the immune sera had a wider specificity and were
bactericidal for strains of both Group I and Group II.
Previous work has suggested that resistance of
gonococci to NHS is not due to the presence of masked
antigens, blocking IgA antibodies, or deficiencies in com¬
plement function, but to the resistant organism's lack of
an LPS determinant that binds the "natural" antibody
(23); our findings support this view. The bactericidal acti¬
vity of NHS towards strains of Group II could be
absorbed in part by a heat-killed suspension of P.
aeruginosa strain ZD8, suggesting that the' activity may
be due to "natural" antibody induced by commensal
flora.
One implication of our findings is that the more NHS-
sensitive Group II organisms should be restricted to
localised infections and that Group I should predominate
in disseminated infections. In an earlier study on pyocin
types of gonococci from a number of geographic sources
(8) 95 (86-4%) of 110 isolates from localised infections
were of Group II compared with only 15 (13-6%) of
Group I. In contrast, of the 24 isolates from disseminated
infections, a higher percentage of Group I organisms
(41 -6 %) were found. The proportion of isolates of Group
II was 58-3%. Since organisms of Group II have been
isolated from disseminated infections, simplicity of LPS
does not appear to be the sole factor in determining the
characteristics of a "disseminated" strain.
A Group II isolate from a disseminated infection was
resistant to immune mouse serum in addition to NHS
and this finding is the subject of further studies. This
suggests that loss or masking of antigens can occur
without interfering with the receptor sites for the R-type
pyocins. This resistance to bactericidal antibody of a
strain from disseminated infections was not found to be
associated with anti-complementary activity of the
organism.
We conclude that the bactericidal effect of NHS on
strains of N. gonorrhoeae is mediated by antibodies that
bind to a LPS portion associated with the binding site of
R1 pyocins present in gonococci of Group II. Strains
lacking this portion of LPS—(Group I)—are resistant to
NHS. Thus "natural immunity" to gonorrhoea appears
to be directed at organisms ofGroup II.
The basis for the increased susceptibility of blood
group B individuals to gonorrhoea is still not established
but seems not to be due to isohaemagglutinins. There is
evidence in E. coli urinary tract infections that the anti-B
titres are raised during infection with organisms
expressing B-like antigens. This rise did not occur with
anti-A isohaemagglutinins in response to A-like
organisms (24). If this difference is reflected in other
"natural antibody" responses of B individuals a possible
basis for increased susceptibility to infection arises.
The sharing of antigens (galactose determinants) be¬
tween the LPS of gonococci and blood group B antigen
could also account for a diminished response in indi¬
viduals of blood group B.
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of chloracne (72). The table shows the mortality figures of both
subgroups stratified by year of birth. 25 men have died, 8 from
myocardial infarction including sudden death and 8 from
neoplasms. In contrast to the 8 who died from tumours, 7 of the 8
men who died from myocardial infarction/sudden death had had
chloracne; 4 belonged to the group of 16 contract cleaners, who did
the dirtiest work and had severe chloracne. These 16 men had many
other exposures to chemicals before and after the period concerned,
and alcohol consumption was relatively high among this group. The
neoplasms do not show an organ related pattern, and are not
considered to represent any excess mortality: expected number of
deaths 21 (SMR 1-19, 95% confidence interval 0 - 78— 1 • 70);
expected number malignant diseases 6-94 (SMR 1-15, 95%
confidence interval 0-49-2-09).
Morbidity data are being collected on 35 of the cohort, most of
them being employees of the factory concerned. The data are being
compared with those of a matched control group, and to date no
significant differences have been found. The study continues.
We thank Prof F. de Waard and Dr H. B. Bueno de Mesquita, National
Institute for Public Health, Bilthoven, for statistical calculations.
titre of bactericidal antibody against nmeningitidis
strains of serogroup a, b, and c, and two non-groupable







GONORRHOEA, A PREDISPOSING FACTOR FOR
MENINGOCOCCAL DISEASE?
Sir,—Immunity to meningococcal disease correlates with the
presence of bactericidal antibodies for Neisseria meningitidis.
Development of protective antibodies in the absence of
meningococcal disease is associated with carriage of non-
serogroupable strains of the organism which are also usually non¬
pathogenic.1'2 Children not yet colonised by these strains are at
greater than usual risk of meningococcal disease. We have noted
abnormally low levels of antibody bactericidal for N meningitidis
serogroup A and two non-serogroupable strains among individuals
with gonorrhoea,3 and report here the bactericidal activity ofserum
from individuals with gonorrhoea against strains ofN meningitidis
serogroups A, B, and C, those most frequently associated with
meningococcal disease, and against the two non-serogroupable
strains (0452 and NG846).
Strains ofN meningitidis were cultured on modified New York
City medium at 37°C in a humidified atmosphere enriched with
10% C02. Titration ofbactericidal antibody was done as described
previously (see table).4
The results demonstrate very low or undetectable levels of
antibodies bactericidal for the strains ofmeningococci serogroups
A, B, or C in sera from patients with gonorrhoea. This contrasts
with the titres against a group A strain found in serum ofuninfected
"normal" individuals from the same geographical area (only 5/16
sera having titres below 4)3 and with titres against serogroups A, B,
and C reported by Craven et al.5
Absence of bactericidal antibody against serogroupable
meningococci is a common feature of individuals who contract
meningococcal disease and, as Artenstein and Ellis6 suggested,
"since meningococcal disease is a rare event compared to the carrier
state, it may well be that deficiencies in host defences may play a
major role in determining whether systemic invasion occurs".
1. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the
meningococcus II: Development of natural immunity. J Exp Med 1969; 129:
1327-48.
2. Reller LB, MacGregor RB, Beatty HN. Bactericidal antibody after colonization with
Neisseria meningitidis. J Infect Dis 1973; 127: 56-62.
3. Blackwell CC, Winstanley FP, Weir DM. Lipopolysaccharide type and sensitivity of
the pathogenic Neisseria to the bactericidal activity of normal human serum. In:
Proceeding of the fifth international conference on cerebrospinal meningitis
(Marseilles, France, 1983).
4. Winstanley FP, Blackwell CC, Weir DM, Kinane DF. ABO blod groups and
susceptibility to gonorrhoea II: The relationship of lipopolysaccharide type to
gonococcal sensitivity to the bactericidal activity of normal human serum. J Clin
Lab Immunol 1983; 11: 27-32.
5. Craven DE, Shen KT, Frasch CE. Natural bactericidal activity ofhuman serum against
Neisseria meningitidis isolates of different serogroups and serotypes. Infect Immun
1982;37: 132-37.
6. Artenstein MS, Ellis RE. The risk of exposure to a patient with meningococcal
meningitis. Milit Med 1968; 133: 474-77.
Patient A B C 0452 NG846
1 <4 8-16 4-8 32-64 16-32
2 <4 <4 8-16 64-128 <4
3 <4 8-16 8-16 64-128 8-16
4 <4 <4 <4 16-32 <4
5 8-16 8-16 16-32 64-128 32-64
6 <4 <4 8-16 >128 64-128
7 <4 <4 <4 >128 4-8
8 <4 <4 <4 64-128 16-32
9 <4 <4 <4 16-32 <4
10 <4 <4 <4 64-128 4-8
11 <4 <4 4-8 >128 <4
12 <4 <4 4-8 >128 128
13 32-64 <4 4 >128 >128
14 <4 <4 <4 >128 8-16
15 <4 <4 8-16 64-128 64-129
16 4 4 4-8 >128 32-64
17 >128 <4 4-8 >128 >128
18 4-8 <4 4-8 >128 >128
Meningococci and gonococci possess similar lipopolysaccharide
structures,7 and cross-reactions ofmonoclonal antibodies have been
shown between lipopolysaccharide antigens of meningococci and
gonococci.8 Bactericidal antibodies against both these species
appear to be directed against lipopolysaccharide antigens. The low
titre of bactericidal antibody towards groups A, B, and C
meningococci in sera from patients with gonorrhoea could be due to
absorption of cross-reactive antibodies by the infecting strain of
N gonorrhoeae.
We propose that gonorrhoea may compromise host defences
against meningococcal disease and that this may explain in part the
following observations:
(a) The age range most at risk of meningococcal disease is 0-4
years (ie, children lacking bactericidal antibodies') but the group
next most at risk is 15-19 years, the age when sexual activity begins
and when the incidence ofgonorrhoea is high.9'10
(b) During outbreaks of meningococcal disease in military
establishments most patients are aged 18-24 years,11,12 the range in
which most cases of gonorrhoea in servicemen are found.
(c) The incidence ofmeningococcal colonisation ofthe pharynx is
higher in patients with genital gonorrhoea (26%) than in those
without (11%). The relative risk ofharbouring meningococci when
infected with gonococci is 2-44 (95% confidence limits,
1-4-4-2).13,14
A recent history of gonoccal infection or exposure to infection
may be one ofthe contributing factors to the increased susceptibility
of young adults to meningococcal disease.
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SHORT COMMUNICATION
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A laboratory-grown strain of Neisseria gonorrhoeae, selected in vivo, BS4 (agar), is susceptible to
complement-mediated killing by fresh human serum but is relatively resistant to killing by
human phagocytes. It can be induced to serum resistance by incubation with a small molecular
weight fraction of guinea pig serum. The serum-susceptible and induced-resistant forms show
differences in pyocin sensitivity tests. This indicates either differences in the structure of their
lipopolysaccharides or masking of some determinant(s). The pyocin sensitivity pattern of
BS4 (agar) is only slightly different from that of a closely related strain, BSSH, which is more
susceptible to killing by human phagocytes.
introduction
A strain ofNeisseria gonorrhoeae selected from a small colony forming, pilate laboratory strain
(BS) by three or four passages through plastic chambers implanted subcutaneously in guinea
pigs was resistant to killing by human serum and human phagocytes when examined without
subculture (Penn et al., 1976, 1977). When cultured in laboratory media, the in w'ro-selected
strain, BS4 (agar), lost its serum resistance but retained its resistance to killing by phagocytes
(Penn et al., 1976, 1977). The serum resistance could be restored phenotypically to BS4 (agar) by
incubating it for 3 h at 37 °C in a defined medium (DM) containing 0-1% (w/v) bovine serum
albumin (BSA) and small molecular weight fractions of either guinea pig or some human sera
(Veale et al., 1981; Martin et al., 1981).
The determinant(s) of the induced resistance of BS4 (agar) to killing by human serum has not
yet been investigated. The limited supply of host-derived inducer has prevented the production
of sufficient organisms for investigation of outer membrane proteins (OMP) and lipopolysac¬
charides (LPS) comparable to those studies on the culture-stable type of serum resistance shown
by strains from disseminated gonorrhoea (Brooks et al., 1978; Lambden etal., 1979; James et al.,
1982). An investigation of the LPS of susceptible and induced-resistant forms of BS4 (agar)
seems particularly relevant because LPS appears to be the target antigen for the 'natural'
antibody responsible for the bactericidal activity of normal human serum (Brooks et al., 1978;
Schneider et al., 1982). A method for indicating changes in LPS of N. gonorrhoeae became
available when it was shown that partially purified, Kageyama R-type' pyocins from
Pseudomonas aeruginosa (Kageyama, 1975), the receptor sites for which reside on the LPS
(Meadow & Wells, 1978), reacted with gonococci and could form the basis of a typing system
(Morse et al., 1976; Sidberry & Sadoff, 1977; Blackwell et al., 1979). Only small numbers of
gonococci are required and the pyocin method has been used to indicate LPS differences in
mutational and epidemiological studies on gonococcal sensitivity to serum killing and
attachment to polymorphonuclear leucocytes (Guymon et al., 1982; Blackwell et al., 1983;
0022-1287/84/0001-1764 $02.00 © 1984 sgm
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Winstanley et al., 1983). This paper reports tests with a range of R-type pyocins on strain
BS4 (agar) before and after induction to serum resistance by the low molecular weight fraction
from guinea pig serum.
The determinants of the resistance of strain BS4 (agar) to killing by phagocytes have been
investigated by comparing it with a closely related phagocyte-susceptible strain, BSSH, selected
in vitro by colonial appearance from the original parent strain BS (Penn et al., 1977). In this case,
sufficient organisms could be obtained for biochemical examination. The putative determinant
of resistance was not pili and resided in outer membrane vesicles (OMV) (Parsons et al., 1981).
Examination of the proteins of purified OMV from BS4 (agar) and BSSH on sodium dodecyl
sulphate polyacrylamide gel electrophoresis associated three OMP with the resistance of
BS4 (agar) to killing by phagocytes (Parsons et al., 1982). However, it was thought interesting to
include in the pyocin tests a comparison of the phagocyte-resistant [BS4 (agar)] and phagocyte-
susceptible (BSSH) strains.
METHODS
Neisseria gonorrhoeae. Strains BS4 (agar) and BSSH were derived, stored, cultured and counted as described
previously (Penn et al., 1976, 1977; Parsons et al., 1981, 1982).
Induction of BS4 (agar) to serum resistance. The method used was described by Veale et al. (1981): 104-105
gonococci were incubated for 3 h at 37 °C in equal volumes ofDM containing 0-1 % (w/v) BSA and an ultrafiltrate
of guinea pig serum containing molecules of less than 5000 daltons (Veale et al., 1980; Martin et al., 1981). The
serum-susceptible BS4 (agar) used for comparison with the resistant organisms in the pyocin tests (Table 1) had
been incubated in DM containing 0-1% BSA for 3 h at 37 °C without the inducer.
Pyocins, Representatives of four of the five groups (R1-R5) of R-type pyocins described by Kageyama (1975)
were prepared from the following strains of P. aeruginosa and partially purified and stored as described by
Blackwell et al. (1979). These included: R1 pyocins from strains ISD, 2285, IS6 and IS8; R2 pyocin from strain
ISB; R3 pyocin from strain ISE; R5 pyocins from strains ISA and ISC; and two unclassified pyocins from strains
R205 and 9579.
Tests for pyocin sensitivity. A suspension (15 pi) of partially purified pyocin was added to a suspension of
gonococci (100 pi; 104-105 c.f.u. ml-1 in DM (Veale et al., 1981) in a sterile plastic test tube (10 ml capacity).
Control tubes received DM (15 pi) but no pyocin. After 30 min incubation at 37 °C, DM (0-5 ml) was added to
each tube. The gonococci were deposited by centrifugation (1500 15 min, 37 °C) and the supernatant was
removed. The gonococci were resuspended in 0-3 ml DM, which was plated out on haemoglobin agar. After
incubation at 37 °C in candle extinction cans the colonies were counted. Results of the experimental samples were
recorded as + , ± and — when the viable counts were <5%, <20% (but >5%), and >20%, respectively, of the
colony counts for the control tubes. All gonococcal strains were tested against the 10 different pyocins in many
tests (see Table 1).
RESULTS
The results are summarized in Table 1. During the 3 h induction period to resistance the
serum-susceptible form of BS4 (agar) had lost its sensitivity to the pyocin produced by strain
R205 and its partial sensitivity to that produced by strain IS8; also its full sensitivity to the R5
pyocin produced by strain ISC became partial. The serum- and phagocyte-susceptible strain
BSSH (Penn et al., 1976, 1977) showed a partial sensitivity to the R1 pyocin from strain IS6 in
contrast to the insensitivity of the two forms of BS4 (agar), both of which were relatively
resistant to killing by phagocytes (Penn et al., 1976, 1977; N. J. Parsons & H. Smith,
unpublished observations). In reactions with the pyocins from strains IS8 and ISC, BSSH
behaved similarly to the serum-susceptible form of BS4 (agar). With the pyocin from strain
R205, BSSH was less sensitive than the serum-susceptible form of BS4 (agar), whereas the
serum-resistant form of BS4 (agar) was fully resistant to this pyocin.
DISCUSSION
The pyocin sensitivity tests suggest that a change in LPS occurs when the serum-susceptible
gonococcal strain BS4 (agar) is converted to serum resistance by the low molecular weight
inducer from guinea pig serum in the short time of 3 h at 37 °C. Overall, a loss of sensitivity to
three pyocins accompanied the increase in serum resistance and this indicates that the LPS
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Table 1. Activity of 10 different pyocins on strain BS4 (agar) before and after induction to serum
resistance and on strain BSSH
Each result was obtained on at least four different tests with each pyocin and at least eight different tests
with pyocins from strains IS6, IS8, R205,9579 and ISC. The differences between the serum-susceptible
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* Results were recorded as +, ± and — when the viable counts were <5%, <20% (but >5%), and >20%
respectively, of the counts of the control tubes not containing pyocin.
structure had been altered, since three receptor sites appear to have been removed ormodified or
masked by a new component. This result complements recent correlations made between the
susceptibility of clinical isolates to serum killing and the presence of LPS receptors for the R1
pyocins (Winstanley et al., 1983). Any speculation on the precise changes in LPS structure which
accompanied the increase in serum resistance depends on the assumption that observations on
pyocin reactions with the LPS of P. aeruginosa apply to the LPS of N. gonorrhoeae. Mutants of
gonococci selected for resistance to R1 pyocins remain sensitive to R5 pyocins, indicating that
the receptor for the R5 pyocins is in the portion of the LPS nearest to the cytoplasm and those for
R1 pyocins are more distal (Winstanley et al., 1983). These are similar to the results obtained for
P. aeruginosa (Kageyama, 1975). Little can be drawn from the most marked change in pyocin
sensitivity accompanying the increase in serum resistance, namely the complete loss of
sensitivity to the unclassified pyocin from strain R205, since its receptor site is unknown even
for the LPS of P. aeruginosa. It should be noted that in the majority of clinical isolates of
gonococci, if the strain is sensitive to R1 pyocins it is also sensitive to the pyocin produced by
strain R205 (Blackwell eta/., 1979). The smaller losses in sensitivity to the R1 pyocin from strain
IS8 and the R5 pyocin from strain ISC suggest that receptor sites both in the polysaccharide side
chain and in or near the core of the LPS may have been affected. The receptor sites may not have
been produced, or they may have been modified, or even obscured by new structures such as
proteins under the influence of the small molecular weight inducing factor whose mechanism of
action is unknown. However, one possible masking agency, the formation of a capsule under the
influence of the inducer, does not occur; in electron microscopy similar to that which
demonstrated capsules on some gonococci (Demarco de Hormaeche et al., 1978), capsules could
not be seen on BS4 (agar) organisms either before or after being induced to resistance (P. M. V.
Martin, unpublished observations).
It is tempting to suggest that changes in pyocin sensitivity which occur as the result of the
action of the small molecular weight inducer indicate changes in LPS which are responsible for
the increased resistance to serum killing. However, the evidence at present is only that of
association (Smith, 1983) and can only be strengthened by deeper investigations on the
connections with serum resistance of the LPS and any other bacterial components (for example,
OMP) that may be formed under the influence of the inducer.
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SHORT ARTICLE
ABSENCE OF BACTERICIDAL ANTIBODIES AGAINST
GROUP-I LIPOPOLYSACCHARIDE DETERMINANTS OF
NEISSERIA GONORRHOEAE DURING HUMAN INFECTION
C. Caroline Blackwell, F. P. Winstanley. D. M. Weir and D. F. Kinane
Department of Bacteriology, University of Edinburgh Medical School, Teviot Place, Edinburgh
EH8 9AG
Summary. None of 34 sera from patients with gonorrhoea contained antibodies
bactericidal for strains ofNeisseria gonorrhoeae with Group-I lipopolysaccharide
(LPS). All contained antibodies against a strain with Group-II LPS, as do sera
from uninfected controls. The absence of Group I-LPS antibodies in infected
humans contrasts with previous findings that mice immunised with strains from
either of the LPS groups produced bactericidal antibody to Group I. Our hope
that detection of antibodies to Group-I strains would provide a screening test for
gonorrhoea was, therefore, not realised.
Introduction
Gonococcal isolates from uncomplicated genital infections and disseminated infections have
been divided into two broad groups based upon their pyocin-sensitivity spectrum. This
classification has been shown to correlate with interactions of strains from localised genital
infections with both humoral and phagocytic components of the human immune system.
Briefly, gonococcal strains sensitive to pyocins of Kageyama's group R5, lipopolysaccharide
(LPS) Group I, are resistant to normal human serum and they bind in lower numbers to
polymorphonuclear leukocytes than strains of Group II (Blackwell et al.. 1983). This second
group is sensitive to pyocins of Kageyama's group R1 in addition to R5 and strains of this group
are killed by the majority of normal human sera tested (Kageyama, 1975; Blackwell. Young and
Anderson, 1979; Winstanley et al., 1983). Strains of Group II are thought to have extra LPS
components, absent or cryptic in strains ofGroup I, to which there are bactericidal antibodies in
the majority of normal human sera (Schneider et al., 1982; Winstanley et al., 1983).
Earlier studies revealed that specific antisera raised in mice against strains of Group I or II
were bactericidal for other strains of the homologous group. They were also active against
strains of the heterologous group (Winstanley et al., 1983). In that study we also screened sera
from a control population of women attending a postnatal clinic for bactericidal antibodies to
both groups of gonococci. Antibodies against Group II only were found. This is a population
in which there is a very low incidence of gonorrhoea. We have now screened sera from
individuals with gonorrhoea for bactericidal activity against strains of LPS Groups I and II.
Our hypothesis was that individuals exposed to or infected with N. gonorrhoeae would, like the
mouse model, have antibodies to both groups and that detection of bactericidal activity for
Group I might be used as a serological screening test for gonococcal infection.
Materials and methods
Bacteria. Strains of LPS Group I (E757 and M9131) and Group II (P280) were isolated
from patients attending the Department of Genitourinary Medicine, Royal Infirmary,
Edinburgh. All were from localised genital infections (Winstanley et al., 1983). They were
Received 5 Sep. 1983; revised version accepted 2 Dec. 1983.
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cultivated on Modified New York City Medium (MNYC) (Young, 1978) at 37°C in a humidified
atmosphere enriched with 10% CO2.
Assay for bactericidal antibodies. Bactericidal tests were performed as described by
Winstanley et al. (1983) and as outlined below.
Sera taken for syphilis serology from patients attending the Department of Genitourinary
Medicine were obtained from Dr H. Young, STD Diagnostic Laboratory, Department of
Bacteriology, University of Edinburgh. Human AB serum from a donor with no history of
gonococcal infection was used as the source of complement. It was absorbed for 24 h at 4°C
with a live suspension of the gonococcal strains used in the study, in order to remove
cross-reacting antibodies, and was distributed in 200-/d portions and stored at — 20°C before
use. The haemolytic titre of this complement source was 32-64. An 18-h culture of each
gonococcal strain was diluted in Dulbecco's phosphate buffered saline, supplemented with
Mg++ and Ca++ ions (0-5mmol and 0-9mmol respectively), to give c. 104 cfu/ml. Twofold
dilutions (50/d) of the sera to be tested were made in microtitre plates and to each was added 40/(1
of the gonococcal suspension and 10/d of the human complement source. After incubation at
37°C for 30 min. the numbers ofviable organisms in each well were determined by culturing three
20-/d drops from each on MNYC. The bactericidal titre of a serum was the highest dilution that
caused a reduction in viable count of 80%, compared with that of a control to which no
complement was added.
Results
The titres of bactericidal antibody in sera from 22 patients with gonorrhoea against strains
E757 (Group I) and P280 (Group II), are shown in the table. Similar results were obtained with
a second set of 37 sera from the STD Diagnostic Laboratory; the patients' diagnoses were not
known at the time the sera were tested. They were screened for bactericidal activity against
strain P280 and Group-I strain M9131. Amongst these sera, 12 were from patients with
gonococcal infection and 25 from patients from whom no neisseriae were isolated. There were
no differences in titres of bactericidal antibodies to strain M9131 between sera from the infected
Table. Titres of bactericidal antibody against gonococcal strains E757 (Group I) and P280
(Group II) in sera from patients with gonorrhoea.
Titre of antibody
to strain
Patient No. E757 P280
1 <4 > 128











13 <4 > 128






20 <4 > 128
21 4 > 128
22 <4 >128
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and uninfected patients; titres were < 4. The titres to strain P280 were similar to those recorded
in the table.
Discussion
The absence or extremely low titres of bactericidal antibodies against strains M9131 and
E757 in sera from patients with gonorrhoea refutes our hypothesis, based on results obtained
with immune mouse sera (Winstanley et al., 1983), that infection with N. gonorrhoeae in man
would result in the production of antibodies bactericidal for strains of Group I. This failure
may result from the stimulation by Group-I antigens of antibodies of classes that do not activate
the classical complement pathway, e.g., classes IgA and IgG4, or by failure of the human
immune system to respond to antigens of the gonococcal LPS associated with the binding site for
R5 pyocins.
It has been suggested recently that susceptibility and resistance to gonorrhoea of a group of
Chinese prostitutes was associated with differences in the major histocompatibility complex
genes. The HLA "haplotype" A11, B15 appeared to be associated with resistance to the disease
amongst these women who were at very high risk of exposure to infection (Chan and Rajan,
1982). Similarly, the ability to respond immunologically to LPS antigens associated with the
binding site of R5 pyocins might depend upon the genetic constitution of the individual.
Bactericidal antibody is an important host defence that prevents the dissemination of
gonococci from the mucosa (Brooks, Ingwer and Peterson, 1978). The majority (c. 85%) of
gonococcal strains isolated from localised genital infection are of Group II (Winstanley et al.,
1983) and are thought to be prevented from dissemination by "natural" bactericidal antibodies
and complement. Strains ofGroup 1, however, being resistant to normal human serum, have a
greater predisposition to cause bacteraemia; they are isolated from approximately 42% of
disseminated infections (Winstanley et al., 1983).
The apparent inability of man to produce antibodies bactericidal for gonococcal strains of
Group I may be a host factor that retards recovery from disseminated gonococcal infection and
it may also pose difficulties in the immunoprophylaxis of gonorrhoea. These results indicate
that, like other attempts to identify antibodies against gonococcal LPS (Ward and Glynn, 1971
and 1972; Watt, Ward and Glynn, 1971; Maeland and Matre, 1975), screening of sera for
bactericidal activity against LPS-group-I strains will not be of use as a diagnostic test.
We are grateful to Dr H. Young and the staff of the Serology Laboratory, Department of
Bacteriology, for supplying us with sera and to Mrs M. Cole for help in preparation of the
manuscript. The work was supported by grants G81/103811/SB and G979/64/S from the
Medical Research Council. Mr D.F. Kinane was a recipient of the Davidson Research
Fellowship, Faculty of Medicine, University of Edinburgh.
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